
<html lang="en"     class="pb-page"  data-request-id="a8ee0dfd-2915-4799-b8cc-9b96da5c3fb5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.9b00335;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-12"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure–Activity Relationships" /></meta><meta name="dc.Creator" content="Leo  Leung" /></meta><meta name="dc.Creator" content="Dan  Niculescu-Duvaz" /></meta><meta name="dc.Creator" content="Deborah  Smithen" /></meta><meta name="dc.Creator" content="Filipa  Lopes" /></meta><meta name="dc.Creator" content="Cedric  Callens" /></meta><meta name="dc.Creator" content="Robert  McLeary" /></meta><meta name="dc.Creator" content="Grazia  Saturno" /></meta><meta name="dc.Creator" content="Lawrence  Davies" /></meta><meta name="dc.Creator" content="Mohammed  Aljarah" /></meta><meta name="dc.Creator" content="Michael  Brown" /></meta><meta name="dc.Creator" content="Louise  Johnson" /></meta><meta name="dc.Creator" content="Alfonso  Zambon" /></meta><meta name="dc.Creator" content="Tim  Chambers" /></meta><meta name="dc.Creator" content="Delphine  Ménard" /></meta><meta name="dc.Creator" content="Natasha  Bayliss" /></meta><meta name="dc.Creator" content="Ruth  Knight" /></meta><meta name="dc.Creator" content="Laura  Fish" /></meta><meta name="dc.Creator" content="Rae  Lawrence" /></meta><meta name="dc.Creator" content="Mairi  Challinor" /></meta><meta name="dc.Creator" content="HaoRan  Tang" /></meta><meta name="dc.Creator" content="Richard  Marais" /></meta><meta name="dc.Creator" content="Caroline  Springer" /></meta><meta name="dc.Description" content="Lysyl oxidase (LOX) is a secreted copper-dependent amine oxidase that cross-links collagens and elastin in the extracellular matrix and is a critical mediator of tumor growth and metastatic spread...." /></meta><meta name="Description" content="Lysyl oxidase (LOX) is a secreted copper-dependent amine oxidase that cross-links collagens and elastin in the extracellular matrix and is a critical mediator of tumor growth and metastatic spread...." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 9, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00335" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00335" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00335" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00335" /></link>
        
    
    

<title>Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure–Activity Relationships | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00335" /></meta><meta property="og:title" content="Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure–Activity Relationships" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0033.jpeg" /></meta><meta property="og:description" content="Lysyl oxidase (LOX) is a secreted copper-dependent amine oxidase that cross-links collagens and elastin in the extracellular matrix and is a critical mediator of tumor growth and metastatic spread. LOX is a target for cancer therapy, and thus the search for therapeutic agents against LOX has been widely sought. We report herein the medicinal chemistry discovery of a series of LOX inhibitors bearing an aminomethylenethiophene (AMT) scaffold. High-throughput screening provided the initial hits. Structure–activity relationship (SAR) studies led to the discovery of AMT inhibitors with sub-micromolar half-maximal inhibitory concentrations (IC50) in a LOX enzyme activity assay. Further SAR optimization yielded the orally bioavailable LOX inhibitor CCT365623 with good anti-LOX potency, selectivity, pharmacokinetic properties, as well as anti-metastatic efficacy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00335"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00335">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00335&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00335&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00335&amp;href=/doi/10.1021/acs.jmedchem.9b00335" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5863-5884</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00255" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00517" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure–Activity Relationships</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Leo Leung</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leo Leung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leo++Leung">Leo Leung</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6537-6178" title="Orcid link">http://orcid.org/0000-0002-6537-6178</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dan Niculescu-Duvaz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dan Niculescu-Duvaz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Niculescu-Duvaz">Dan Niculescu-Duvaz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deborah Smithen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deborah Smithen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deborah++Smithen">Deborah Smithen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Filipa Lopes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Filipa Lopes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Filipa++Lopes">Filipa Lopes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cedric Callens</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cedric Callens</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cedric++Callens">Cedric Callens</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert McLeary</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert McLeary</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++McLeary">Robert McLeary</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Grazia Saturno</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Grazia Saturno</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Oncology Team, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Grazia++Saturno">Grazia Saturno</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lawrence Davies</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lawrence Davies</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence++Davies">Lawrence Davies</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mohammed Aljarah</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mohammed Aljarah</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mohammed++Aljarah">Mohammed Aljarah</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Brown</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Brown</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Brown">Michael Brown</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Louise Johnson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Louise Johnson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Louise++Johnson">Louise Johnson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alfonso Zambon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alfonso Zambon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alfonso++Zambon">Alfonso Zambon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tim Chambers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tim Chambers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Oncology Team, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tim++Chambers">Tim Chambers</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Delphine Ménard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Delphine Ménard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Delphine++M%C3%A9nard">Delphine Ménard</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Natasha Bayliss</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Natasha Bayliss</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Natasha++Bayliss">Natasha Bayliss</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruth Knight</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruth Knight</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruth++Knight">Ruth Knight</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura Fish</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura Fish</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Fish">Laura Fish</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rae Lawrence</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rae Lawrence</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rae++Lawrence">Rae Lawrence</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mairi Challinor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mairi Challinor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mairi++Challinor">Mairi Challinor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">HaoRan Tang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">HaoRan Tang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Oncology Team, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=HaoRan++Tang">HaoRan Tang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard Marais</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard Marais</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular Oncology Team, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Marais">Richard Marais</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Caroline Springer</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Caroline Springer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</div><div class="loa-info-affiliations-info">Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#06656774696a6f6863287576746f68616374466574736d286b6768656e637572637428676528736d"><span class="__cf_email__" data-cfemail="0d6e6c7f6261646368237e7d7f64636a687f4d6e7f786623606c636e65687e79687f236c6e237866">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Caroline++Springer">Caroline Springer</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00335&amp;href=/doi/10.1021%2Facs.jmedchem.9b00335" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5863–5884</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 9, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 February 2019</li><li><span class="item_label"><b>Published</b> online</span>9 May 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 June 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00335" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00335</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00335"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3255</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00335" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure–Activity Relationships&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Leo&quot;,&quot;last_name&quot;:&quot;Leung&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Niculescu-Duvaz&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;Smithen&quot;},{&quot;first_name&quot;:&quot;Filipa&quot;,&quot;last_name&quot;:&quot;Lopes&quot;},{&quot;first_name&quot;:&quot;Cedric&quot;,&quot;last_name&quot;:&quot;Callens&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;McLeary&quot;},{&quot;first_name&quot;:&quot;Grazia&quot;,&quot;last_name&quot;:&quot;Saturno&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;Davies&quot;},{&quot;first_name&quot;:&quot;Mohammed&quot;,&quot;last_name&quot;:&quot;Aljarah&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Brown&quot;},{&quot;first_name&quot;:&quot;Louise&quot;,&quot;last_name&quot;:&quot;Johnson&quot;},{&quot;first_name&quot;:&quot;Alfonso&quot;,&quot;last_name&quot;:&quot;Zambon&quot;},{&quot;first_name&quot;:&quot;Tim&quot;,&quot;last_name&quot;:&quot;Chambers&quot;},{&quot;first_name&quot;:&quot;Delphine&quot;,&quot;last_name&quot;:&quot;Ménard&quot;},{&quot;first_name&quot;:&quot;Natasha&quot;,&quot;last_name&quot;:&quot;Bayliss&quot;},{&quot;first_name&quot;:&quot;Ruth&quot;,&quot;last_name&quot;:&quot;Knight&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Fish&quot;},{&quot;first_name&quot;:&quot;Rae&quot;,&quot;last_name&quot;:&quot;Lawrence&quot;},{&quot;first_name&quot;:&quot;Mairi&quot;,&quot;last_name&quot;:&quot;Challinor&quot;},{&quot;first_name&quot;:&quot;HaoRan&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Marais&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;Springer&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5863-5884&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00335&quot;},&quot;abstract&quot;:&quot;Lysyl oxidase (LOX) is a secreted copper-dependent amine oxidase that cross-links collagens and elastin in the extracellular matrix and is a critical mediator of tumor growth and metastatic spread. LOX is a target for cancer therapy, and thus the search for therapeutic agents against LOX has been widely sought. We report herein the medicinal chemistry discovery of a series of LOX inhibitors bearing an aminomethylenethiophene (AMT) scaffold. High-throughput screening provided the initial hits. Structure–activity relationship (SAR) studies led to the discovery of AMT inhibitors with sub-micromolar half-maximal inhibitory concentrations (IC50) in a LOX enzyme activity assay. Further SAR optimization yielded the orally bioavailable LOX inhibitor CCT365623 with good anti-LOX potency, selectivity, pharmacokinetic properties, as well as anti-metastatic efficacy.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00335&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00335" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00335&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00335" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00335&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00335" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00335&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00335&amp;href=/doi/10.1021/acs.jmedchem.9b00335" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00335" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00335" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00335%26sid%3Dliteratum%253Aachs%26pmid%3D31070916%26genre%3Darticle%26aulast%3DLeung%26date%3D2019%26atitle%3DAnti-metastatic%2BInhibitors%2Bof%2BLysyl%2BOxidase%2B%2528LOX%2529%253A%2BDesign%2Band%2BStructure%25E2%2580%2593Activity%2BRelationships%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D12%26spage%3D5863%26epage%3D5884%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=292234" title="Chromatography">Chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292017" title="Solvents">Solvents</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/jmcmar.2019.62.issue-12/20190627/jmcmar.2019.62.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0033.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Lysyl oxidase (LOX) is a secreted copper-dependent amine oxidase that cross-links collagens and elastin in the extracellular matrix and is a critical mediator of tumor growth and metastatic spread. LOX is a target for cancer therapy, and thus the search for therapeutic agents against LOX has been widely sought. We report herein the medicinal chemistry discovery of a series of LOX inhibitors bearing an aminomethylenethiophene (AMT) scaffold. High-throughput screening provided the initial hits. Structure–activity relationship (SAR) studies led to the discovery of AMT inhibitors with sub-micromolar half-maximal inhibitory concentrations (IC<sub>50</sub>) in a LOX enzyme activity assay. Further SAR optimization yielded the orally bioavailable LOX inhibitor <b>CCT365623</b> with good anti-LOX potency, selectivity, pharmacokinetic properties, as well as anti-metastatic efficacy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41525" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Lysyl oxidase (LOX) and its family members LOX-like (LOX-L) 1–4 are copper-dependent amine oxidases that covalently cross-link collagens and elastin in the tumor extracellular matrix.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> LOX is secreted as a catalytically inactive 50 kDa pro-protein, which is cleaved to an active 32 kDa enzyme by proteases such as procollagen C-proteinase. LOX and LOXL1–4 have variable N-termini, and they share a highly conserved C-terminus, where the catalytic domain is located. The catalytic site comprises a copper binding motif and a covalently bound lysine tyrosylquinone (LTQ) cofactor, where peptidyl lysine residues (H<sub>2</sub>NCH<sub>2</sub>R) are converted to the corresponding α-aminoadipic-δ-semialdehyde (O═CHR) in an oxidative deamination reaction.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The newly formed aldehyde residues undergo spontaneous cross-linking with adjacent nucleophilic functionalities, leading to the insoluble extracellular protein matrices.</div><div class="NLM_p">LOX and LOXL2 also have important roles in promoting tumor growth in many types of cancer.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12">(5−12)</a> In particular, LOX has been demonstrated to be a critical mediator of cancer metastasis.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Therapeutic agents targeting the activity of LOX are thus proposed as cancer treatments, especially against metastasis where no effective therapeutic methods are currently available.</div><div class="NLM_p">Until recently, no druglike small molecule inhibitors of LOX itself have been reported. Noticeably, the irreversible inhibitor β-aminopropionitrile<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> (BAPN) has found widespread applications in LOX-family-related biological studies (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), although the lack of amenable sites for chemical modification has prevented its development into a clinically optimal drug. More recently, haloallylamine-based inhibitors PXS-S1A and PXS-S2A (full structures not disclosed)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and trifluoromethyl (CF<sub>3</sub>)-substituted aminomethylene-pyridine <b>1</b> were reported to be potent selective inhibitors of one of the family members, LOXL2; the latter also showed weak inhibition against LOX.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> Intriguingly, analogues of pyridine <b>1</b> without the CF<sub>3</sub> functionality were less selective toward LOXL2, with low micromolar IC<sub>50</sub>s against LOX.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0001.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Small molecule inhibitors of LOX-family enzymes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We have recently reported the elucidation of a mechanism by which LOX drives tumor progression in breast cancer<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and that treatment with the aminomethylenethiophene (AMT) inhibitor <b>CCT365623</b> (<b>9f</b>) led to significant reduction in tumor growth and, importantly, in metastatic burden too, in a LOX-dependent breast tumor transgenic mouse model. In our current study, we present the medicinal chemistry development leading to the discovery of the orally efficacious AMT inhibitor <b>9f</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85147" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85147" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> LOX Inhibition, Initial SAR</h3><div class="NLM_p">We ran a high-throughput screen (HTS) at Evotec, of 267 000 diverse compounds and 5000 fragments, on LOX, which yielded a hit rate of 0.4%. (5-(Piperidin-1-ylsulfonyl)thiophen-2-yl)methanamine <b>2a</b> was identified as a positive hit with a mean IC<sub>50</sub> of 19 μM. Since no crystal structure of LOX is available, the design of inhibitors could not be aided by crystallographic or in silico methods. Therefore, the SAR of enzyme inhibition is largely elucidated by introducing systematic modifications to different regions of the hit molecule.</div><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5"> Substitutions at the 5-Sulfonyl Linker, Sulfonamides</h4><div class="NLM_p">SAR exploration commenced with the investigation of sulfonamide substitutions on LOX inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Acyclic sulfonamides show no improvement (<b>2b</b> and <b>2c</b> vs <b>2a</b>), whereas 2-amido- and 2-hydroxymethylpyrrolidine substitutions exhibit comparable or better LOX potencies (<b>2d</b> and <b>2e</b> vs <b>2a</b>). 2-Phenylpyrrolidine <b>2f</b> is also effective against LOX, as is the bicyclic indoline <b>2g</b>, which is ∼10-fold more potent than the piperidine hit <b>2a</b>. Similarly, tetrahydroquinoline <b>2h</b> is equipotent to indoline <b>2g</b>. Replacement of the piperidine ring with morpholine does not improve LOX inhibition (<b>2i</b> vs <b>2a</b>), whereas homopiperazine (<b>2j</b>) substitution leads to ∼2-fold improvement in IC<sub>50</sub>. Functionalization of the free homopiperazine nitrogen with small groups leads to gains in potency compared with the initial hit, as exemplified in <i>N</i>-methyl analogue <b>2k</b>, ethyl urea <b>2l</b> and, in particular, sulfonamide <b>2m</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effects of Sulfonamide Substitution on LOX Potency</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0019.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0020.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Reported IC<sub>50</sub> values were determined in at least two separate experiments (<i>n</i> ≥ 2). When <i>n</i> = 2, individual IC<sub>50</sub> values are shown. When <i>n</i> > 2, the values are reported as the geometric mean with the error in square brackets expressed as the 95% confidence interval of the geometric mean.</p></div></div><div></div></div></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Substitution at the 5-Sulfonyl Linker, Sulfones</h4><div class="NLM_p">The effect of alkyl and aryl substitutions at the 5-sulfonyl linker on LOX inhibition was investigated next (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Replacements of the piperidine moiety on HTS hit <b>2a</b> with cyclohexyl (<b>3a</b>) and phenyl groups (<b>3b</b>) are beneficial, as are pyridine (<b>3c</b>) and thiophene (<b>3d</b>). Biphenylsulfone is a weaker inhibitor than the phenyl analogue (<b>3e</b> vs <b>3b</b>), whereas 2-naphthalylsulfone <b>3g</b> is more potent than the 1-regiosiomer <b>3f</b>. Methanesulfonamido-phenyl analogue <b>3h</b> moderately inhibits LOX, whereas methanesulfonylphenyl sulfone <b>3i</b> is an excellent LOX inhibitor with an IC<sub>50</sub> of 0.26 μM, ∼70-fold more potent than the HTS hit <b>2a</b>. Replacement of the phenyl moiety of inhibitor <b>3i</b> with an alkyl group (<b>3j</b>) leads to a reduction in potency. The SAR data illustrate that the attachment of cyclic alkyl or aryl groups to the sulfonyl linker greatly improves LOX potency and the inhibitory effect is further enhanced by the addition of a second sulfonyl group.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effects of Sulfonyl-Alkyl and -Aryl Substitutions on LOX Potency</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0021.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0022.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Reported IC<sub>50</sub> values were determined in at least two separate experiments (<i>n</i> ≥ 2). When <i>n</i> = 2, individual IC<sub>50</sub> values are shown. When <i>n</i> > 2, the values are reported as the geometric mean with the error in square brackets expressed as the 95% confidence interval of the geometric mean.</p></div></div><div></div></div></div><div id="sec2_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Modification of the 5-Sulfonyl Linker</h4><div class="NLM_p">The impact of the sulfonyl linker was subsequently examined (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). A noticeable correlation can be observed between the electron-withdrawing ability of the linker and the LOX IC<sub>50</sub>, with the most electron-withdrawing sulfonyl group achieving the most potent inhibition (LOX IC<sub>50</sub>: <b>3b</b> < <b>4a</b> < <b>4b</b>). Carboxamide substitution does not improve LOX inhibition (<b>4d</b> vs <b>4c</b>). Finally, exchanging the sulfonyl linker and the phenyl ring leads to reduction in potency (<b>4e</b> vs <b>3b</b>). It is thus apparent that the sulfonyl moiety is the optimum linker for the AMT core and that the electron-withdrawing effect of the linker is likely to play an important role in the mechanism of inhibition even though the possibility of H-bond and dipole–dipole interactions cannot be ruled out.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of Sulfonyl Linker (X) Modification on LOX Potency</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0023.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0024.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Reported IC<sub>50</sub> values were determined in at least two separate experiments (<i>n</i> ≥ 2). When <i>n</i> = 2, individual IC<sub>50</sub> values are shown. When <i>n</i> > 2, the values are reported as the geometric mean with the error in square brackets expressed as the 95% confidence interval of the geometric mean.</p></div></div><div></div></div></div><div id="sec2_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Modification of the Thiophene Ring</h4><div class="NLM_p">Aminomethylene-pyridine <b>5a</b> is ∼10-fold weaker than the aminomethylenethiophene counterpart (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>; <b>5a</b> vs <b>5b</b>). 1,4-Thiazole <b>5c</b> is considerably less potent as an inhibitor than the 1,3-regiomer <b>5d</b>, whereas 1,3-thiazole <b>5d</b> demonstrates potency that is similar to the thiophene <b>3g</b>. Furan replacement does not improve the effectiveness of the inhibitors (<b>5e</b> vs <b>4d</b>). Additional substitutions on the thiophene ring can potentially be a useful handle for the development of the series, but the introduction of a small methyl group is highly unfavorable (<b>5f</b> vs <b>2g</b>). Overall, although the replacements of the thiophene core with some unsubstituted 5-membered heterocycles are tolerated for LOX inhibition, they are not superior to thiophene itself.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effects of Thiophene Modifications on LOX Potency</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0025.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Reported IC<sub>50</sub> values were determined in at least two separate experiments (<i>n</i> ≥ 2). When <i>n</i> = 2, individual IC<sub>50</sub> values are shown. When <i>n</i> > 2, the values are reported as the geometric mean with the error in square brackets expressed as the 95% confidence interval of the geometric mean.</p></div></div><div></div></div></div><div id="sec2_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Modification of the Aminomethylene Moiety</h4><div class="NLM_p">All inhibitors contain the aminomethylene moiety (H<sub>2</sub>NCH<sub>2</sub>), which forms a part of the core AMT scaffold. We therefore investigate a series of modifications to this group where the replacement moieties are sufficiently diverse for probing noncovalent interactions, such as H-bond, electrostatic, and dipolar interactions, while small enough to minimize unfavorable steric clashes. The SAR data reveals that all substitutions or modifications at this site result in total loss of activity (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, <b>6a</b>–<b>6f</b>). It is thus apparent that the aminomethylene moiety has a unique role in LOX inhibition; it is likely to be involved in the formation of a Schiff base similar to that of the natural lysyl substrates.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effects of Aminomethylene Modifications (R<sup>1</sup>) on LOX Potency</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0026.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0027.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Reported IC<sub>50</sub> values were determined in at least two separate experiments (<i>n</i> ≥ 2). When <i>n</i> = 2, individual IC<sub>50</sub> values are shown. When <i>n</i> > 2, the values are reported as the geometric mean with the error in square brackets expressed as the 95% confidence interval of the geometric mean.</p></div></div><div></div></div><div class="NLM_p">Next, regiosiomers on the thiophene ring were investigated (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Both 2-aminomethyl-3-sulfonyl-thiophene <b>7a</b> and 3-aminomethyl-4-sulfonylthiophene <b>7b</b> show no inhibitory activity against LOX, whereas 2-aminomethyl-4-sulfonylthiophene <b>7c</b> is a weak inhibitor. Therefore, from these modifications, the thiophene ring is the optimal ring type and the aminomethylene and sulfonyl groups are the most effective substituents when placed on the 2- and 5-positions of the ring, respectively.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Effects of Regioisomers on the Thiophene Ring on LOX Potency</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0028.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Reported IC<sub>50</sub> values were determined in at least two separate experiments (<i>n</i> ≥ 2). When <i>n</i> = 2, individual IC<sub>50</sub> values are shown. When <i>n</i> > 2, the values are reported as the geometric mean with the error in square brackets expressed as the 95% confidence interval of the geometric mean.</p></div></div><div></div></div><div class="NLM_p">Although the exact mode of binding of these AMT inhibitors remains unclear due to the absence of a cocrystal structure or a homology model, the observed SAR suggests that a stable Schiff base formed from the inhibitor and the LTQ cofactor (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) is likely to be involved. Although the formation of the Schiff base is reversible, its stabilization by the sulfonyl substituent on the thiophene ring by resonance stabilization and/or direct binding to the enzyme by noncovalent processes, such as H-bonding, electrostatic, dipolar, or van der Waals interactions, can lead to a tightly bound enzyme–inhibitor complex. This can potentially rationalize the improvement in potency observed in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. The SAR also suggests an additional noncovalent interaction between the methanesulfonylphenyl moiety and the enzyme, which further enhances the potency of bis-sulfonyl inhibitors such as compound <b>9f</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0002.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed binding mode of AMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Optimization toward In Vivo-Compatible Inhibitors</h3><div class="NLM_p">As our aim is to discover LOX inhibitors that can be administered orally, metabolic stability and pharmacokinetic (PK) studies were performed on the most promising AMT inhibitors described above. The highly potent bis-sulfonylphenyl analogue <b>3i</b> has good stability against mouse microsomal (MLM) degradation (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>), but its poor detectability by mass spectrometry renders it unsuitable for in vivo studies. Bis-sulfonylhomopiperazine <b>2m</b> also exhibits good anti-LOX potency, but it cannot be progressed further due to poor stability against microsomal metabolism. Naphthalenesulfone <b>3g</b> demonstrates good MLM stability but only moderate plasma exposure (AUC = 4.2 μM h) when administered orally in mice at 50 mg/kg. It was apparent that further medicinal chemistry development was necessary to achieve both potent LOX inhibition and oral plasma drug exposure compatible with in vivo studies.</div><div class="NLM_p">Due to its superior LOX potency and ease of synthesis, inhibitor <b>3i</b> was chosen as the platform for the next phase of discovery. Initial SAR established that modifications of the aminomethylene group, the thiophene ring, and the sulfonyl linker were unfavorable to target inhibition. Therefore, optimization to improve PK properties focused on the aryl ring and its side-chain substituents. The aim of the subsequent studies therefore targeted improvement to oral in vivo PK exposure whilst maintaining/improving LOX potency.</div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Side-Chain Substitutions</h4><div class="NLM_p">Further SAR studies began with the investigation of the sulfonyl side-chain substitutions (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). The attachment of the sulfonyl side chain through the 3-position (with respect to the thiophene sulfone) affords inhibitors with similar LOX IC<sub>50</sub>s as the 4-regioisomers (<b>8a</b> vs <b>3i</b>, <b>8d</b> vs <b>8c</b>), whilst 2-substitution is disfavored (<b>8b</b> vs <b>3i</b>). Sulfonylpyrrolidines exhibit similar potencies as the methyl sulfone counterparts (<b>8c</b>–<b>8e</b> vs <b>3i</b> and <b>8a</b>), but phenyl sulfone <b>8f</b> is a weaker inhibitor. Small alkyl substituents on the sulfonyl group are generally well tolerated (<b>8g</b>–<b>8k</b>). Inhibitors <b>8d</b>, <b>8e</b>, and <b>8j</b> show good anti-LOX potency and MLM stability (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>) and were thus selected for in vivo PK evaluation. Unfortunately, they have poor plasma exposure in mice when dosed orally.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Effects of Side-Chain Substitutions on LOX Potency of Phenylsulfonyl-AMT Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0029.gif" alt="" id="fx11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0030.gif" alt="" id="fx12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Reported IC<sub>50</sub> values were determined in at least two separate experiments (<i>n</i> ≥ 2). When <i>n</i> = 2, individual IC<sub>50</sub> values are shown. When <i>n</i> > 2, the values are reported as the geometric mean with the error in square brackets expressed as the 95% confidence interval.</p></div></div><div></div></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Phenyl Ring Substitution</h4><div class="NLM_p">1,3- and 1,4-Bis-sulfonylphenyl-AMT inhibitors containing an additional substituent on the 5-position of the phenyl ring were evaluated against LOX inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). All of <i>tert</i>-butyl, <i>tert</i>-butoxy, trimethylsilylethynyl, <i>N</i>-methylpyrazolyl, and pyridinyl substitutions on the 1,3-bisulfonylphenyl motif lead to moderate reduction in LOX potency (<b>9a</b>–<b>9e</b> vs <b>8a</b>), whereas a phenyl substituent is well tolerated (<b>9f</b>). Replacement of the phenyl group with <i>p</i>-tolyl affords an equipotent LOX inhibitor (<b>9g</b> vs <b>9f</b>), but <i>m</i>-xylyl (<b>9h</b>) and <i>o</i>-ethylphenyl (<b>9i</b>) substitutions are disfavored. For the 1,4-bis-sulfonylphenyl-AMT motif, all of the <i>N</i>-methylpyrazolyl (<b>9j</b>), phenyl (<b>9k</b>), and <i>p</i>-tolyl (<b>9l</b>) analogues exhibit sub-micromolar LOX IC<sub>50</sub> values.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Effects of 5-Substitutions on LOX Potency of Bis-sulfonylphenyl-AMT Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0031.gif" alt="" id="fx13" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0032.gif" alt="" id="fx14" /></img><div></div></div><div class="NLM_p">In vivo mouse PK studies were then conducted for selected 5-substituted compounds. Both <i>tert</i>-butoxy (<b>9b</b>) and <i>N</i>-methylpyrazolyl (<b>9j</b>) analogues exhibit low AUCs of 2.3 and 2.8 μM h, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>), although this improves to 6.5 μM h when the oxygen atom of the <i>tert</i>-butoxy group is removed from the parent compound (<b>9a</b> vs <b>9b</b>). Pleasingly, the 5-<i>p</i>-tolyl-substituted bis-sulfones have greatly improved and therapeutically relevant plasma exposures (11 and 12 μM h for <b>9g</b> and <b>9l</b> respectively) are obtained. Although the exposure for 5-phenyl-1,4-bis-sulfone <b>9k</b> is disappointing (AUC = 1.4 μM h), 5-phenyl-1,3-bis-sulfonyl-AMT <b>9f</b> achieves a desirable in vivo PK profile, with the highest AUC, <i>C</i><sub>max</sub>, longest half-life, lowest clearance of the series (albeit this is still moderate), and a respectable intermediate oral bioavailability (<i>F</i>) of 45%.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. In Vitro Mouse Liver Microsome (MLM) Stability and in Vivo Pharmacokinetic (PK) Properties of AMT Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">MLM stability (%)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max(PO)</sub> (μM)<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">AUC<sub>(PO)</sub> (μM h)<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>(IV)</sub> (mL/(min kg))<a class="ref internalNav" href="#t9fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2(IV)</sub> (h)<a class="ref internalNav" href="#t9fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)<a class="ref internalNav" href="#t9fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2m</b></td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3i</b></td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8j</b></td><td class="colsep0 rowsep0" align="char" char=".">91</td><td class="colsep0 rowsep0" align="left">0.38</td><td class="colsep0 rowsep0" align="left">0.36</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8e</b></td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.46</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9k</b></td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9j</b></td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3g</b></td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="char" char=".">68</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9g</b></td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9l</b></td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="left">9.4</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="char" char=".">106</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="char" char=".">65</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">45</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Mouse liver microsome (MLM) stability values represent the percentage of compound remaining after 30 min; mouse plasma PK parameters were determined following a single dose by oral gavage (PO) or intravenous injection (IV) at 50 or 10 mg/kg, respectively.</p></div><div class="footnote" id="t9fn2"><sup><sup>b</sup></sup><p class="last"><i>C</i><sub>max</sub>: maximum concentration.</p></div><div class="footnote" id="t9fn3"><sup><sup>c</sup></sup><p class="last">AUC: area under curve.</p></div><div class="footnote" id="t9fn4"><sup><sup>d</sup></sup><p class="last">CL: clearance.</p></div><div class="footnote" id="t9fn5"><sup><sup>e</sup></sup><p class="last"><i>t</i><sub>1/2</sub>: half-life.</p></div><div class="footnote" id="t9fn6"><sup><sup>f</sup></sup><p class="last"><i>F</i>: bioavailability; ND: could not be detected by MS.</p></div></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Profile of Orally Available AMT Inhibitors</h3><div class="NLM_p">We have discovered three AMT inhibitors <b>9g</b>, <b>9l</b>, and <b>9f</b> that are highly effective in inhibiting LOX activity as well as possessing therapeutically relevant PK profiles. These compounds are equally potent inhibitors of LOXL2 (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>), which is as expected due to the highly conserved catalytic site across the LOX-family members. Pleasingly, all three inhibitors are inactive against common amine oxidases, including the copper-containing diamine oxidase (DAO), semicarbazide-sensitive amine oxidase (SSAO), and the flavin-containing monoamine oxidases (MAO) A and B. It is noteworthy that AMT <b>9f</b> is a substrate of SSAO; thus, SSAO-catalyzed metabolism could be a potential mechanism of degradation in vivo.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Potency, Selectivity, and Permeability of Optimized AMT Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">Caco-2 <i>P</i><sub>app</sub><a class="ref internalNav" href="#t10fn2" aria-label="b">b</a> (10<sup>–6</sup> cm/s)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">inhibitor</th><th class="colsep0 rowsep0" align="center">LOX IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">LOXL2 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">DAO IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">SSAO IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">MAO-A MAO-B IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">hERG IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">A → B</th><th class="colsep0 rowsep0" align="center" char=".">B → A</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>9g</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">1.1 [0.75, 1.62]</td><td class="colsep0 rowsep0" rowspan="2" align="left">2.0 [1.3, 3.0]</td><td class="colsep0 rowsep0" rowspan="2" align="left">>100, >100</td><td class="colsep0 rowsep0" rowspan="2" align="left">49, 59</td><td class="colsep0 rowsep0" align="left">A: >100, >100</td><td class="colsep0 rowsep0" rowspan="2" align="center" char=".">4.6</td><td class="colsep0 rowsep0" rowspan="2" align="center" char=".">8.0</td><td class="colsep0 rowsep0" rowspan="2" align="center" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B: 87, 89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>9l</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">0.76, 0.86</td><td class="colsep0 rowsep0" rowspan="2" align="left">2.2 [1.4, 3.7]</td><td class="colsep0 rowsep0" rowspan="2" align="left">>100, >100</td><td class="colsep0 rowsep0" rowspan="2" align="left">>100, 100</td><td class="colsep0 rowsep0" align="left">A: 33, 33</td><td class="colsep0 rowsep0" rowspan="2" align="center" char=".">68</td><td class="colsep0 rowsep0" rowspan="2" align="center" char=".">18</td><td class="colsep0 rowsep0" rowspan="2" align="center" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B: >100, >100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>9f</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">0.90 [0.55, 1.48]</td><td class="colsep0 rowsep0" rowspan="2" align="left">1.5 [0.28, 8.1]</td><td class="colsep0 rowsep0" rowspan="2" align="left">>100, >100</td><td class="colsep0 rowsep0" rowspan="2" align="left">48, 90</td><td class="colsep0 rowsep0" align="left">A: >100, >100</td><td class="colsep0 rowsep0" rowspan="2" align="center" char=".">25</td><td class="colsep0 rowsep0" rowspan="2" align="center" char=".">8.5</td><td class="colsep0 rowsep0" rowspan="2" align="center" char=".">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B: >100, >100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">Reported IC<sub>50</sub> values were determined in at least two separate experiments (<i>n</i> ≥ 2). When <i>n</i> = 2, individual IC<sub>50</sub> values are shown. When <i>n</i> > 2, the values are reported as the geometric mean with the error in square brackets expressed as the 95% confidence interval of the geometric mean.</p></div><div class="footnote" id="t10fn2"><sup><sup>b</sup></sup><p class="last"><i>P</i><sub>app</sub>: permeability coefficient.</p></div></div></div><div class="NLM_p last">AMT <b>9g</b> is a weak inhibitor of the human potassium-ion channel hERG, whereas inhibitors <b>9l</b> and <b>9f</b> are highly selective. All three inhibitors exhibit high permeability through colon Caco-2 cells, which is reflected in their good oral availabilities in mice (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). AMT inhibitor <b>9f</b> achieves the most favorable overall profile and was therefore chosen for in vivo efficacy studies.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Evaluation of Anti-metastatic Efficacy</h3><div class="NLM_p">Compound <b>9f</b> was assessed in a LOX-driven genetically engineered mouse model (GEMM) of breast cancer that metastasizes to the lungs.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Mice were dosed daily by oral gavage (70 mg/kg) from day 60 when primary tumors start to be palpable (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The metastatic nodules in the lungs are measured when the primary tumors reach an ethical size limit. Pleasingly, compound <b>9f</b> reduces lung metastasis significantly, as measured by the total surface area (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0003.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Anti-metastatic efficacy of compound <b>9f</b> in LOX-driven GEMM model. Animals treated with vehicle (black) or compound <b>9f</b> at 70 mg/kg qd (blue). All values are reported as the arithmetic mean with the error expressed as the standard error of the means. (<b>A</b>) Number of lung metastasis, vehicle, <i>n</i> = 7; <b>9f</b> treated, <i>n</i> = 5; (B) Lung metastasis area in μm<sup>2</sup>, vehicle, <i>n</i> = 7; <b>9f</b> treated, <i>n</i> = 5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Synthetic Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> AMT-Sulfonamides</h3><div class="NLM_p">All sulfonamide analogues were synthesized from the sulfonyl chloride intermediates <b>11a</b> and <b>11b</b> by condensation with the corresponding amines in dichloromethane (DCM) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Subsequent trifluoroacetamide hydrolysis or methanolysis using aqueous NaOH or 7 N NH<sub>3</sub> in methanol furnishes the desired amines <b>2a</b>–<b>2i</b>. 3-Methylthiophene sulfonamide <b>5f</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) was also synthesized by this method. Sulfonyl chlorides <b>11a</b> and <b>11b</b> were derived from the commercially available thiophen-2-ylmethanamines <b>10a</b>/<b>10b</b> in straightforward steps. Access to sulfonylhomopiperazine analogues with additional functionalization at the free amino group could be achieved via the amine hydrochloride intermediate <b>12</b>, where N-substituted sulfonylhomopiperazines <b>2k</b>, <b>2l</b>, and <b>2m</b> were obtained in three steps. The unsubstituted sulfonylhomopiperazine <b>2j</b> was synthesized from sulfonyl chloride <b>11a</b> by condensation with <i>N</i>-Boc-homopiperazine and trifluoroacetamide hydrolysis, followed by Boc removal.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Routes to AMT-Sulfonamide Analogues <b>2a</b>–<b>n</b> and <b>5f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFAA, Et<sub>3</sub>N, DCM, room temperature (rt); (b) ClSO<sub>3</sub>H, DCM, −78 °C to rt, then H<sub>2</sub>O; (c) oxalyl chloride, dimethylformamide (DMF), DCM, rt; (d) R<sub>2</sub>NH, Et<sub>3</sub>N, DCM, rt; (e) aq. NaOH, MeOH, rt or 7 N NH<sub>3</sub> in MeOH, rt; (f) <i>N</i>-Boc-homopiperazine, Et<sub>3</sub>N, DCM, rt; (g) 2 M HCl in Et<sub>2</sub>O, rt; (h) R′-Cl (EtNCO for <b>2l</b>), Et<sub>3</sub>N, DCM, rt.</p></p></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> AMT-Sulfones</h3><div class="NLM_p">Synthesis of 2-pyridinesulfonyl <b>3c</b> proceeded by the lithiation of 2-methylthiophene <b>14</b> followed by condensation with aldrithiol-2 to afford the corresponding sulfide, which underwent S-oxidation with mCPBA to afford sulfone <b>15</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Subsequent methyl bromination was followed by the displacement of the bromide by sodium azide to give the resulting alkyl azide, which was catalytically hydrogenated to afford the desired 2-pyridinesulfonyl-AMT <b>3c</b>. Similarly, ring opening of 1,2-dithiane with lithiated 2-methylthiophene followed by condensation with iodomethane afforded the corresponding bis-sulfide, which underwent subsequent S-oxidation to afford bis-sulfone <b>16</b>. This intermediate was subsequently converted to bis-sulfonylbutyl-AMT <b>3j</b> by the method described above.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes to AMT-Sulfone Analogues <b>3c</b> and <b>3j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i><sup>n</sup></i>BuLi, tetrahydrofuran (THF), −40 °C, then aldrithiol-2, −40 °C to rt; (b) mCPBA, DCM, rt; (c) NBS, Bz<sub>2</sub>O<sub>2</sub>, 1,2-dichloroethane (DCE), 70 °C; (d) NaN<sub>3</sub>, DMF, rt; (e) H<sub>2</sub>, Pd/C, THF, rt; (f) <i><sup>n</sup></i>BuLi, THF, −40 °C, then 1,2-dithiane, −40 °C to rt, then MeI, rt.</p></p></figure><div class="NLM_p">The commercially available 5-bromo-2-thiophenecarbonitrile <b>17a</b> (interchangeable with 5-chloro-2-thiophenecarbonitrile) and 2-bromothiazole-5-carbonitrile <b>17b</b> served as valuable building blocks for the AMT-sulfone inhibitors (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Nucleophilic aromatic substitution with a range of thiols afforded the corresponding sulfides, which were oxidized with mCPBA to afford sulfone intermediates <b>18</b>. Subsequent nitrile reduction with borane–tetrahydrofuran complex afforded AMT-sulfones <b>3a</b>, <b>3b</b>, <b>3d</b>, <b>3f</b>, <b>3g</b>, <b>3i</b>, <b>5b</b>, <b>8a</b>, <b>8b</b>, and <b>9b</b>. For sulfonylaniline <b>3h</b>, the product from the initial condensation <b>19</b> underwent an additional sulfonamide formation step. Subsequent mCPBA-mediated oxidation afforded the usual sulfone intermediate <b>18</b>, which was converted to the desired target. Analogues <b>3e</b> and <b>5c</b> were synthesized from carbamates <b>20</b>, which were derived from nitriles <b>17a</b> and <b>17b</b>, respectively, by condensation with the corresponding thiols, followed by nitrile reduction and subsequent Boc protection.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes to AMT-sulfone Analogues <b>3a</b>, <b>3b</b>, <b>3d</b>–<b>3i</b>, <b>5b</b>, <b>5c</b>, <b>8a</b>, <b>8b</b>, and <b>9b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) RSH, K<sub>2</sub>CO<sub>3</sub>, DMF, heat; (b) mCPBA, DCM, rt; (c) BH<sub>3</sub>·THF, THF, rt; (d) MsCl, Et<sub>3</sub>N, DCM, rt; (e) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt; (f) 4 M HCl in dioxane, rt.</p></p></figure><div class="NLM_p">Sulfonamide-substituted phenylsulfonyl-AMT analogues <b>8c</b>–<b>8e</b> were synthesized from the corresponding thiols <b>22</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Hence, condensation of 3- or 4-fluorophenylsulfonyl chloride <b>21</b> with the desired amines (HNR<sub>2</sub>) afforded the corresponding sulfonamides, which were thiolated by treatment with sodium thiomethoxide to afford intermediate thiols <b>22</b>. The thiols were condensed with 5-chloro-2-thiophene-carbonitrile to yield sulfides <b>23</b>. The nitrile group of sulfides <b>23</b> was then converted to the corresponding trifluoroacetamide by nitrile reduction and amide formation. S-oxidation of sulfides <b>24</b> and subsequent amine deprotection affords the desired AMT targets <b>8c</b>–<b>8e</b>.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to Sulfonamide-Substituted Phenylsulfonyl-AMTs <b>8c</b>–<b>8e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HNR<sub>2</sub>, DCM; (b) NaSMe, DMF, 165 °C; (c) 5-chloro-2-thiophene-carbonitrile, K<sub>2</sub>CO<sub>3</sub>, DMF, 120–130 °C; (d) BH<sub>3</sub>·THF, THF, rt; (e) TFAA, Et<sub>3</sub>N, DCM; (f) mCPBA, DCM, rt; (g) 7 N NH<sub>3</sub> in MeOH, rt.</p></p></figure><div class="NLM_p">The sulfonyl side chains of AMT analogues <b>8g</b>–<b>8k</b> were introduced through the nucleophilic substitution of the chlorine atom on intermediate <b>26</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>), which could be obtained in straightforward steps using methods previously described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Condensation of intermediate <b>26</b> with 2-mercaptoethanol or 3-mercaptopropanol followed by sulfide oxidation led to alkanol intermediates <b>27</b>. After Boc removal, these intermediates afforded AMT targets <b>8g</b> and <b>8h</b>. Alternatively, treatment of hydroxyethylsulfone <b>27</b> (<i>n</i> = 1) with methanesulfonyl chloride led to concomitant sulfonylation and elimination, furnishing vinyl sulfone <b>28</b>. Addition of pyrrolidine to vinyl sulfone <b>28</b> followed by Boc removal gives AMT target <b>8i</b>. Ammonia addition to intermediate <b>28</b> provided the corresponding aminoethyl sulfone, which was treated with acetic anhydride to afford the corresponding AMT-acetamide <b>8j</b> after Boc removal. Methoxyethylsulfone <b>8k</b> was also obtained by from vinyl sulfone <b>28</b> by methoxide addition followed by Boc removal.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Routes to Phenylsulfonyl-AMTs with Sulfonyl Side-Chain Modifications (<b>8g</b>–<b>8k</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-mercaptoethanol or 3-mercaptopropanol, K<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C; (b) mCPBA, DCM, rt (45–61% over two steps); (c) 4 M HCl in dioxane, rt; (d) MsCl, Et<sub>3</sub>N, DCM, rt (quant.); (e) pyrrolidine, DCM, rt (85% for steps e + c); (f) 7 N NH<sub>3</sub> in MeOH, rt; (g) Ac<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt; (h) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt.</p></p></figure><div class="NLM_p">Phenyl sulfide <b>29</b>, obtained from methods previously described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, underwent a Friedel–Crafts sulfonylation to afford the corresponding phenylsulfonyl (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>), which was subsequently oxidized to bis-sulfone <b>30</b> using mCPBA. Reduction of the nitrile group with borane–tetrahydrofuran complex afforded the bis-sulfonylphenyl-AMT analogue <b>8f</b>.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route to Bis-sulfonylphenyl-AMT <b>8f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PhSO<sub>2</sub>Cl, FeCl<sub>3</sub>, neat, 100 °C; (b) mCPBA, DCM, rt (c) BH<sub>3</sub>·THF, THF, rt.</p></p></figure><div class="NLM_p"><i>tert</i>-Butyl-bis-sulfonylphenyl-AMT <b>9a</b> was synthesized from 1,3-dibromo-5-(<i>tert</i>-butyl)benzene <b>31</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). <i>tert</i>-Butyllithium-mediated lithium-bromine exchange of dibromide <b>31</b> and treatment of the resultant lithium phenylate with dimethyl disulfide afforded the corresponding methyl sulfide, which was oxidized to sulfone <b>32</b> using mCPBA. This underwent Pd-catalyzed cross coupling with thiophene-2-thiol to yield the corresponding thiophene sulfide, which was formylated under Vilsmeier–Haack conditions to give aldehyde <b>33</b>. After reduction of the aldehyde with sodium borohydride and subsequent sulfide oxidation, the hydroxyl group was substituted with azide using diphenyl phosphoryl azide (DPPA) before it was subsequently reduced to the desired AMT target <b>9a</b>.</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthetic Route to <i>tert</i>-Butyl-bis-sulfonylphenyl-AMT <b>9a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i><sup>t</sup></i>BuLi, THF, −78 °C then MeSSMe, −78 °C to rt; (b) mCPBA, DCM, rt; (c) thiophene-2-thiol, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, K<sub>2</sub>CO<sub>3</sub>, <i>p</i>-xylene; 140 °C; (d) POCl<sub>3</sub>, DMF, 50 °C; (e) NaBH<sub>4</sub>, THF, rt; (f) DPPA, PPh<sub>3</sub>, diisopropyl azodicarboxylate, THF, rt; (g) H<sub>2</sub>, Pd/C, EtOH, rt.</p></p></figure><div class="NLM_p">5-Substituted 1,3-bis-sulfonylphenyl-AMTs <b>9c</b>–<b>9i</b> were synthesized from aryl bromide <b>34</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Hence, Pd-catalyzed cross coupling of aryl bromide <b>34</b> with trimethylsilylacetylene under Sonogashira conditions afforded the corresponding aryl-alkyne (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>), which was subjected to HCl-mediated Boc deprotection to afford AMT analogue <b>9c</b>. The Suzuki–Miyaura coupling with boronic acids gave the corresponding biaryl products, which underwent Boc removal to furnish the desired AMT inhibitors <b>9d</b>–<b>9i</b>.</div><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthetic Routes to Substituted Bis-sulfonylphenyl-AMTs <b>9c</b>–<b>9i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, Et<sub>3</sub>N, trimethylsilylacetylene, dioxane, rt; (b) 4 M HCl in dioxane, DCM, rt; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, RB(OR′)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C.</p></p></figure><div class="NLM_p">5-Substituted 1,4-bis-sulfonylphenyl-AMTs <b>9j</b>–<b>9l</b> were synthesized from bromofluorobenzene intermediate <b>36</b> (<a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>), which could be obtained from the commercially available 5-bromothiophene-2-carbonitrile <b>17a</b> and 3-bromo-4-fluorobenzenethiol <b>35</b> by methods previously described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Selective substitution of the fluorine atom of intermediate <b>36</b> with thiomethoxide afforded the corresponding sulfide, which was oxidized to sulfone <b>37</b> using mCPBA. The Suzuki–Miyaura coupling with boronic acids and subsequent Boc removal furnished the desired AMT inhibitors <b>9j</b>–<b>9l</b>.</div><figure id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthetic Routes to Substituted Bis-sulfonylphenyl-AMTs <b>9j</b>–<b>9l</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaSMe, DMF, rt; (b) mCPBA, DCM, rt; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, RB(OR′)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C; (d) 4 M HCl in dioxane, DCM, rt.</p></p></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> AMT-Sulfide, AMT-Sulfoxide, and Aminomethylene Modifications</h3><div class="NLM_p">AMT-sulfide <b>4b</b> and AMT-sulfoxide <b>4a</b> (<a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>) were derived from intermediate sulfide <b>29</b> (see <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>; R = Ph). Mono S-oxidation of sulfide <b>29</b> with 1 equivalent of mCPBA and subsequent nitrile reduction leads to AMT-sulfoxide <b>4a</b>. Reduction of intermediate <b>29</b> with borane–tetrahydrofuran complex, followed by Boc protection affords carbamate <b>38</b>. Removal of Boc from carbamate <b>38</b> led to AMT-sulfide <b>4b</b>, whereas <i>N</i>-methylation using sodium hydride/iodomethane and subsequent oxidation with mCPBA affords intermediate <b>39</b>, which was deprotected to afford the <i>N</i>-methyl AMT analogue <b>6a</b>. Alternatively, sulfone <b>6c</b> can be obtained from the condensation of bromothiophene <b>17a</b> and sodium benzenesulfinate in DMF. This intermediate was converted to the corresponding thiopheneacetimidamide <b>6d</b> and thiophenecarboxamide <b>6e</b> by treatment with indium trichloride (InCl<sub>3</sub>) and lithium hexamethyldisilazide (LiHMDS), respectively.</div><figure id="sch10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthetic Routes to Compounds <b>4a</b>, <b>4b</b>, <b>6a</b>, <b>6c</b>–<b>6e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) mCPBA (2 equiv), DCM, rt; (b) mCPBA (1 equiv), DCM, rt; (c) BH<sub>3</sub>·THF, THF, rt; (d) InCl<sub>3</sub>, acetaldoxime, toluene, reflux; (e) LiHMDS, Et<sub>2</sub>O, rt, then 2 M HCl, rt; (f) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt; (g) NaH, MeI, THF, rt; (h) 4 M HCl in dioxane, DCM, rt; (i) sodium benzenesulfinate, DMF, 135 °C.</p></p></figure><div class="NLM_p">Condensation of 1-(5-chlorothiophen-2-yl)ethan-1-one <b>40</b> with thiophenol afforded the corresponding sulfide (<a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>), which was oxidized to sulfone <b>41</b> using mCPBA. Subsequent oxime formation followed by reduction using zinc powder in trifluoroacetic acid furnished C-methylated AMT <b>6b</b>. Sulfide <b>42</b> was obtained in straightforward steps by methods previously illustrated in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Oxidation of sulfide <b>42</b> with mCPBA afforded the corresponding sulfone <b>43</b>. This was reduced to the corresponding aldehyde with DIBAL-H before conversion to oxime <b>6f</b> by treatment with hydroxylamine hydrochloride.</div><figure id="sch11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0014.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthetic Routes to Compounds <b>6b</b> and <b>6f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) thiophenol, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; (b) mCPBA, DCM, rt; (c) H<sub>2</sub>NOH·HCl, <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), EtOH, rt; (d) Zn, TFA, rt; (e) DIBAL-H, DCM, 45 °C; (f) H<sub>2</sub>NOH·HCl, K<sub>2</sub>CO<sub>3</sub>, EtOH, 70 °C.</p></p></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> AMT- and Aminomethylenefuran-amides</h3><div class="NLM_p">Synthesis of AMT-amide <b>4d</b> and aminomethylenefuran-amide <b>5f</b> were accomplished via methyl esters <b>44</b> (<a class="ref internalNav" href="#sch12" aria-label="Scheme 12">Scheme 12</a>; A = S or O).<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> Esters <b>44</b> first underwent saponification with aqueous hydroxide, and the resultant carboxylic acids were then converted to acid chlorides <b>45</b> using oxalyl chloride. Condensation with benzylamine in dichloromethane followed by catalytic hydrogenation using 10% Pd/C in tetrahydrofuran furnished the desired amides <b>4d</b> and <b>5e</b>.</div><figure id="sch12" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0015.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Synthetic Routes to Amide Analogues <b>4d</b> and <b>5e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1 M NaOH, MeOH, rt; (b) (COCl)<sub>2</sub>, DMF, DCM, rt; (c) benzylamine, DCM, rt; (d) H<sub>2</sub>, Pd/C, THF, rt.</p></p></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Aminomethylene-pyridine, Aminomethylene-1,3-Thiazole, and Aminomethylene-Imidazole</h3><div class="NLM_p">Aminomethylene-pyridine <b>5a</b> was obtained from the commercially available <i>tert</i>-butyl ((6-chloropyridin-3-yl)methyl)carbamate <b>46</b>. Condensation with sodium benzylthiolate afforded the corresponding sulfide <b>47</b> (<a class="ref internalNav" href="#sch13" aria-label="Scheme 13">Scheme 13</a>). Sulfide oxidation with mCPBA and subsequent HCl-mediated Boc removal furnished the desired target <b>5a</b>. 2-(Aminomethylene)-1,3-thiazole <b>5d</b> was obtained from sulfide intermediate <b>49</b> in a similar manner. Sulfide <b>49</b> was synthesized from <i>tert</i>-butyl ((5-bromothiazol-2-yl)methyl)carbamate<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a><b>48</b> and naphthalene-2-thiol by a Pd-catalyzed cross-coupling reaction.</div><figure id="sch13" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0016.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Synthetic Routes to Aminomethylene-Pyridine, Aminomethylene-Thiazole, and Aminomethylene-Imidazole <b>5a</b> and <b>5d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, benzylmercaptan, DMF, 70 °C; (b) mCPBA, DCM, rt; (c) 2 M HCl in Et<sub>2</sub>O or 4 M HCl in dioxane, rt; (d) Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, naphthalene-2-thiol, NaO<i><sup>t</sup></i>Bu, <i><sup>t</sup></i>BuOH/toluene, 100 °C.</p></p></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> AMT-Sulfone Regiosiomers</h3><div class="NLM_p">The AMT regioisomers <b>7a</b>–<b>7c</b> were synthesized by two different methods (<a class="ref internalNav" href="#sch14" aria-label="Scheme 14">Scheme 14</a>). The synthesis of 2,3-regioisomer <b>7a</b> began with nucleophilic aromatic substitution between 3-bromothiophene-2-carbonitrile <b>51</b> and naphthalene-2-thiol. The resultant sulfide underwent subsequent sulfide oxidation followed by nitrile reduction to afford the desired target <b>7a</b>. The initial nucleophilic aromatic substitution step was replaced with a Pd-catalyzed cross coupling for the synthesis of the 3,4- and 2,4-regioisomers <b>7b</b> and <b>7c</b>, starting from bromothiophenes <b>53</b> and <b>55</b>. The resultant sulfides were oxidized to sulfones <b>54</b> and <b>56</b>, which were subsequently converted to the corresponding AMT targets <b>7b</b> and <b>7c</b> by nitrile reduction.</div><figure id="sch14" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0017.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Synthetic Routes to AMT Regioisomers <b>7a</b>–<b>7c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) naphthalene-2-thiol, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; (b) mCPBA, DCM, rt; (c) BH<sub>3</sub>·THF, THF, rt; (d) Pd<sub>2</sub>dba<sub>3</sub>, xantphos, naphthalene-2-thiol, NaO<i><sup>t</sup></i>Bu, toluene, 110 °C.</p></p></figure><div class="NLM_p">Finally, the Suzuki–Miyaura coupling between 5-bromothiophene-2-carbonitrile <b>17a</b> and (4-(methylthio)phenyl)boronic acid <b>57</b> affords phenyl thiophene <b>58</b> (<a class="ref internalNav" href="#sch15" aria-label="Scheme 15">Scheme 15</a>). This was converted to carbamate <b>59</b> by nitrile reduction, Boc protection, and sulfide oxidation. Subsequent Boc removal furnished the phenyl-linked AMT analogue <b>4e</b>.</div><figure id="sch15" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0018.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 15. Synthetic Route to Phenyl-Linked AMT <b>4e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 °C; (b) BH<sub>3</sub>·THF, THF, rt; (c) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt; (d) mCPBA, DCM, rt; (e) 4 M HCl in dioxane, DCM, rt.</p></p></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We described herein a series of LOX inhibitors containing a 2-aminomethylene-5-sulfonyl-thiophene core. The attachment of a sulfonylphenyl side chain to the core scaffold via the 5-sulfonyl linker furnishes inhibitors with sub-micromolar LOX IC<sub>50</sub> values. Further SAR optimization leads to the discovery of inhibitor <b>9f</b> with potent anti-LOX activity as well as desirable selectivity and PK profile, making it a valuable asset for LOX research. More importantly, we have described its ability to reduce the growth of spontaneous breast tumor lung metastasis in a GEMM,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> thus demonstrating the promise of <b>9f</b> as a drug candidate.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Synthesis of Inhibitors</h3><div class="NLM_p">Commercial building blocks, reagents, and solvents for reactions were reagent grade and used as purchased. Flash chromatography was performed on a Biotage Isolera flash purification system using prepacked silica gel cartridges (Biotage) with HPLC grade solvents. Thin-layer chromatography analysis was performed using silica gel 60 F-254 thin-layer plates. Liquid chromatography mass spectrometry (LCMS) and high-resolution mass spectrometry (HRMS) analyses of chemical compounds were performed on an Agilent 1200 series HPLC and a diode array detector coupled to a 6210 time-of-flight mass spectrometer with a multimode ESI source or a Waters Acquity UPLC and diode array detector coupled to a Waters G2 QToF mass spectrometer fitted with a multimode ESI/APCI source. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance 500 MHz or a 300 MHz spectrometer using an internal deuterium lock. NMR data is given as follows: chemical shift (δ) in ppm, multiplicity, coupling constants (<i>J</i>) given in hertz and integration. All final inhibitors submitted for biological evaluation were at least 95% pure by HPLC, apart from compound <b>2g</b>, which has a purity of 94%.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> General Procedures GP1</h4><div class="NLM_p last">Alkylamine was added to a solution of sulfonyl chloride <b>11a</b> in DCM, and the reaction mixture was stirred at rt for 1–16 h. One molar HCl was added, and the aqueous phase was extracted with DCM (3×). The combined organic layer was dried over MgSO<sub>4</sub> and filtered, and the solvent was removed under reduced pressure. MeOH and aq. NaOH were then added, and the mixture was stirred at rt for 16 h (MeOH and aq. NaOH can be replaced by 7 N NH<sub>3</sub> in MeOH). H<sub>2</sub>O was added, and the aqueous phase was extracted with DCM (3×). The combined organic phase was dried over MgSO<sub>4</sub> and filtered, and the solvent was removed under reduced pressure to afford the desired AMT-sulfonamide, which could be further purified if necessary.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> General Procedures GP2</h4><div class="NLM_p last">Four molar HCl in dioxane or 2 M HCl in Et<sub>2</sub>O was added to <i>tert</i>-butyl carbamate (neat or as a solution in DCM), and the mixture was stirred at rt for 1–16 h. EtOAc was added to precipitate the solids if necessary. The solids were collected by filtration or centrifugation, washed with EtOAc, and dried under vacuum to afford the desired amine hydrochloride. If necessary, this can be further purified by chromatography in its free amine form, which can be obtained by treatment with 7 N NH<sub>3</sub> in MeOH.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> General Procedures GP3</h4><div class="NLM_p last">BH<sub>3</sub>·THF was added to a solution of heteroaryl nitrile in THF, and the mixture was stirred at rt for 1–5 h. EtOH (equal volume to reaction mixture) was then carefully added to quench the reaction. The solution was subsequently heated at 70 °C for 1 h to aid borane decomplexation. The solvent was removed under reduced pressure to afford the desired amine, which could be purified if necessary.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> General Procedures GP4</h4><div class="NLM_p last">A mixture of 5-bromothiophene-2-carbonitrile <b>17a</b> (interchangeable with 5-chorothiophene-2-carbonitrile) or 2-bromothiazole-5-carbonitrile <b>17b</b>, alkyl or aryl thiol, K<sub>2</sub>CO<sub>3</sub>, and DMF was stirred at 50–140 °C. After cooling to rt, the mixture was diluted with EtOAc. The organic phase was washed with 1:1 H<sub>2</sub>O/brine (3×), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure to afford the desired sulfide product, which could be further purified if necessary.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> General Procedures GP5</h4><div class="NLM_p last">mCPBA (>2 equiv for sulfones, 1.0 equiv for sulfoxides) was added in small portions to a solution of sulfide in DCM at 0 °C, and the mixture was stirred at rt (0 °C for sulfoxides) for 3–16 h. When complete conversion was achieved, EtOAc was added. The organic phase was washed with sat. NaHCO<sub>3</sub> (3×) and sat. Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (until no color was detected on starch iodide paper), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure to afford the desired sulfone/sulfoxide, which could be further purified if necessary.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> General Procedures GP6</h4><div class="NLM_p last">The alkylamine was dissolved in DCM. Et<sub>3</sub>N followed by Boc<sub>2</sub>O were added, and the mixture was stirred at rt for 16 h. When complete conversion was achieved, DCM was added. The organic phase was washed with H<sub>2</sub>O and brine, dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure to afford the desired <i>tert</i>-butyl-carbamate, which could be further purified if necessary.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> General Procedures GP7</h4><div class="NLM_p last">A mixture of aryl bromide, Pd(PPh<sub>3</sub>)<sub>4</sub>, ArB(OR′)<sub>2</sub> (boronic acid or pinacolatoboronate), Cs<sub>2</sub>CO<sub>3</sub>, and 1,4-dioxane was degassed with argon and then stirred at 100 °C for 16 h. After cooling to rt, the mixture was filtered through celite and washed with EtOAc. The solvent was removed under reduced pressure to afford the desired biaryl, which could be further purified if necessary.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> General Procedures GP8</h4><div class="NLM_p last">A mixture of aryl bromide, Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, alkyl or aryl thiol, NaO<i><sup>t</sup></i>Bu, and <i><sup>t</sup></i>BuOH/toluene (1:4) was degassed with argon and then stirred at 100 °C for 16 h. After cooling to rt, the suspension was filtered through celite and washed with DCM. The solvent was removed under reduced pressure to afford the desired sulfide, which could be further purified if necessary.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (5-(Piperidin-1-ylsulfonyl)thiophen-2-yl)methanamine (<b>2a</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11a</b> (150 mg, 0.487 mmol), piperidine (96.3 μL, 0.975 mmol), and DCM (2.4 mL), 16 h, rt and (ii) 1 M NaOH (2 mL) and MeOH (2 mL), rt, 16 h. Compound <b>2a</b> was obtained as a white crystalline solid (109 mg, 86%) and did not require further purification. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.37 (d, <i>J</i> = 3.6 Hz, 1H), 6.92 (d, <i>J</i> = 3.6 Hz, 1H), 4.20 (br, 2H), 3.11–2.96 (m, 4H), 1.82–1.12 (m, 8H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 134.51, 132.45, 123.57, 47.10, 25.23, 23.58. HRMS (ESI) for C<sub>10</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 261.0726; observed 261.0743; error = 4.8 ppm.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-(Aminomethyl)-<i>N</i>,<i>N</i>-dimethylthiophene-2-sulfonamide (<b>2b</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11a</b> (100 mg, 0.325 mmol), dimethylamine (40% in H<sub>2</sub>O; 0.206 mL, 1.62 mmol), and DCM (1.63 mL), 16 h, rt and (ii) 30% NaOH (0.5 mL) and MeOH (3 mL), rt, 16 h. Compound <b>2b</b> was obtained as a white solid (38 mg, 53%) and did not require further purification. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.41 (d, <i>J</i> = 3.7 Hz, 1H), 6.95 (dt, <i>J</i> = 3.7, 1.0 Hz, 1H), 4.12 (d, <i>J</i> = 0.6 Hz, 2H), 2.76 (s, 6H), 1.61 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 155.65, 133.60, 132.76, 123.60, 41.66, 38.18. HRMS (ESI) for C<sub>7</sub>H<sub>13</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 221.0413; observed 221.0409; error = 1.8 ppm.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 5-(Aminomethyl)-<i>N</i>-ethylthiophene-2-sulfonamide (<b>2c</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11a</b> (100 mg, 0.325 mmol), ethylamine (2.0 M in MeOH; 0.812 mL, 1.62 mmol), and DCM (1.63 mL), 16 h, rt and (ii) 30% NaOH (0.5 mL) and MeOH (3 mL), rt, 16 h. Compound <b>2c</b> was obtained as a colorless oil (23 mg, 32%) and did not require further purification. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.46 (d, <i>J</i> = 3.7 Hz, 1H), 6.88 (d, <i>J</i> = 3.7 Hz, 1H), 4.68 (br, 1H), 4.09 (s, 2H), 3.09 (q, <i>J</i> = 7.2 Hz, 2H), 1.76 (br, 2H), 1.15 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 155.38, 138.81, 132.43, 123.47, 41.60, 38.62, 15.11. HRMS (ESI) for C<sub>7</sub>H<sub>10</sub>NO<sub>2</sub>S<sub>2</sub> ([M – NH<sub>2</sub>]<sup>+</sup>): calculated 204.1480; observed 204.01460; error = 0.98 ppm.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (<i>S</i>)-1-(5-(Aminomethyl)thiophen-2-ylsulfonyl)pyrrolidine-2-carboxamide (<b>2d</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11a</b> (75 mg, 0.244 mmol), prolinamide hydrochloride (30.6 mg, 0.268 mmol), Et<sub>3</sub>N (74.7 μL, 0.536 mmol), and DCM (1.2 mL), 16 h, rt and (ii) 1 M NaOH (1.2 mL) and MeOH (1.2 mL), rt, 16 h. The crude was purified by chromatography (1 N NH<sub>3</sub> in MeOH/DCM 0 → 20%) to afford an orange oil (10 mg, 14%). [α]<sub class="stack">D</sub><sup class="stack">21</sup> −134.2 (c 0.16, MeOH/CHCl<sub>3</sub>). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 7.58 (d, <i>J</i> = 3.8 Hz, 1H), 7.15 (d, <i>J</i> = 3.8 Hz, 1H), 4.10 (s, 2H), 4.06 (dd, <i>J</i> = 8.3, 4.0 Hz, 1H), 3.61 (ddd, <i>J</i> = 10.2, 6.1, 4.6 Hz, 1H), 3.32 (m, 1H), 1.99 (m, 1H), 1.93–1.82 (m, 2H), 1.67 (m, 1H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 177.35, 154.70, 135.83, 134.45, 126.75, 63.79, 50.93, 41.12, 32.07, 25.51. HRMS (ESI) for C<sub>10</sub>H<sub>13</sub>N<sub>2</sub>O<sub>3</sub>S<sub>2</sub> ([M – NH<sub>2</sub>]<sup>+</sup>): calculated 273.0362; observed 273.0334; error = 10 ppm.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (<i>S</i>)-(1-(5-(Aminomethyl)thiophen-2-ylsulfonyl)pyrrolidin-2-yl)methanol (<b>2e</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11a</b> (100 mg, 0.325 mmol), (<i>S</i>)-pyrrolidin-2-ylmethanol (35.3 μL, 0.358 mmol), Et<sub>3</sub>N (100 μL, 0.715 mmol), and DCM (1.6 mL), 2 h, rt and (ii) 7 N NH<sub>3</sub> in MeOH (5 mL), rt, 20 h. The crude was purified by chromatography (1 N NH<sub>3</sub> in MeOH/DCM 0 → 15%) to afford a yellow oil (47 mg, 52%). [α]<sub class="stack">D</sub><sup class="stack">21</sup> −33.6 (c 2.76, MeOH/CHCl<sub>3</sub>). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.47 (d, <i>J</i> = 3.8 Hz, 1H), 6.94 (dt, <i>J</i> = 3.7, 1.0 Hz, 1H), 4.11 (d, <i>J</i> = 0.8 Hz, 2H), 3.80–3.57 (m, 3H), 3.53–3.45 (m, 1H), 3.30 (dt, <i>J</i> = 10.5, 7.1 Hz, 1H), 2.18–1.95 (m, 3H), 1.90–1.69 (m, 3H), 1.60–1.50 (m, 1H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 155.82, 134.49, 133.01, 123.57, 65.67, 62.29, 50.22, 41.55, 28.90, 24.41. HRMS (ESI) for C<sub>10</sub>H<sub>17</sub>N<sub>2</sub>O<sub>3</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 277.0675; observed 277.0629; error = 17 ppm.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (5-(2-Phenylpyrrolidin-1-ylsulfonyl)thiophen-2-yl)methanamine (<b>2f</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11a</b> (100 mg, 0.325 mmol), 2-phenylpyrrolidine (40.7 mg, 0.357 mmol), Et<sub>3</sub>N (100 μL, 0.715 mmol), and DCM (1.6 mL), 2 h, rt and (ii) 7 N NH<sub>3</sub> in MeOH (4 mL), rt, 16 h. The crude was purified by chromatography (1 N NH<sub>3</sub> in MeOH/DCM 0 → 20%) to afford a brown oil (40 mg, 38%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.42 (d, <i>J</i> = 3.7 Hz, 1H), 7.38–7.21 (m, 5H), 6.90 (dt, <i>J</i> = 3.7, 1.0 Hz, 1H), 4.80 (dd, <i>J</i> = 8.0, 3.6 Hz, 1H), 4.10 (d, <i>J</i> = 0.9 Hz, 2H), 3.68 (m, 1H), 3.45 (dt, <i>J</i> = 10.5, 7.3 Hz, 1H), 2.04 (m, 1H), 1.96–1.81 (m, 2H), 1.70 (m, 1H), 1.53 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 155.35, 143.01, 135.67, 132.68, 128.44, 127.18, 126.22, 123.38, 63.71, 49.77, 41.57, 35.82, 24.08. HRMS (ESI) for C<sub>15</sub>H<sub>19</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 323.0883; observed 323.0873; error = 3.1 ppm.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (5-(Indolin-1-ylsulfonyl)thiophen-2-yl)methanamine (<b>2g</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11a</b> (100 mg, 0.325 mmol), indoline (142 mg, 0.358 mmol), Et<sub>3</sub>N (100 μL, 0.715 mmol), and DCM (1.6 mL), 2 h, rt and (ii) 7 N NH<sub>3</sub> in MeOH (5 mL) at rt, for 20 h. The crude was purified by chromatography (1 N NH<sub>3</sub> in MeOH/DCM 0 → 15%) to afford a brown solid (73 mg, 76%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.58 (d, <i>J</i> = 8.1 Hz, 1H), 7.42 (d, <i>J</i> = 3.8 Hz, 1H), 7.24–7.16 (m, 1H), 7.12 (d, <i>J</i> = 7.4 Hz, 1H), 7.00 (td, <i>J</i> = 7.4, 0.9 Hz, 1H), 6.88–6.78 (m, 1H), 4.01 (s, 2H), 3.95 (d, <i>J</i> = 8.4 Hz, 2H), 2.98 (t, <i>J</i> = 8.4 Hz, 2H), 1.56 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 156.23, 141.59, 133.90, 132.97, 131.84, 127.81, 125.24, 124.07, 123.43, 115.10, 50.30, 50.25, 41.51, 27.91. HRMS (ESI) for C<sub>13</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 295.0569; observed 295.0577; error = 2.7 ppm.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (5-(3,4-Dihydroquinolin-1(2<i>H</i>)-ylsulfonyl)thiophen-2-yl)methanamine (<b>2h</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11a</b> (100 mg, 0.325 mmol), tetrahydroquinoline (44.9 μL, 0.357 mmol), Et<sub>3</sub>N (100 μL, 0.715 mmol), and DCM (1.6 mL), 2 h, rt and (ii) 7 N NH<sub>3</sub> in MeOH (5 mL), rt, 20 h. The crude was purified by chromatography (1 N NH<sub>3</sub> in MeOH/DCM 0 → 10%) to afford a brown foam (27 mg, 27%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.78 (d, <i>J</i> = 8.3 Hz, 1H), 7.25–7.16 (m, 2H), 7.13–7.02 (m, 2H), 6.84 (d, <i>J</i> = 3.7 Hz, 1H), 4.04 (s, 2H), 3.87–3.81 (m, 2H), 2.54 (t, <i>J</i> = 6.7 Hz, 2H), 2.37–1.82 (m, 2H), 1.80–1.72 (br, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 137.52, 136.43, 132.42, 130.96, 129.27, 126.69, 125.28, 125.03, 123.78, 46.98, 41.34, 26.93, 21.78. HRMS (ESI) for C<sub>14</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 309.0726; observed 309.0732; error = 1.9 ppm.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (5-(Morpholinosulfonyl)thiophen-2-yl)methanamine (<b>2i</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11a</b> (75 mg, 0.244 mmol), morpholine (42.7 μL, 0.487 mmol), and DCM (1.2 mL), 16 h, rt and (ii) 1 M NaOH (1 mL) and MeOH (1 mL), rt, 16 h. The crude was dissolved in MeOH, passed through an SCX ion exchange (sulfonic acid) column, and washed with MeOH. The amine was released by the addition of 1 N NH<sub>3</sub> in MeOH to afford a crystalline solid (47 mg, 73%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.40 (d, <i>J</i> = 3.7 Hz, 1H), 6.95 (d, <i>J</i> = 3.6 Hz, 1H), 4.08 (br, 2H), 3.90–3.65 (m, 4H), 3.15–2.89 (m, 4H), 1.64 (br, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 133.16, 133.01, 123.70, 66.13, 46.12. HRMS (ESI) for C<sub>9</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 263.0519; observed 263.0533; error = 5.3 ppm.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (5-(1,4-Diazepan-1-ylsulfonyl)thiophen-2-yl)methanamine Dihydrochloride (<b>2j</b>)</h3><div class="NLM_p"><i>tert</i>-Butyl 4-((5-(aminomethyl)thiophen-2-yl)sulfonyl)-1,4-diazepane-1-carboxylate was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11a</b> (75 mg, 0.244 mmol), <i>N</i>-Boc-homopiperazine (53.7 mg, 0.268 mmol), Et<sub>3</sub>N (74.7 μL, 0.536 mmol), and DCM (1.2 mL), rt, 16 h and (ii) 1 M NaOH (5 mL), MeOH (5 mL), rt, 16 h. The crude was used in the subsequent transformation immediately.</div><div class="NLM_p last">Compound <b>2j</b> was synthesized according to general procedure GP2, from <i>tert</i>-butyl 4-((5-(aminomethyl)thiophen-2-yl)sulfonyl)-1,4-diazepane-1-carboxylate (crude) and 2 M HCl in Et<sub>2</sub>O (10 mL), rt, 16. Compound <b>2j</b> was obtained as a pink solid (43 mg, 63%). <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O) δ 7.77 (br, 1H), 7.44 (br, 1H), 4.55 (s, 2H), 3.75 (br, 2H), 3.60–3.45 (m, 6H), 2.23 (br, 2H). <sup>13</sup>C NMR (126 MHz, D<sub>2</sub>O) δ 141.90, 137.80, 133.32, 130.36, 47.20, 46.84, 44.85, 44.38, 37.31, 25.22. HRMS (ESI) for C<sub>10</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 276.0835; observed 276.0771; error = 23 ppm.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (5-(4-Methyl-1,4-diazepan-1-ylsulfonyl)thiophen-2-yl)methanamine (<b>2k</b>)</h3><div class="NLM_p">A mixture of sulfonyl chloride <b>11a</b> (645 mg, 2.10 mmol), <i>N</i>-Boc-homopiperazine (449 μL, 2.31 mmol), Et<sub>3</sub>N (643 μL, 4.61 mmol), and DCM (10 mL) was stirred at rt for 2 h. One molar HCl (30 mL) was added. The aqueous phase was extracted with DCM (3 × 15 mL). The combined organic phase was dried over MgSO<sub>4</sub> and filtered, and the solvent was removed under reduced pressure. The intermediate was dissolved in 2 M HCl in Et<sub>2</sub>O (10 mL), and the mixture was stirred at rt for 16 h. The solids were collected, washed with Et<sub>2</sub>O, and dried under vacuum to afford <i>N</i>-((5-((1,4-diazepan-1-yl)sulfonyl)thiophen-2-yl)methyl)-2,2,2-trifluoroacetamide hydrochloride as a beige solid (580 mg, 68%). <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O) δ 7.70 (m, 1H), 7.27 (m, 1H), 3.74–3.70 (m, 2H), 3.56–3.42 (m, 6H), 2.27–2.13 (m, 2H). HRMS (ESI) for C<sub>12</sub>H<sub>17</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 372.0658.</div><div class="NLM_p last">A mixture of <i>N</i>-((5-((1,4-diazepan-1-yl)sulfonyl)thiophen-2-yl)methyl)-2,2,2-trifluoroacetamide hydrochloride (80 mg, 0.196 mmol), MeI (18.0 μL, 0.294 mmol), Et<sub>3</sub>N (68.0 μL, 0.490 mmol), and DCM (1.0 mL) was stirred at rt for 48 h. H<sub>2</sub>O (10 mL) was added. The aqueous phase was extracted with DCM (3 × 10 mL). The combined organic phase was removed under reduced pressure. The intermediate was dissolved in 7 N NH<sub>3</sub> in MeOH (3 mL), and the mixture was stirred at rt for 24 h. The solvent was removed under reduced pressure, and the crude was purified by chromatography (1 N NH<sub>3</sub> in MeOH/DCM 0 → 20%) to afford compound <b>2k</b> as a brown oil (12 mg, 21%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.40 (d, <i>J</i> = 3.7 Hz, 1H), 6.89 (dt, <i>J</i> = 3.7, 0.9 Hz, 1H), 4.10 (d, <i>J</i> = 0.8 Hz, 2H), 3.45–3.38 (m, 4H), 2.69–2.61 (m, 4H), 2.36 (s, 2H), 1.88 (dt, <i>J</i> = 11.7, 6.2 Hz, 2H), 1.69 (s, 3H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 155.05, 137.16, 131.90, 123.37, 58.55, 56.84, 48.04, 47.38, 46.58, 41.66, 27.55. HRMS (ESI) for C<sub>11</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 290.0992; observed 290.0861; error = 45 ppm.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 4-(5-(Aminomethyl)thiophen-2-ylsulfonyl)-<i>N</i>-ethyl-1,4-diazepane-1-carboxamide (<b>2l</b>)</h3><div class="NLM_p last">A mixture of <i>N</i>-((5-((1,4-diazepan-1-yl)sulfonyl)thiophen-2-yl)methyl)-2,2,2-trifluoroacetamide hydrochloride (80 mg, 0.196 mmol), EtNCO (17.0 μL, 0.216 mmol), Et<sub>3</sub>N (54.7 μL, 0.392 mmol), and DCM (1.0 mL) was stirred at rt for 2 h. DCM (10 mL) was added. The organic phase was washed with H<sub>2</sub>O and brine (10 mL each), dried over MgSO<sub>4</sub>, and filtered, and the solvent was removed under reduced pressure. The intermediate was dissolved in 7 N NH<sub>3</sub> in MeOH (3 mL), and the mixture was stirred at rt for 16 h. The solvent was removed under reduced pressure, and the crude was purified by chromatography (MeOH/DCM 0 → 20%) to afford compound <b>2l</b> as a colorless oil (60 mg, 88%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.38 (d, <i>J</i> = 3.7 Hz, 1H), 6.88 (dt, <i>J</i> = 3.7, 0.9 Hz, 1H), 4.39 (s, 1H), 4.08 (s, 2H), 3.62–3.57 (m, 2H), 3.49 (t, <i>J</i> = 6.4 Hz, 2H), 3.36–3.32 (m, 2H), 3.29–3.20 (m, 4H), 2.02–1.94 (m, 2H), 1.69 (s, 2H), 1.11 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 157.38, 155.48, 136.96, 132.01, 123.40, 50.69, 48.51, 48.13, 45.28, 41.58, 35.79, 28.24, 15.70. HRMS (ESI) for C<sub>13</sub>H<sub>23</sub>N<sub>4</sub>O<sub>3</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 347.1206; observed 347.1196; error = 2.9 ppm.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (5-(4-(Methylsulfonyl)-1,4-diazepan-1-ylsulfonyl)thiophen-2-yl)methanamine (<b>2m</b>)</h3><div class="NLM_p last">A mixture of <i>N</i>-((5-((1,4-diazepan-1-yl)sulfonyl)thiophen-2-yl)methyl)-2,2,2-trifluoroacetamide hydrochloride (80 mg, 0.196 mmol), MsCl (16.7 μL, 0.216 mmol), Et<sub>3</sub>N (68.0 μL, 0.490 mmol), and DCM (1.0 mL) was stirred at rt for 48 h·H<sub>2</sub>O (10 mL) was added. The aqueous phase was extracted with DCM (3 × 10 mL). The combined organic phase was dried over MgSO<sub>4</sub> and filtered, and the solvent was removed under reduced pressure. The intermediate was dissolved in 7 N NH<sub>3</sub> in MeOH (3 mL), and the mixture was stirred at rt for 24 h. The solvent was removed under reduced pressure, and the crude was purified by chromatography (1 N NH<sub>3</sub> in MeOH/DCM 0 → 20%) to afford compound <b>2m</b> as a white solid (44 mg, 63%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.39 (d, <i>J</i> = 3.8 Hz, 1H), 6.88 (dt, <i>J</i> = 3.7, 1.0 Hz, 1H), 4.08 (d, <i>J</i> = 0.9 Hz, 2H), 3.54–3.34 (m, 8H), 2.85 (s, 3H), 2.00 (pentet, <i>J</i> = 6.3 Hz, 2H), 1.62 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 155.81, 136.76, 132.10, 123.37, 51.25, 50.49, 47.76, 47.27, 41.56, 38.13, 29.33. HRMS (ESI) for C<sub>11</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 354.0611; observed 354.0530; error = 23 ppm.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (5-(Cyclohexylsulfonyl)thiophen-2-yl)methanamine (<b>3a</b>)</h3><div class="NLM_p">NaH (60% in mineral oil; 39.6 mg, 0.985 mmol) was added to a solution of 5-bromothiophene-2-carbonitrile <b>17a</b> (100 μL, 0.901 mmol) and cyclohexylmercaptan (121 μL, 0.991 mmol) in DMF (3.0 mL), and the mixture was stirred at 130 °C for 16 h. After cooling to rt, EtOAc (15 mL) was added. The organic phase was washed with 1:1 H<sub>2</sub>O/brine (3 × 15 mL), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure, and the intermediate was dissolved in DCM (3.0 mL). mCPBA (77%; 489 mg, 2.18 mmol) was added in small portions, and the mixture was stirred at rt for 3 h. DCM (15 mL) was added. The organic phase was washed with 1 M NaOH (3 × 15 mL) and brine (15 mL), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure, and the crude was purified by chromatography (EtOAc/cyclohexane 0 → 20%) to afford 5-(cyclohexylsulfonyl)thiophene-2-carbonitrile as a white crystalline solid (50 mg, 22%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.65 (d, <i>J</i> = 4.0 Hz, 1H), 7.61 (d, <i>J</i> = 4.0 Hz, 1H), 3.03 (tt, <i>J</i> = 12.1, 3.4 Hz, 1H), 2.19–2.11 (m, 2H), 1.97–1.88 (m, 2H), 1.72 (m, 1H), 1.65–1.10 (m, 5H). LCMS (ESI) <i>m</i>/<i>z</i> 278 [M + Na]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>3a</b> was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 0.58 mL, 0.58 mmol), 5-(cyclohexylsulfonyl)thiophene-2-carbonitrile (49 mg, 0.192 mmol), and THF (1.9 mL), rt, 1 h. The crude was purified by chromatography (MeOH/DCM 0 → 15%) to afford a white solid (12 mg, 24%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.50 (d, <i>J</i> = 3.8 Hz, 1H), 6.96 (m, 1H), 4.12 (s, 2H), 2.95 (tt, <i>J</i> = 12.1, 3.4 Hz, 1H), 2.20–2.12 (m, 2H), 1.92–1.84 (m, 2H), 1.68 (d, <i>J</i> = 21.7 Hz, 3H), 1.51–1.38 (m, 2H), 1.33–1.08 (m, 3H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 158.07, 135.80, 135.11, 123.83, 64.77, 41.72, 25.97, 25.27, 25.19. HRMS (ESI) for C<sub>11</sub>H<sub>17 N</sub>O<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 260.0773; observed 260.0785; error = 4.6 ppm.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (5-(Phenylsulfonyl)thiophen-2-yl)methanamine (<b>3b</b>)</h3><div class="NLM_p last">A mixture of nitrile <b>6c</b> (39 mg, 0.156 mmol), LiAlH<sub>4</sub> (1.0 M in THF; 160 μL, 0.160 mmol), and THF (1.6 mL) was stirred at 0 °C for 1 h. H<sub>2</sub>O (5 mL) was slowly added, and the aqueous phase was extracted with DCM (3 × 8 mL). The combined organic phase was washed with brine (10 mL), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure, and the crude was purified by chromatography (7 N NH<sub>3</sub> in MeOH/DCM 0 → 60%) to afford compound <b>3b</b> as a light brown crystalline solid (15 mg, 38%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.01–7.95 (m, 2H), 7.63–7.48 (m, 4H), 6.88 (dt, <i>J</i> = 3.8, 1.0 Hz, 1H), 4.07 (s, 2H), 1.58 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 158.19, 142.50, 140.63, 133.70, 133.26, 129.39, 127.41, 123.80, 41.71. HRMS (ESI) for C<sub>11</sub>H<sub>12</sub>NO<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 254.0304; observed 254.0309; error = 2.0 ppm.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (5-(Pyridin-2-ylsulfonyl)thiophen-2-yl)methanamine (<b>3c</b>)</h3><div class="NLM_p">A mixture of 2-((5-methylthiophen-2-yl)sulfonyl)pyridine <b>15</b> (310 mg, 1.30 mmol), Bz<sub>2</sub>O<sub>2</sub> (75%; 20.9 mg, 0.0648 mmol), NBS (253 mg, 1.42 mmol), and DCE (6.5 mL) was stirred at 80 °C for 16 h. The solvent was removed under reduced pressure, and the crude was purified by chromatography (EtOAc/cyclohexane 20 → 40%) to afford 2-((5-(bromomethyl)thiophen-2-yl)sulfonyl)pyridine as a white solid (294 mg, 71%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.74 (s, 1H), 8.19 (s, 1H), 7.97 (s, 1H), 7.71 (s, 1H), 7.53 (s, 1H), 7.13 (d, <i>J</i> = 3.9 Hz, 1H), 4.66 (s, 2H). LCMS (ESI) <i>m</i>/<i>z</i> 318/320 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A mixture of 2-((5-(bromomethyl)thiophen-2-yl)sulfonyl)pyridine (133 mg, 0.418 mmol), NaN<sub>3</sub> (32.6 mg, 0.502 mmol), and DMF (2.1 mL) was stirred at 70 °C for 16 h. After cooling to rt, EtOAc (20 mL) was added. The organic phase was washed with 1:1 H<sub>2</sub>O/brine (2 × 20 mL), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure, and the intermediate was dissolved in THF (2.1 mL), and Pd/C (10%; 44 mg, 0.0418 mmol) was then added. The mixture was stirred at rt under a H<sub>2</sub> atmosphere (balloon) for 16 h and subsequently filtered through celite. The solvent was removed under reduced pressure, and the crude was purified by chromatography (MeOH/DCM 0 → 20%) to afford compound <b>3c</b> as a white solid (53 mg, 50%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.69 (ddd, <i>J</i> = 4.7, 1.7, 0.9 Hz, 1H), 8.15 (dt, <i>J</i> = 7.9, 1.0 Hz, 1H), 7.92 (td, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.70 (d, <i>J</i> = 3.8 Hz, 1H), 7.46 (ddd, <i>J</i> = 7.6, 4.7, 1.1 Hz, 1H), 6.92 (dt, <i>J</i> = 3.9, 1.0 Hz, 1H), 4.07 (d, <i>J</i> = 0.9 Hz, 2H), 1.62 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 159.60, 159.12, 150.48, 138.27, 136.95, 135.65, 127.01, 123.94, 121.78, 41.71. HRMS (ESI) for C<sub>10</sub>H<sub>11</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 255.0257; observed 255.0276; error = 7.5 ppm.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> (5-(Thiophen-2-ylsulfonyl)thiophen-2-yl)methanamine Hydrochloride (<b>3d</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP4, GP5, and GP3, from (i) 5-bromothiophene-2-carbonitrile <b>17a</b> (1.0 g, 5.32 mmol), thiophene-2-thiol (586 mg, 5.05 mmol), K<sub>2</sub>CO<sub>3</sub> (881 mg, 6.38 mmol), and DMF (17 mL), 80 °C, 16 h; (ii) mCPBA (77%; 1.30 g, 11.2 mmol) and DCM (36 mL), rt, 3 h; and (iii) BH<sub>3</sub> (1.0 M in THF; 10.6 mL, 10.6 mmol) and THF (10.6 mL), rt, 1 h. Chromatography (EtOH/cyclohexane 0 → 100%) afforded a brown gum (323 mg, 25%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.64 (dd, <i>J</i> = 5.0, 1.3 Hz, 1H), 7.52 (dd, <i>J</i> = 3.7, 1.3 Hz, 1H), 7.43 (d, <i>J</i> = 3.7 Hz, 1H), 7.11 (dd, <i>J</i> = 5.0, 3.7 Hz, 1H), 6.90 (dt, <i>J</i> = 3.7, 0.9 Hz, 1H), 3.93 (s, 2H), 1.63 (br, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 155.85, 147.91, 145.56, 131.64, 130.91, 129.86, 127.48, 123.47, 41.84. HRMS (ESI) for C<sub>9</sub>H<sub>7</sub>O<sub>2</sub>S<sub>3</sub> ([M – NH<sub>2</sub>]<sup>+</sup>): calculated 242.9608; observed 242.9608; error = 0 ppm.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (5-(Biphenyl-3-ylsulfonyl)thiophen-2-yl)methanamine Hydrochloride (<b>3e</b>)</h3><div class="NLM_p">5-([1,1′-Biphenyl]-3-ylthio)thiophene-2-carbonitrile was synthesized according to general procedures GP4, from 5-bromothiophene-2-carbonitrile <b>17a</b> (160 mg, 1.11 mmol), [1,1′-biphenyl]-3-thiol (223 mg, 1.22 mmol), K<sub>2</sub>CO<sub>3</sub> (308 mg, 2.23 mmol), and DMF (4.6 mL), 120 °C, 16 h. Chromatography (EtOAc/cyclohexane 0 → 20%) afforded a brown oil (327 mg, 92%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 7.13–7.80 (m, 11H). LCMS (ESI) <i>m</i>/<i>z</i> 294 [M + H]<sup>+</sup>.</div><div class="NLM_p"><i>tert</i>-Butyl ((5-([1,1′-biphenyl]-3-ylthio)thiophen-2-yl)methyl)carbamate was synthesized according to general procedures GP3 and GP6, from (i) 5-([1,1′-biphenyl]-3-ylthio)thiophene-2-carbonitrile (264 mg, 0.910 mmol), BH<sub>3</sub> (1.0 M in THF; 2.7 mL, 2.70 mmol), THF (2.7 mL), rt, 1 h and (ii) Boc<sub>2</sub>O (590 mg, 2.70 mmol), Et<sub>3</sub>N (250 μL, 1.80 mmol), and DCM (3.5 mL), rt, 16 h. Chromatography (EtOAc/cyclohexane 0 → 30%) afforded a yellow oil (64 mg, 18%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.56 (m, 1H), 7.55 (m, 1H), 7.49 (m, 1H), 7.46 (m, 2H), 7.43–7.33 (m, 3H), 7.20 (m, 2H), 6.93 (d, <i>J</i> = 3.3 Hz, 1H), 5.04 (s, 1H), 4.49 (s, 2H), 1.50 (s, 9H). LCMS (ESI) <i>m</i>/<i>z</i> 281 [M – BocNH]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>3e</b> was synthesized according to general procedures GP5 and GP2, from (i) <i>tert</i>-butyl ((5-([1,1′-biphenyl]-3-ylthio)thiophen-2-yl)methyl)carbamate (64 mg, 0.161 mmol), mCPBA (77%; 69 mg, 0.402 mmol), and DCM (2.0 mL), 45 °C, 1.5 h and (ii) 4 M HCl in dioxane (8.0 mL), rt, 16 h. The white precipitate was filtered and washed with excess EtOAc to afford a white solid (25 mg, 42% over two steps). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.19 (m, 1H), 7.99 (ddd, <i>J</i> = 7.8, 1.8, 1.0 Hz, 1H), 7.96 (ddd, <i>J</i> = 7.8, 1.8, 1.0 Hz, 1H), 7.81 (d, <i>J</i> = 3.9 Hz, 1H), 7.70 (t, <i>J</i> = 7.7 Hz, 1H), 7.65 (m, 2H), 7.52 (m, 2H), 7.44 (m, 1H), 7.32 (d, <i>J</i> = 3.8 Hz, 1H), 4.38 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 144.2, 143.8, 142.8, 142.4, 138.8, 133.8, 131.9, 130.3, 130.1, 128.9, 128.2, 126.7, 125.7, 125.1, 37.1. HRMS (ESI) for C<sub>17</sub>H<sub>13</sub>O<sub>2</sub>S<sub>2</sub> ([M – NH<sub>2</sub>]<sup>+</sup>): calculated 313.0357; observed 313.0359; error = 0.64 ppm.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> (5-(Naphthalen-1-ylsulfonyl)thiophen-2-yl)methanamine (<b>3f</b>)</h3><div class="NLM_p">5-(Naphthalen-1-ylsulfonyl)thiophene-2-carbonitrile was synthesized according to general procedures GP4 and GP5, from (i) 5-chlorothiophene-2-carbonitrile <b>17a</b> (95 μL, 0.901 mmol), naphthalene-1-thiol (137 μL, 0.991 mmol), K<sub>2</sub>CO<sub>3</sub> (250 mg, 1.80 mmol), and DMF (3.0 mL), 120 °C, 16 h and (ii) mCPBA (77%; 504 mg, 2.25 mmol) and DCM (15 mL), rt, 16 h. Chromatography (EtOAc/cyclohexane 0 → 15%) afforded a colorless oil (170 mg, 63%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.78 (m, 1H), 8.51 (dd, <i>J</i> = 7.4, 1.2 Hz, 1H), 8.17 (d, <i>J</i> = 8.2 Hz, 1H), 7.96 (d, <i>J</i> = 8.2 Hz, 1H), 7.75–7.67 (m, 2H), 7.67–7.59 (m, 2H), 7.49 (d, <i>J</i> = 4.1 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 300 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>3f</b> was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 1.10 mL, 1.10 mmol), 5-(naphthalen-1-ylsulfonyl)thiophene-2-carbonitrile (110 mg, 0.367 mmol), and THF (1.8 mL), rt, 2 h. Chromatography (MeOH/DCM 0 → 20%) afforded a white crystalline solid (25 mg, 23%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.86 (dd, <i>J</i> = 8.7, 0.8 Hz, 1H), 8.47 (dd, <i>J</i> = 7.4, 1.2 Hz, 1H), 8.09 (d, <i>J</i> = 8.2 Hz, 1H), 7.95–7.87 (m, 1H), 7.70–7.64 (m, 2H), 7.63–7.54 (m, 2H), 6.84 (dt, <i>J</i> = 3.9, 1.0 Hz, 1H), 4.01 (d, <i>J</i> = 0.9 Hz, 2H), 1.58 (s, 3H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 157.61, 141.08, 137.18, 135.25, 134.40, 133.68, 129.61, 129.23, 128.54, 127.07, 124.65, 124.63, 123.50, 41.67. HRMS (ESI) for C<sub>15</sub>H<sub>11</sub>O<sub>2</sub>S<sub>2</sub> ([M – NH<sub>2</sub>]<sup>+</sup>): calculated 287.0195; observed 287.0226; error = 11 ppm.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (5-(Naphthalen-2-ylsulfonyl)thiophen-2-yl)methanamine (<b>3g</b>)</h3><div class="NLM_p last">Compound <b>3g</b> was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 5.10 mL, 5.10 mmol), 5-(naphthalen-2-ylsulfonyl)thiophene-2-carbonitrile <b>43</b> (510 mg, 1.71 mmol) and THF (10 mL), rt, 3 h. Chromatography (EtOH/cyclohexane 30 → 100%) afforded a white solid (273 mg, 54%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.58 (s, 1H), 8.01–7.87 (m, 4H), 7.68–7.57 (m, 3H), 6.88 (m, 1H), 4.05 (s, 2H), 1.56 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 158.24, 140.73, 139.30, 135.17, 133.73, 132.40, 129.75, 129.59, 129.25, 128.71, 128.06, 127.75, 123.82, 122.58, 41.68. HRMS (ESI) for C<sub>15</sub>H<sub>11</sub>O<sub>2</sub>S<sub>2</sub> ([M – NH<sub>2</sub>]<sup>+</sup>): calculated 287.0195; observed 287.0207; error = 4.2 ppm.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>N</i>-(4-(5-(Aminomethyl)thiophen-2-ylsulfonyl)phenyl)methanesulfonamide (<b>3h</b>)</h3><div class="NLM_p">A mixture of 5-((4-aminophenyl)thio)thiophene-2-carbonitrile <b>19</b> (120 mg, 0.517 mmol), MsCl (44.0 μL, 0.568 mmol), and pyridine (1.7 mL) was stirred at rt for 16 h. Two molar HCl (30 mL) was added. The aqueous phase was extracted with DCM (3 × 20 mL). The combined organic phase was dried over MgSO<sub>4</sub> and filtered. The solvent was removed under reduced pressure, and the crude was dissolved in DCM (2.6 mL). mCPBA (77%; 254 mg, 1.14 mmol) was added, and the mixture was stirred at rt for 5 h. sat. NaHCO<sub>3</sub> (40 mL) was added, and the aqueous phase was extracted with EtOAc (3 × 40 mL). The combined organic phase was dried over MgSO<sub>4</sub> and filtered. The solvent was removed under reduced pressure, and the crude was purified by chromatography (MeOH/DCM 0 → 15%) to afford <i>N</i>-(4-((5-cyanothiophen-2-yl)sulfonyl)phenyl)methanesulfonamide as a white solid (69 mg, 39%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.50 (d, <i>J</i> = 3.9 Hz, 1H), 7.41–7.37 (m, 2H), 7.26–7.19 (m, 3H), 7.09 (d, <i>J</i> = 3.9 Hz, 1H), 3.05 (s, 3H). LCMS (ESI) <i>m</i>/<i>z</i> 365 [M + Na]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>3h</b> was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 0.61 mL, 0.61 mmol), <i>N</i>-(4-((5-cyanothiophen-2-yl)sulfonyl)phenyl)methanesulfonamide (69 mg, 0.202 mmol), and THF (0.6 mL), rt, 1 h. Chromatography (MeOH/DCM 5 → 25%) afforded a yellow solid (2 mg, 3%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 7.90–7.84 (m, 2H), 7.58 (d, <i>J</i> = 3.8 Hz, 1H), 7.38–7.32 (m, 2H), 7.04 (d, <i>J</i> = 3.8 Hz, 1H), 4.02 (s, 2H), 3.03 (s, 3H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 156.79, 146.06, 142.74, 136.92, 134.52, 130.00, 126.62, 119.69, 41.34, 40.06. HRMS (ESI) for C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 347.0189; observed 347.0190; error = 0.29 ppm.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (5-(4-(Methylsulfonyl)phenylsulfonyl)thiophen-2-yl)methanamine (<b>3i</b>)</h3><div class="NLM_p">5-((4-(Methylsulfonyl)phenyl)sulfonyl)thiophene-2-carbonitrile was synthesized according to general procedures GP4 and GP5, from (i) 5-chlorothiophene-2-carbonitrile (500 mg, 3.48 mmol), 4-(methylthio)benzenethiol (599 mg, 3.83 mmol), K<sub>2</sub>CO<sub>3</sub> (960 mg, 7.00 mmol), and DMF (11.6 mL), 120 °C, 16 h and (ii) mCPBA (77%; 3.90 g, 17.4 mmol) and DCM (23 mL), rt, 2 h. A white solid was obtained, which did not require further purification (770 mg, 68%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35–8.29 (m, 2H), 8.24–8.18 (m, 2H), 8.13–8.08 (m, 2H), 3.31 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 147.29, 145.83, 144.19, 140.29, 134.79, 128.78, 128.56, 116.87, 112.57, 42.92.</div><div class="NLM_p last">Compound <b>3i</b> was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 8.40 mL, 8.40 mmol), 5-((4-(methylsulfonyl)phenyl)sulfonyl)thiophene-2-carbonitrile (921 mg, 2.81 mmol), and THF (18 mL), 50 °C, 3 h. Chromatography (MeOH/DCM 0 → 20%) afforded a white solid (310 mg, 34%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.19–8.15 (m, 2H), 8.11–8.06 (m, 2H), 7.63 (d, <i>J</i> = 3.9 Hz, 1H), 6.93 (dt, <i>J</i> = 3.8, 1.0 Hz, 1H), 4.09 (d, <i>J</i> = 0.8 Hz, 2H), 3.08 (s, 3H), 1.61 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 160.12, 147.61, 144.80, 138.67, 134.95, 128.64, 128.46, 124.12, 44.41, 41.70. HRMS (ESI) for C<sub>12</sub>H<sub>14</sub>NO<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 332.0080; observed 332.0070; error = 3.0 ppm.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (5-(4-(Methylsulfonyl)butylsulfonyl)thiophen-2-yl)methanamine (<b>3j</b>)</h3><div class="NLM_p">A mixture of 2-methyl-5-((4-(methylsulfonyl)butyl)sulfonyl)thiophene <b>16</b> (860 mg, 2.90 mmol), Bz<sub>2</sub>O<sub>2</sub> (75%; 46.8 mg, 0.145 mmol), NBS (568 mg, 3.19 mmol), and DCE (14.5 mL) was stirred at 70 °C for 16 h. The solvent was removed under reduced pressure, and the crude was dissolved in DMF (14.5 mL). NaN<sub>3</sub> (226 mg, 3.40 mmol) was added and the mixture was stirred at 70 °C for 5 h. After cooling to rt, EtOAc (30 mL) was added. The organic phase was washed with 1:1 H<sub>2</sub>O/brine (3 × 30 mL), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure, and the crude was purified by chromatography (EtOAc/DCM 5 → 30%) to afford 2-(azidomethyl)-5-((4-(methylsulfonyl)butyl)sulfonyl)thiophene as a colorless oil (414 mg, 42%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.61 (d, <i>J</i> = 3.9 Hz, 1H), 7.09 (m, 1H), 4.59 (s, 2H), 3.33–3.22 (m, 2H), 3.13–3.01 (m, 2H), 2.92 (s, 3H), 2.13–1.92 (m, 4H). LCMS (ESI) <i>m</i>/<i>z</i> 360 [M + Na]<sup>+</sup>.</div><div class="NLM_p last">A mixture of (azidomethyl)-5-((4-(methylsulfonyl)butyl)sulfonyl)-thiophene (410 mg, 1.22 mmol) and Pd/C (10%; 129 mg, 0.122 mmol) in THF (6.1 mL) was stirred at rt under H<sub>2</sub> atmosphere (balloon) for 16 h and subsequently filtered through celite. The solvent was removed under reduced pressure, and the crude was purified by chromatography (MeOH/DCM 0 → 20%) to afford compound <b>3j</b> as a white solid (27 mg, 6%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.54 (d, <i>J</i> = 3.8 Hz, 1H), 6.95 (mm, 1H), 4.11 (s, 2H), 3.25–3.19 (m, 2H), 3.05–3.00 (m, 2H), 2.89 (s, 3H), 2.03–1.91 (m, 4H), 1.71 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 158.73, 137.14, 134.65, 123.97, 56.81, 53.92, 41.63, 40.85, 22.16, 21.11. HRMS (ESI) for C<sub>10</sub>H<sub>18</sub>NO<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 312.0393; observed 312.0417; error = 7.7 ppm.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (5-(Phenylsulfinyl)thiophen-2-yl)methanamine (<b>4a</b>)</h3><div class="NLM_p">5-(Phenylsulfinyl)thiophene-2-carbonitrile was synthesized according to general procedures GP5, from mCPBA (77%; 143 mg, 0.636 mmol) and 5-(phenylthio)thiophene-2-carbonitrile <b>29</b> (138 mg, 0.636 mmol) in DCM (3 mL), rt, 16 h. Chromatography (EtOAc/cyclohexane 0 → 20%) afforded a colorless oil (127 mg, 86%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.76–7.70 (m, 2H), 7.60–7.50 (m, 4H), 7.44 (d, <i>J</i> = 4.0 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 233 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>4a</b> was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 1.70 mL, 1.70 mmol), 5-(naphthalen-2-ylsulfonyl)thiophene-2-carbonitrile (132 mg, 0.568 mmol), and THF (2.8 mL), rt, 2 h. Chromatography (MeOH/DCM 0 → 20%) afforded a yellow oil (53 mg, 40%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.72–7.65 (m, 2H), 7.54–7.43 (m, 4H), 6.86 (m, 1H), 4.00 (s, 2H), 1.80 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 156.03, 145.85, 145.18, 132.03, 131.13, 129.26, 124.42, 123.46, 41.74. HRMS (ESI) for C<sub>11</sub>H<sub>12</sub>NOS<sub>2</sub> ([M + H]<sup>+</sup>): calculated 238.0355; observed 238.0378; error = 9.7 ppm.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> (5-(Phenylthio)thiophen-2-yl)methanamine Hydrochloride (<b>4b</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP2, from 4 M HCl in dioxane (2.5 mL) and <i>tert</i>-butyl ((5-(phenylthio)thiophen-2-yl)methyl)carbamate (60.1 mg, 0.189 mmol), rt, 3 h. A white solid was obtained, which did not require further purification (29 mg, 60%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 7.36–7.14 (m, 7H), 4.32 (s, 2H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 141.06, 138.75, 136.99, 135.89, 131.40, 130.24, 129.20, 127.91, 38.79. HRMS (ESI) for C<sub>11</sub>H<sub>9</sub>S<sub>2</sub> ([M – NH<sub>2</sub>]<sup>+</sup>): calculated 205.0146; observed 205.1050; error = 2.0 ppm.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 5-(Aminomethyl)-<i>N</i>-benzylthiophene-2-sulfonamide (<b>4c</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11a</b> (100 mg, 0.325 mmol), benzylamine (88.7 μL, 0.812 mmol), and DCM (1.63 mL), 16 h, rt and (ii) 30% NaOH (0.5 mL) and MeOH (3 mL), rt, 16 h. A colorless oil (59 mg, 64%) was obtained, which did not require further purification. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.44 (d, <i>J</i> = 3.7 Hz, 1H), 7.32–7.20 (m, 5H), 6.84 (d, <i>J</i> = 3.6 Hz, 1H), 5.24 (br, 1H), 4.19 (s, 2H), 4.02 (s, 2H), 1.87 (br, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 132.60, 128.77, 128.02, 127.98, 123.55, 47.50, 41.43. HRMS (ESI) for C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 283.0570; observed 283.0573; error = 1.1 ppm.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 5-(Aminomethyl)-<i>N</i>-benzylthiophene-2-carboxamide (<b>4d</b>)</h3><div class="NLM_p">A mixture of methyl 5-(azidomethyl)thiophene-2-carboxylate <b>44</b> (A = S) (1.77 g, 8.98 mmol), 1 M NaOH (30 mL), and MeOH (30 mL) was stirred at rt for 16 h. The pH was subsequently adjusted to <2 with 2 M HCl. The aqueous phase was extracted with DCM (3 × 30 mL). The combined organic phase was dried over MgSO<sub>4</sub> and filtered, and the solvent was removed under reduced pressure. The crude was dissolved in DCM (21.8 mL), and oxalyl chloride (0.61 mL, 7.20 mmol) was added, followed by DMF (two drops). The mixture was stirred at rt for 3 h, and the solvent was removed under reduced pressure to afford acyl chloride <b>45</b> (A = S) as an orange oil (1.25 g, 75%). Acyl chloride <b>45</b> was used in the subsequent transformation without further purification</div><div class="NLM_p last">Benzylamine (120 μL, 1.09 mmol) was added to a solution of acyl chloride <b>45</b> (100 mg, 0.496 mmol) and DCM (2.5 mL), and the mixture was stirred at rt for 3 h. Two molar HCl (10 mL) was added, and the aqueous phase was extracted with DCM (3 × 10 mL). The combined organic phase was dried over MgSO<sub>4</sub>, filtered, and the solvent was removed under reduced pressure. The crude was dissolved in THF (2.5 mL), and 10% Pd/C (53 mg) was added. The mixture was stirred under a H<sub>2</sub> atmosphere (balloon) at rt for 24 h and was subsequently filtered through celite. The solvent was removed under reduced pressure, and the crude was purified by chromatography (1 N NH<sub>3</sub> in MeOH/DCM 0 → 20%) to afford compound <b>4d</b> as a white solid (55 mg, 45%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 7.36–7.19 (m, 5H), 7.04 (d, <i>J</i> = 3.4 Hz, 1H), 6.37 (d, <i>J</i> = 3.3 Hz, 1H), 4.52 (s, 2H), 3.81 (s, 2H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 160.84, 159.70, 147.96, 140.02, 129.53, 128.59, 128.25, 116.26, 109.12, 43.74, 39.37. HRMS (ESI) for C<sub>13</sub>H<sub>15</sub>N<sub>2</sub>OS ([M + H]<sup>+</sup>): calculated 247.0905; observed 247.0907; error = 0.81 ppm.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (5-(4-(Methylsulfonyl)phenyl)thiophen-2-yl)methanamine Hydrochloride (<b>4e</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP2, from <i>tert</i>-butyl ((5-(4-(methylsulfonyl)phenyl)thiophen-2-yl)methyl)carbamate <b>59</b> (267 mg, 0.797 mmol), 4 M HCl in dioxane (4 mL), and DCM (4 mL), rt, 16 h. A light yellow solid was obtained that did not require further purification (138 mg, 64%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.01–7.96 (m, 2H), 7.93–7.89 (m, 2H), 7.57 (d, <i>J</i> = 3.7 Hz, 1H), 7.29 (d, <i>J</i> = 3.8 Hz, 1H), 4.36 (s, 2H), 3.16 (s, 3H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 144.98, 140.90, 140.20, 137.74, 131.83, 129.37, 127.31, 126.97, 44.36, 38.86. HRMS (ESI) for C<sub>12</sub>H<sub>11</sub>O<sub>2</sub>S<sub>2</sub> ([M – NH<sub>2</sub>]<sup>+</sup>): calculated 251.0200; observed 251.0196; error = 1.6 ppm.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (6-(Benzylsulfonyl)pyridin-3-yl)methanamine Dihydrochloride (<b>5a</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP5 and GP2, from (i) sulfide <b>47</b> (44 mg, 0.133 mmol), mCPBA (50%; 115 mg, 0.333 mmol), and DCM (0.6 mL) at rt for 16 h and (ii) 2 M HCl in Et<sub>2</sub>O (2.0 mL), DCM (1.0 mL), rt, 20 h. Chromatography (1 N NH<sub>3</sub> in MeOH/DCM 0 → 20%) afforded a white solid (27 mg, 77%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.76 (m, 1H), 7.92 (m, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.30–7.16 (m, 5H), 4.68 (s, 2H), 3.92 (s, 2H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 155.78, 150.77, 144.38, 138.22, 132.22, 129.66, 129.53, 129.19, 129.14, 124.10, 59.32, 43.72. HRMS (ESI) for C<sub>13</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S ([M + H]<sup>+</sup>): calculated 263.0849; observed 263.0848; error = 0.38 ppm.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (5-(Benzylsulfonyl)thiophen-2-yl)methanamine (<b>5b</b>)</h3><div class="NLM_p">5-(Benzylsulfonyl)thiophene-2-carbonitrile was synthesized according to general procedures GP4 and GP5, from (i) 5-bromothiophene-2-carbonitrile <b>17a</b> (150 μL, 1.35 mmol), benzylmercaptan (174 μL, 1.49 mmol), NaH (60% in mineral oil; 59.5 mg, 1.49 mmol), and DMF (4.5 mL), 140 °C, 16 h and (ii) mCPBA (77%; 757 mg, 3.38 mmol) and DCM (4.5 mL), rt, 4 h. Chromatography (EtOAc/cyclohexane 0 → 20%) afforded a white solid (318 mg, 89%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.07 (d, <i>J</i> = 4.0 Hz, 1H), 7.72 (d, <i>J</i> = 4.0 Hz, 1H), 7.40–7.32 (m, 3H), 7.25–7.18 (m, 2H), 4.93 (s, 2H). LCMS (ESI) <i>m</i>/<i>z</i> 286 [M + Na]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>5b</b> was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 1.10 mL, 1.10 mmol), 5-(benzylsulfonyl)thiophene-2-carbonitrile (151 mg, 0.570 mmol), and THF (2.8 mL) at rt for 1 h. Chromatography (MeOH/DCM 0 → 20%) afforded a white crystalline solid (23 mg, 15%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.38–7.26 (m, 3H), 7.21–7.15 (m, 3H), 6.84 (dt, <i>J</i> = 3.8, 1.0 Hz, 1H), 4.39 (s, 2H), 4.07 (d, <i>J</i> = 0.9 Hz, 2H), 1.59 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 158.50, 136.25, 135.25, 130.88, 129.00, 128.74, 128.52, 123.68, 64.15, 41.68. HRMS (ESI) for C<sub>12</sub>H<sub>14</sub>NO<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 268.0461; observed 268.0462; error = 0.37 ppm.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> (2-(Naphthalen-2-ylsulfonyl)thiazol-5-yl)methanamine hydrochloride (<b>5c</b>)</h3><div class="NLM_p"><i>tert-</i>Butyl ((2-(naphthalen-2-ylthio)thiazol-5-yl)methyl)carbamate was synthesized according to general procedures GP4, GP3, and GP6, from (i) 2-chlorothiazole-5-carbonitrile <b>17b</b> (580 mg, 4 mmol), naphthalene-2-thiol (640 mg, 4 mmol), K<sub>2</sub>CO<sub>3</sub> (800 mg, 5.8 mmol), and DMF (10 mL) at 60 °C for 24 h. Chromatography (DCM/cyclohexane 0 → 100%) 400 mg, 37%; (ii) 2-(naphthalen-2-ylthio)thiazole-5-carbonitrile (400 mg, 1.5 mmol), BH<sub>3</sub> (1.0 M in THF; 5 mL, 5 mmol), THF (20 mL) at rt for 18 h. Chromatography (EtOAc/DCM 0 → 100%) 120 mg, 26%; (iii) (2-(naphthalen-2-ylthio)thiazol-5-yl)methanamine (120 mg, 0.4 mmol), Boc<sub>2</sub>O (109 mg, 0.5 mmol), Et<sub>3</sub>N (70 μL, 0.5 mmol), THF (5 mL), rt, 18 h. Chromatography (EtOAc/DCM 0 → 50%) to afford <i>tert</i>-butyl ((2-(naphthalen-2-ylthio)thiazol-5-yl)methyl)carbamate (110 mg, 74%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (d, <i>J</i> = 1.9 Hz, 1H), 8.29 (d, <i>J</i> = 8.2 Hz, 1H), 8.20 (d, <i>J</i> = 8.7 Hz, 1H), 8.09 (d, <i>J</i> = 8.1 Hz, 1H), 7.95 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 7.91 (s, 1H), 7.82–7.75 (m, 1H), 7.72 (ddd, <i>J</i> = 8.0, 6.9, 1.3 Hz, 1H), 7.65 (t, <i>J</i> = 6.1 Hz, 1H), 4.36 (d, <i>J</i> = 6.0 Hz, 2H), 1.38 (s, 9H). LCMS (ESI) <i>m</i>/<i>z</i> 373 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>5c</b> was synthesized according to general procedures GP5 and GP2, from (i) <i>tert-butyl</i> ((2-(naphthalen-2-ylthio)thiazol-5-yl)methyl)carbamate (110 mg, 0.296 mmol), mCPBA (77%; 340 mg, 1.52 mmol), and DCM (5.0 mL) at rt for 3 h and (ii) 4 M HCl in dioxane (2.0 mL) and dioxane (5 mL), at rt, for 16 h. The white precipitate was filtered, washed with excess dioxane, and dried under vacuum to afford the desired compound as a white solid (33 mg, 37%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.82 (d, <i>J</i> = 2.0 Hz, 1H), 8.49 (s, 3H), 8.31 (d, <i>J</i> = 8.2 Hz, 1H), 8.23 (d, <i>J</i> = 8.7 Hz, 1H), 8.15 (s, 1H), 8.10 (d, <i>J</i> = 8.1 Hz, 1H), 7.97 (dd, <i>J</i> = 8.6, 2.1 Hz, 1H), 7.84–7.77 (m, 1H), 7.77–7.71 (m, 1H), 4.39 (s, 2H). HRMS (ESI) for C<sub>14</sub>H<sub>13</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> [M + H]<sup>+</sup>: calculated 305.0413; observed 305.0471; error = 19 ppm.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> (5-(Naphthalen-2-ylsulfonyl)thiazol-2-yl)methanamine Hydrochloride (<b>5d</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP5 and GP2, from (i) <i>tert</i>-butyl ((5-(naphthalen-2-ylthio)thiazol-2-yl)methyl)carbamate <b>49</b> (200 mg, 0.537 mmol), mCPBA (77%; 300 mg, 1.34 mmol), and DCM (4 mL) at rt for 18 h; chromatography (EtOAc/cyclohexane 0 → 60%) and (ii) 4 M HCl in dioxane (1.6 mL) at rt for 4 h. The mixture was diluted with Et<sub>2</sub>O and the precipitate collected using filtration, washed with excess Et<sub>2</sub>O, and dried under vacuum to afford the compound as a white solid (106 mg, 52% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 8.79 (d, 1H, <i>J</i> = 1.8 Hz), 8.72 (br s, 3H), 8.65 (s, 1H), 8.27 (d, 1H, <i>J</i> = 8.4 Hz), 8.21 (d, 1H, <i>J</i> = 8.8 Hz), 8.09 (d, 1H, <i>J</i> = 8.2 Hz), 8.00 (dd, 1H, <i>J</i> = 8.7, 2.0 Hz), 7.78 (ddd, 1H, <i>J</i> = 8.2, 6.9, 1.3 Hz), 7.73 (ddd, 1H, <i>J</i> = 8.1, 6.9, 1.3 Hz), 4.46 (s, 2H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 170.3, 147.4, 140.2, 137.6, 134.9, 131.8, 130.4, 130.0, 129.7, 128.8, 128.2, 128.0, 121.8, 39.7; HRMS (ESI) for C<sub>14</sub>H<sub>13</sub>N<sub>2</sub>S<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>: calculated 305.0402; observed 305.0413; error = 3.6 ppm.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 5-(Aminomethyl)-<i>N</i>-benzylfuran-2-carboxamide (<b>5e</b>)</h3><div class="NLM_p last">Benzylamine (130 μL, 1.19 mmol) was added to a solution of acyl chloride <b>45</b> (A = O; 100 mg, 0.539 mmol) and DCM (2.7 mL), and the mixture was stirred at rt for 1 h. Two molar HCl (10 mL) was added, and the aqueous phase was extracted with DCM (3 × 10 mL). The combined organic phase was dried over MgSO<sub>4</sub> and filtered, and the solvent was removed under reduced pressure. The crude was dissolved in THF (2.7 mL), and 10% Pd/C (57.3 mg) was added. The mixture was stirred under a H<sub>2</sub> atmosphere (balloon) at rt for 20 h and was subsequently filtered through celite. The solvent was removed under reduced pressure, and the crude was purified by chromatography (1 N NH<sub>3</sub> in MeOH/DCM 0 → 20%) to afford compound <b>5e</b> as a light brown oil (48 mg, 39%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 7.56 (d, <i>J</i> = 3.8 Hz, 1H), 7.38–7.18 (m, 5H), 6.98 (d, <i>J</i> = 3.8 Hz, 1H), 4.51 (s, 2H), 3.96 (s, 2H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 164.43, 152.94, 140.21, 138.59, 129.85, 129.56, 128.56, 128.22, 126.28, 44.41, 41.61. HRMS (ESI) for C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>Na ([M + Na]<sup>+</sup>): calculated 253.0953; observed 253.0960; error = 2.8 ppm.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> (5-(Indolin-1-ylsulfonyl)-4-methylthiophen-2-yl)methanamine (<b>5f</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP1, from (i) sulfonyl chloride <b>11b</b> (crude), Et<sub>3</sub>N (44.4 μL, 0.319 mmol), indoline (33 μL, 0.294 mmol), and DCM (1.2 mL), rt, 3 h; (ii) 7 N NH<sub>3</sub> in MeOH (5 mL), rt for 20 h. Chromatography (1 N NH<sub>3</sub> in MeOH/DCM 0 → 10%) afforded a compound as a light brown foam (54 mg, 73%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.59 (d, <i>J</i> = 8.1 Hz, 1H), 7.21–7.10 (m, 2H), 7.00 (td, <i>J</i> = 7.4, 0.9 Hz, 1H), 6.68 (s, 1H), 4.03 (t, <i>J</i> = 8.4 Hz, 2H), 3.96 (s, 2H), 2.97 (t, <i>J</i> = 8.3 Hz, 2H), 2.33 (s, 3H), 1.68–1.35 (br, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 153.13, 143.82, 141.96, 132.09, 129.42, 127.97, 127.69, 125.15, 124.08, 115.79, 50.22, 41.39, 28.16, 15.56. HRMS (ESI) for C<sub>14</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 309.0726; observed 309.0726; error = 0 ppm.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> <i>N</i>-Methyl-1-(5-(phenylsulfonyl)thiophen-2-yl)methanamine Hydrochloride (<b>6a</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP2, from <i>tert</i>-butyl methyl((5-(phenylsulfonyl)thiophen-2-yl)methyl)carbamate (57 mg, 0.155 mmol) and 4 M HCl in dioxane (2.5 mL) at rt for 16 h. Chromatography (EtOH/cyclohexane 50 → 100%) afforded a white solid (43 mg, quant.). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.01–7.93 (m, 2H), 7.67–7.55 (m, 4H), 7.05 (d, <i>J</i> = 3.8 Hz, 1H), 3.93 (s, 2H), 2.38 (s, 3H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 154.35, 143.60, 142.54, 134.90, 134.63, 130.61, 128.22, 127.79, 50.42, 35.41. HRMS (ESI) for C<sub>12</sub>H<sub>14</sub>NO<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 268.0461; observed 268.0457; error = 1.5 ppm.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 1-(5-(Phenylsulfonyl)thiophen-2-yl)ethanamine (<b>6b</b>)</h3><div class="NLM_p">A mixture of sulfone <b>41</b> (177 mg, 0.665 mmol), hydroxylamine hydrochloride (76 mg, 1.10 mmol), and DIPEA (174 μL, 1.00 mmol) in EtOH (10 mL) was stirred at reflux for 18 h. After cooling to rt, the solvent was removed under reduced pressure. The crude was purified by chromatography (EtOAc/DCM 0 → 100%) to afford 1-(5-(phenylsulfonyl)thiophen-2-yl)ethanone oxime (80 mg, 43%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.72 (s, 1H), 8.01–7.95 (m, 2H), 7.79 (d, <i>J</i> = 4.0 Hz, 1H), 7.75–7.70 (m, 1H), 7.68–7.62 (m, 2H), 7.41 (d, <i>J</i> = 4.0 Hz, 1H), 2.14 (s, 3H).</div><div class="NLM_p last">A mixture of 1-(5-(phenylsulfonyl)thiophen-2-yl)ethanone oxime (80 mg, 0.142 mmol), Zn powder (∼10 mg), and TFA (4 mL) was stirred at rt for 1 h. The mixture was diluted with DCM and filtered through celite, and the solvent was removed under reduced pressure. EtOAc was added, and the solution was washed with sat. NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, and filtered, and the solvent was removed under reduced pressure to afford compound <b>6b</b> (17 mg, 43%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.96–7.92 (m, 2H), 7.70–7.67 (m, 2H), 7.65–7.61 (m, 2H), 7.01 (dd, <i>J</i> = 3.9, 1.0 Hz, 1H), 4.21 (qd, <i>J</i> = 6.5, 1.0 Hz, 1H), 2.40 (s, 2H), 1.30 (d, <i>J</i> = 6.6 Hz, 3H). LCMS (ESI) <i>m</i>/<i>z</i> 251 [M – NH<sub>2</sub>]<sup>+</sup>.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 5-(Phenylsulfonyl)thiophene-2-carbonitrile (<b>6c</b>)</h3><div class="NLM_p last">The titled compound can be obtained in two steps from the method illustrated in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> in the manuscript. An alternative one-step method is shown here: A mixture of 5-bromothiophene-2-carbonitrile <b>17a</b> (100 mg, 0.532 mmol), sodium benzenesulfinate (138 mg, 0.691 mmol), and DMF (1.0 mL) was stirred at 135 °C for 16 h. After cooling to rt, EtOAc (10 mL) was added. The organic phase was washed with H<sub>2</sub>O (2 × 10 mL) and brine (10 mL), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure, and the crude was purified by chromatography (EtOAc/cyclohexane 0 → 20%) to afford nitrile <b>6c</b> as a white crystalline solid (67 mg, 51%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.03–7.98 (m, 2H), 7.70–7.53 (m, 5H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 150.24, 140.54, 137.42, 134.47, 132.39, 129.89, 127.86, 117.10, 112.37. HRMS (ESI) for C<sub>11</sub>H<sub>7</sub>NO<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 249.9996; observed 250.0001; error = 2.0 ppm.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 5-(Phenylsulfonyl)thiophene-2-carboximidamide Hydrochloride (<b>6d</b>)</h3><div class="NLM_p last">LiHMDS (225 mg, 1.35 mmol) was added to a mixture of nitrile <b>6c</b> (224 mg, 0.900 mmol) in Et<sub>2</sub>O (10 mL), and the mixture was stirred at rt for 1 h. Two molar HCl (5 mL) was added, and the mixture was stirred for a further 1 h. The aqueous layer was washed with Et<sub>2</sub>O, basified with NaOH pellets, and extracted with Et<sub>2</sub>O. The combined organic phase was dried over MgSO<sub>4</sub> and filtered, and the solvent was removed under reduced pressure to afford compound <b>6d</b> as a yellow solid (40 mg, 16%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.07 (d, <i>J</i> = 6.9 Hz, 2H), 7.89 (br s, 2H), 7.54–7.80 (m, 3H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 160.8, 151.3, 142.2, 137.2, 135.8, 135.1, 134.9, 131.2, 129.0. HRMS (ESI) for C<sub>11</sub>H<sub>10</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub> [M + H]<sup>+</sup>: calculated 267.0256; observed 267.0301; error = 17 ppm.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 5-(Phenylsulfonyl)thiophene-2-carboxamide (<b>6e</b>)</h3><div class="NLM_p last">A mixture of nitrile <b>6c</b> (100 mg, 0.401 mmol), InCl<sub>3</sub> (4.4 mg, 5%), and acetaldoxime (76 mg, 1.21 mmol) in toluene (0.4 mL) was stirred at reflux for 5 h. The solvent was removed under reduced pressure, and the crude was purified by chromatography (EtOAc/cyclohexane 20 → 80%) to afford compound <b>6e</b> as a yellow gel (52 mg, 50%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.94–8.10 (m, 2H), 7.66–7.75 (m, 3H), 7.59–7.66 (m, 2H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>OD) δ 164.8, 148.5, 148.3, 142.9, 135.2, 134.8, 130.9, 130.2, 128.7. HRMS (ESI) for C<sub>11</sub>H<sub>9</sub>NO<sub>3</sub>S<sub>2</sub> [M + H]<sup>+</sup>: calculated 268.0097; observed 268.0187; error = 34 ppm.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 5-(Naphthalen-2-ylsulfonyl)thiophene-2-carbaldehyde Oxime (<b>6f</b>)</h3><div class="NLM_p">DIBAL-H (1.0 M in toluene; 1.0 mL, 1.0 mmol) was added to a solution of 5-(naphthalen-2-ylsulfonyl)thiophene-2-carbonitrile <b>43</b> (104 mg, 0.347 mmol) in DCM (3 mL) at rt. The mixture was stirred at 45 °C for 45 min and cooled in an ice bath. Two molar H<sub>2</sub>SO<sub>4</sub> was added followed by stirring for a further 1 h at rt. The aqueous phase was extracted with DCM. The organic phase was washed with H<sub>2</sub>O and sat. NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the solvent was removed under reduced pressure. The crude was purified by column chromatography (EtOAc/cyclohexane 0 → 30%) to afford 5-(naphthalen-2-ylsulfonyl)thiophene-2-carbaldehyde as a yellow solid (96 mg, 92%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 9.92 (s, 1H), 8.62 (s, 1H), 8.07–7.96 (m, 2H), 7.96–7.87 (m, 2H), 7.78 (d, <i>J</i> = 3.8 Hz, 1H), 7.72–7.61 (m, 3H). HRMS (ESI) for C<sub>15</sub>H<sub>10</sub>O<sub>3</sub>S<sub>2</sub> [M + H]<sup>+</sup>: calculated 303.0144; observed 303.0159; error = 5.0 ppm.</div><div class="NLM_p last">A mixture of 5-(naphthalen-2-ylsulfonyl)thiophene-2-carbaldehyde (96 mg, 0.318 mmol), hydroxylamine hydrochloride (28 mg, 0.406 mmol), and K<sub>2</sub>CO<sub>3</sub> (132 mg, 0.957 mmol) in EtOH (6.0 mL) was stirred 70 °C for 2 h. After cooling to rt, the mixture was filtered and the solvent was removed under reduced pressure. The crude was purified by chromatography (EtOAc/cyclohexane) to afford oxime <b>6f</b> as a white solid (38 mg, 38%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.61 (s, 1H), 7.95–8.08 (m, 2H), 7.87–7.95 (m, 2H), 7.58–7.74 (m, 4H), 7.41 (d, <i>J</i> = 4.1 Hz, 1H), 5.8 (br s, OH). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 161.8, 147.8, 145.1, 137.9, 135.3, 132.8, 132.2, 129.9, 129.5, 129.3, 128.5, 128.0, 127.9, 122.3. HRMS (ESI) for C<sub>15</sub>H<sub>11</sub>NO<sub>3</sub>S<sub>2</sub> [M – OH]<sup>+</sup>: calculated 300.0153; observed 300.0192; error = 13 ppm.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> (3-(Naphthalen-2-ylsulfonyl)thiophen-2-yl)methanamine (<b>7a</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 6.0 mL, 6.0 mmol), 3-(naphthalen-2-ylsulfonyl)thiophene-2-carbonitrile <b>52</b> (602 mg, 2.01 mmol), and THF (6.0 mL), for 2 h, at rt. Chromatography (EtOH/cyclohexane 0 → 90%) afforded a white crystalline solid (289 mg, 48%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.55 (d, <i>J</i> = 1.5 Hz, 1H), 8.00 (d, <i>J</i> = 7.9 Hz, 1H), 7.95 (d, <i>J</i> = 8.7 Hz, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 1H), 7.84 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 7.69–7.60 (m, 2H), 7.42 (d, <i>J</i> = 5.4 Hz, 1H), 7.20 (d, <i>J</i> = 5.4 Hz, 1H), 4.31 (s, 2H), 1.92 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 154.77, 138.97, 135.19, 135.00, 132.29, 129.85, 129.57, 129.32, 128.68, 128.45, 128.09, 127.85, 124.02, 122.36, 40.04. HRMS (ESI) for C<sub>15</sub>H<sub>14</sub>NO<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 304.0460; observed 304.0462; error = 0.66 ppm.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> (4-(Naphthalen-2-ylsulfonyl)thiophen-3-yl)methanamine (<b>7b</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 8.2 mL, 8.2 mmol), 4-(naphthalen-2-ylsulfonyl)thiophene-3-carbonitrile <b>54</b> (0.821 g, 2.75 mmol), and THF (8.2 mL); 2 h, rt. Chromatography (EtOH/cyclohexane 0 → 100%) afforded a white crystalline solid (386 mg, 47%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.55 (br, 1H), 8.27 (d, <i>J</i> = 3.4 Hz, 1H), 7.97 (d, <i>J</i> = 7.9 Hz, 1H), 7.92 (d, <i>J</i> = 8.7 Hz, 1H), 7.87 (d, <i>J</i> = 8.0 Hz, 1H), 7.79 (dd, <i>J</i> = 8.7, 1.8 Hz, 1H), 7.71–7.53 (m, 2H), 7.26 (d, <i>J</i> = 14.5 Hz, 1H), 3.85 (s, 2H), 1.82–1.54 (m, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 142.19, 138.80, 137.83, 135.08, 134.87, 132.08, 129.73, 129.46, 129.34, 128.86, 127.98, 127.79, 124.96, 122.48, 77.42, 77.17, 76.92, 40.35. HRMS (ESI) for C<sub>15</sub>H<sub>14</sub>NO<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 304.0460; observed 304.0460; error = 0 ppm.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> (4-(Naphthalen-2-ylsulfonyl)thiophen-2-yl)methanamine (<b>7c</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 5.0 mL, 5.0 mmol), 4-(naphthalen-2-ylsulfonyl)thiophene-2-carbonitrile <b>56</b> (501 mg, 1.68 mmol), and THF (5.0 mL), 2 h, rt. Chromatography (EtOH/cyclohexane 5 → 100%) afforded a light orange solid (256 mg, 51%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.57 (s, 1H), 8.02 (s, 1H), 8.00–7.91 (m, 2H), 7.90–7.84 (m, 2H), 7.67–7.54 (m, 2H), 7.16 (s, 1H), 3.97 (s, 2H), 1.71 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 151.36, 141.20, 138.42, 135.07, 132.24, 130.33, 129.71, 129.44, 129.20, 128.89, 127.99, 127.70, 122.56, 121.52, 41.27. HRMS (ESI) for C<sub>15</sub>H<sub>14</sub>NO<sub>2</sub>S<sub>2</sub> ([M + H]<sup>+</sup>): calculated 304.0460; observed 304.0444; error = 5.2 ppm.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> (5-(3-(Methylsulfonyl)phenylsulfonyl)thiophen-2-yl)methanamine (<b>8a</b>)</h3><div class="NLM_p">5-((3-(Methylsulfonyl)phenyl)sulfonyl)thiophene-2-carbonitrile was synthesized according to general procedures GP4 and GP5, from (i) 5-chlorothiophene-2-carbonitrile <b>17a</b> (120 μL, 1.14 mmol), 3-(methylthio)benzenethiol (178 mg, 1.14 mmol), K<sub>2</sub>CO<sub>3</sub> (157 mg, 1.14 mmol), and DMF (5.7 mL), 120 °C, 16 h and (ii) mCPBA (77%; 1.15 g, 5.13 mmol) and DCM (5.7 mL), rt, 16 h. Chromatography (EtOAc/DCM 5 → 30%) afforded a white solid (207 mg, 56%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.57 (t, <i>J</i> = 1.7 Hz, 1H), 8.28 (ddd, <i>J</i> = 7.9, 1.8, 1.1 Hz, 1H), 8.23 (ddd, <i>J</i> = 7.9, 1.6, 1.1 Hz, 1H), 7.83 (t, <i>J</i> = 7.9 Hz, 1H), 7.72 (d, <i>J</i> = 4.1 Hz, 1H), 7.60 (d, <i>J</i> = 4.1 Hz, 1H), 3.13 (s, 3H).</div><div class="NLM_p last">Compound <b>8a</b> was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 0.88 mL, 0.88 mmol), 5-((3-(methylsulfonyl)phenyl)sulfonyl)thiophene-2-carbonitrile (96 mg, 0.293 mmol), and THF (1.5 mL); rt, 1 h. Chromatography (MeOH/DCM 0 → 20%) afforded a white solid (60 mg, 63%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.50 (t, <i>J</i> = 1.6 Hz, 1H), 8.24 (ddd, <i>J</i> = 7.9, 1.7, 1.1 Hz, 1H), 8.13 (ddd, <i>J</i> = 7.8, 1.7, 1.1 Hz, 1H), 7.74 (t, <i>J</i> = 7.9 Hz, 1H), 7.62 (d, <i>J</i> = 3.9 Hz, 1H), 6.91 (dt, <i>J</i> = 3.9, 1.0 Hz, 1H), 4.07 (d, <i>J</i> = 0.9 Hz, 2H), 3.09 (s, 3H), 1.65 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 160.00, 144.45, 142.31, 138.59, 134.88, 132.21, 131.73, 130.82, 126.38, 124.12, 44.45, 41.64. HRMS (ESI) for C<sub>12</sub>H<sub>11</sub>O<sub>4</sub>S<sub>3</sub> ([M – NH<sub>2</sub>]<sup>+</sup>): calculated 314.9814; observed 314.9820; error = 1.9 ppm.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> (5-(2-(Methylsulfonyl)phenylsulfonyl)thiophen-2-yl)methanamine (<b>8b</b>)</h3><div class="NLM_p">5-((2-(Methylsulfonyl)phenyl)sulfonyl)thiophene-2-carbonitrile was synthesized according to general procedures GP4 and GP5, from (i) 5-chlorothiophene-2-carbonitrile <b>17a</b> (87.8 μL, 0.832 mmol), 2-(methylthio)benzenethiol (130 mg, 0.832 mmol), K<sub>2</sub>CO<sub>3</sub> (172 mg, 1.25 mmol) and DMF (2.8 mL), 120 °C, 16 h and (ii) mCPBA (77%; 839 mg, 3.74 mmol) and DCM (2.8 mL), rt, 6 h. Chromatography (EtOAc/DCM 5 → 30%) afforded a white solid (46 mg, 17%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.47 (m, 1H), 8.37 (m, 1H), 7.96–7.87 (m, 3H), 7.54 (d, <i>J</i> = 4.1 Hz, 1H), 3.49 (s, 3H).</div><div class="NLM_p last">Compound <b>8b</b> was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 0.41 mL, 0.41 mmol), 5-((2-(methylsulfonyl)phenyl)sulfonyl)thiophene-2-carbonitrile (45 mg, 0.137 mmol) and THF (0.8 mL), rt, 1 h. Chromatography (MeOH/DCM 0 → 20%) afforded compound <b>8b</b> as a white solid (17 mg, 39%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.43 (dd, <i>J</i> = 7.5, 1.7 Hz, 1H), 8.33 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.88 (d, <i>J</i> = 3.9 Hz, 1H), 7.85–7.76 (m, 2H), 6.88 (dt, <i>J</i> = 3.9, 0.9 Hz, 1H), 4.06 (d, <i>J</i> = 0.8 Hz, 2H), 3.51 (s, 3H), 1.59 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 159.33, 142.15, 139.62, 138.92, 136.80, 134.50, 134.07, 132.79, 132.44, 123.74, 45.73, 41.73. HRMS (ESI) for C<sub>12</sub>H<sub>14</sub>NO<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 332.0080; observed 332.0108; error = 8.4 ppm.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> (5-((4-(Pyrrolidin-1-ylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methanamine (<b>8c</b>)</h3><div class="NLM_p last">A mixture of 2,2,2-trifluoro-<i>N</i>-((5-((4-(pyrrolidin-1-ylsulfonyl)phenyl)thio)thiophen-2-yl)methyl)acetamide <b>24c</b> (91 mg, 0.202 mmol), mCPBA (77%; 100 mg, 0.444 mmol), and DCM (1.4 mL) was stirred at rt for 4 h. EtOAc (30 mL) was added. The organic phase was washed with sat. NaHCO<sub>3</sub> (3 × 30 mL), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure. The crude was dissolved in 7 N NH<sub>3</sub> in MeOH (3.0 mL), and the mixture was stirred at rt for 16 h. The solvent was removed under reduced pressure, and the crude was purified by chromatography (EtOH/cyclohexane 5 → 40%, then 100%) to afford compound <b>8c</b> as a white solid (38 mg, 49%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.20–8.15 (m, 2H), 8.04–8.00 (m, 2H), 7.70 (d, <i>J</i> = 3.9 Hz, 1H), 7.07 (m, 1H), 4.01 (s, 2H), 3.27–3.22 (m, 4H), 1.79–1.73 (m, 4H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 159.72, 147.61, 143.08, 140.37, 136.09, 129.69, 129.18, 126.59, 49.15, 41.66, 26.28. HRMS (ESI) for C<sub>15</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 387.0502; observed 387.0489; error = 3.4 ppm.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> (5-((3-(Pyrrolidin-1-ylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methanamine (<b>8d</b>)</h3><div class="NLM_p last">A mixture of 2,2,2-trifluoro-<i>N</i>-((5-((3-(pyrrolidin-1-ylsulfonyl)phenyl)thio)thiophen-2-yl)methyl)acetamide <b>24d</b> (107 mg, 0.238 mmol), mCPBA (77%; 117 mg, 0.523 mmol), and DCM (1.6 mL) was stirred at rt for 4 h. EtOAc (30 mL) was added. The organic phase was washed with sat. NaHCO<sub>3</sub> (3 × 30 mL), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure. The crude was dissolved in 7 N NH<sub>3</sub> in MeOH (3.0 mL), and the mixture was stirred at rt for 16 h. The solvent was removed under reduced pressure, and the crude was purified by chromatography (EtOH/cyclohexane 5 → 40%, then 100%) to afford compound <b>8d</b> as a white solid (49 mg, 51%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.37 (br, 1H), 8.16 (m, <i>J</i> = 7.0 Hz, 1H), 8.00 (m, <i>J</i> = 7.2 Hz, 1H), 7.69 (t, <i>J</i> = 7.8 Hz, 1H), 7.60 (m, 1H), 6.90 (br, 1H), 4.07 (br, 2H), 3.25 (br, 4H), 1.78 (br, 4H), 1.64 (br, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 159.69, 144.01, 139.17, 138.94, 134.64, 131.61, 131.00, 130.42, 126.07, 124.06, 48.17, 41.64, 25.40. HRMS (ESI) for C<sub>15</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 387.0502; observed 387.0493; error = 2.3 ppm.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> (<i>S</i>)-(1-((3-((5-(Aminomethyl)thiophen-2-yl)sulfonyl)phenyl)sulfonyl)pyrrolidin-2-yl)methanol (<b>8e</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP5 and GP3, from (i) (<i>S</i>)-5-((3-((2-(hydroxymethyl)pyrrolidin-1-yl)sulfonyl)phenyl)thio)thiophene-2-carbonitrile <b>23e</b> (180 mg, 0.474 mmol), mCPBA (77%; 234 mg, 1.04 mmol) and DCM (3.2 mL), rt, 3 h and (ii) BH<sub>3</sub> (1.0 M in THF; 1.42 mL, 1.42 mmol) and THF (1.42 mL), rt, 1 h. Chromatography (EtOH/cyclohexane 20 → 100%) afforded a white foam (141 mg, 72%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.37 (t, <i>J</i> = 1.8 Hz, 1H), 8.18 (dt, <i>J</i> = 7.9, 1.5 Hz, 1H), 8.02 (dt, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.70 (t, <i>J</i> = 7.9 Hz, 1H), 7.60 (d, <i>J</i> = 3.8 Hz, 1H), 6.91 (m, 1H), 4.07 (d, <i>J</i> = 1.0 Hz, 2H), 3.69–3.58 (m, 3H), 3.45 (ddd, <i>J</i> = 10.4, 6.9, 5.2 Hz, 1H), 3.18 (dt, <i>J</i> = 10.4, 7.1 Hz, 1H), 2.13 (br, 3H), 1.88–1.75 (m, 2H), 1.70–1.58 (m, 1H), 1.55–1.43 (m, 1H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 159.51, 144.04, 139.01, 138.72, 134.73, 131.69, 131.20, 130.61, 126.10, 124.24, 65.27, 62.06, 50.01, 41.54, 28.72, 24.26. HRMS (ESI) for C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>5</sub>S<sub>3</sub>Na ([M + Na]<sup>+</sup>): calculated 439.0427; observed 439.0413; error = 3.2 ppm.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> (5-((4-(Phenylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methanamine (<b>8f</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP3, from 5-((4-(phenylsulfonyl)phenyl)sulfonyl)thiophene-2-carbonitrile <b>30</b> (40 mg, 0.103 mmol), BH<sub>3</sub> (1.0 M in THF; 0.5 mL, 0.5 mmol), and THF (4.0 mL), rt, 3 h. Chromatography (EtOH/cyclohexane 0 → 100%) afforded a glassy solid (8 mg, 20%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.21–8.13 (m, 4H), 7.99 (dt, <i>J</i> = 7.1, 1.3 Hz, 2H), 7.75 (d, <i>J</i> = 3.9 Hz, 1H), 7.73–7.70 (m, 1H), 7.64 (t, <i>J</i> = 7.8 Hz, 2H), 7.02 (dt, <i>J</i> = 3.5, 1.2 Hz, 1H), 3.89 (d, <i>J</i> = 1.3 Hz, 2H), 2.45–2.13 (br, 2H). HRMS calcd for C<sub>17</sub>H<sub>15</sub>NO<sub>4</sub>S<sub>3</sub> [M + H]<sup>+</sup> 394.0236; found 394.0233; error = 0.76 ppm.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> 2-((4-((5-(Aminomethyl)thiophen-2-yl)sulfonyl)phenyl)sulfonyl)ethanol Hydrochloride (<b>8g</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP2, from <i>tert</i>-butyl ((5-((4-((2-hydroxyethyl)sulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>27</b> (<i>n</i> = 1) (52 mg, 0.113 mmol) and 4 M HCl in dioxane (3.0 mL); rt, 3 h. A white solid was obtained, which did not require further purification (39 mg, 87%). <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O) δ 8.37–8.29 (m, 2H), 8.27–8.19 (m, 2H), 7.91 (m, 1H), 7.38 (m, 1H), 4.48 (s, 2H), 4.03–3.95 (m, 2H), 3.72–3.65 (m, 2H). <sup>13</sup>C NMR (126 MHz, D<sub>2</sub>O) δ 146.18, 144.20, 140.94, 136.69, 131.43, 130.19, 129.18, 58.15, 55.77, 38.19. HRMS (ESI) for C<sub>13</sub>H<sub>13</sub>O<sub>5</sub>S<sub>3</sub> ([M – NH<sub>2</sub>]<sup>+</sup>): calculated 344.9920; observed 344.9917; error = 0.87 ppm.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> 3-((4-((5-(Aminomethyl)thiophen-2-yl)sulfonyl)phenyl)sulfonyl)propan-1-ol Hydrochloride (<b>8h</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedure GP2, from 4 M HCl in dioxane (1.5 mL) and <i>tert</i>-butyl ((5-((4-((3-hydroxypropyl)sulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>27</b> (<i>n</i> = 2) 23.5 mg, 0.0494 mmol; rt, 3 h. A white solid was obtained and did not require further purification (23 mg, quant.). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.26 (d, <i>J</i> = 8.5 Hz, 2H), 8.15 (d, <i>J</i> = 8.5 Hz, 2H), 7.83 (d, <i>J</i> = 3.9 Hz, 1H), 7.34 (d, <i>J</i> = 3.9 Hz, 1H), 4.39 (s, 2H), 3.58 (t, <i>J</i> = 6.1 Hz, 2H), 3.37–3.32 (m, 2H), 1.89–1.80 (m, 2H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 148.02, 146.19, 145.44, 144.33, 136.14, 131.84, 130.66, 129.60, 60.56, 53.60, 38.46, 26.85. HRMS (ESI) for C<sub>14</sub>H<sub>18</sub>NO<sub>5</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 376.0342; observed 376.0334; error = 2.1 ppm.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> (5-((4-((2-(Pyrrolidin-1-yl)ethyl)sulfonyl)phenyl)sulfonyl)thiophen-2-yl)methanamine Dihydrochloride (<b>8i</b>)</h3><div class="NLM_p last">Pyrrolidine (12.6 μL, 0.151 mmol) was added to a solution of <i>tert</i>-butyl ((5-((4-(vinylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>28</b> (61 mg, 0.138 mmol) in DCM (0.8 mL), and the mixture was stirred at rt for 16 h. The solvent was removed under reduced pressure. Four molar HCl in dioxane (4 mL) was added to the crude and the mixture was stirred at rt for 16 h. The precipitated solid was collected on a pad of celite and washed with EtOAc. MeOH was added to dissolve the solid, and the suspension was filtered. The solvent was removed under reduced pressure to afford compound <b>8i</b> as a white solid (58 mg, 85%), which did not require further purification. <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O) δ 8.37 (d, <i>J</i> = 7.9 Hz, 2H), 8.27 (d, <i>J</i> = 7.9 Hz, 2H), 7.92 (m, 1H), 7.41 (m, 1H), 4.51 (s, 2H), 3.99 (t, <i>J</i> = 7.2 Hz, 2H), 3.92–2.98 (m, 6H), 2.13 (br, 4H). <sup>13</sup>C NMR (126 MHz, D<sub>2</sub>O) δ 146.87, 145.89, 142.50, 140.91, 136.88, 131.77, 130.49, 129.53, 55.66, 51.65, 48.16, 38.08, 23.47. HRMS (ESI) for C<sub>17</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 415.0815; observed 415.0828; error = 3.1 ppm.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> <i>N</i>-(2-((4-((5-(Aminomethyl)thiophen-2-yl)sulfonyl)phenyl)sulfonyl)ethyl)-acetamide Hydrochloride (<b>8j</b>)</h3><div class="NLM_p">A mixture of <i>tert</i>-butyl ((5-((4-(vinylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>28</b> (448 mg, 1.01 mmol) and 7 N NH<sub>3</sub> in MeOH (10 mL) was stirred at rt for 2 h. The solvent was removed under reduced pressure to afford <i>tert</i>-butyl ((5-((4-((2-aminoethyl)sulfonyl)phenyl)thio)thiophen-2-yl)methyl)carbamate as a white solid (472 mg, quant.), which did not required further purification. <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 7.70 (d, <i>J</i> = 3.8 Hz, 1H), 7.03 (d, <i>J</i> = 3.9 Hz, 1H), 4.39 (s, 2H), 8.16–8.12 (m, 2H), 3.39 (t, <i>J</i> = 6.7 Hz, 2H), 2.96 (t, <i>J</i> = 6.7 Hz, 2H), 1.44 (s, 9H), 8.27–8.21 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> 405 [M – <i><sup>t</sup></i>Bu + 2H]<sup>+</sup>.</div><div class="NLM_p last">Ac<sub>2</sub>O (18.1 μL, 0.191 mmol) was added to a solution of afford <i>tert</i>-butyl ((5-((4-((2-aminoethyl)sulfonyl)phenyl)thio)thiophen-2-yl)methyl)carbamate (80 mg, 0.174 mmol) and Et<sub>3</sub>N (29.1 μL, 0.209 mmol) in DCM (1.2 mL), and the mixture was stirred at rt for 1 h. DCM (20 mL) was added. The organic solution was washed with H<sub>2</sub>O (20 mL) and brine (20 mL), dried over MgSO<sub>4</sub>, and filtered, and the solvent was removed under reduced pressure. Four molar HCl in dioxane (5.0 mL) was added to the crude, and the mixture was stirred at rt for 16 h. The precipitated solid was filtered through a pad of celite and washed with EtOAc. MeOH was added to dissolve the solid, and the suspension was filtered. The solvent was removed under reduced pressure to afford compound <b>8j</b> as a white solid (42 mg, 55%), which did not require further purification. <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.26 (d, <i>J</i> = 8.5 Hz, 2H), 8.15 (d, <i>J</i> = 8.6 Hz, 2H), 7.83 (d, <i>J</i> = 3.9 Hz, 1H), 7.34 (d, <i>J</i> = 3.8 Hz, 1H), 4.39 (s, 2H), 3.57–3.44 (m, 4H), 1.69 (s, 3H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 173.41, 148.05, 146.22, 145.69, 144.29, 136.17, 131.85, 130.69, 129.58, 54.98, 38.43, 34.81, 22.23. HRMS (ESI) for C<sub>15</sub>H<sub>19</sub>N<sub>2</sub>O<sub>5</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 403.0451; observed 403.0453; error = 0.50 ppm.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> (5-((4-((2-Methoxyethyl)sulfonyl)phenyl)sulfonyl)thiophen-2-yl)methanamine Hydrochloride (<b>8k</b>)</h3><div class="NLM_p last">A mixture of <i>tert</i>-butyl ((5-((4-(vinylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>28</b> (65.9 mg, 0.149 mmol), K<sub>2</sub>CO<sub>3</sub> (24.6 mg, 0.178 mmol), and MeOH (1 mL) was stirred at rt for 2 h before it was diluted with EtOAc (20 mL). The organic layer was washed with 1:1 H<sub>2</sub>O/brine (20 mL), dried over MgSO<sub>4</sub>, and filtered, and the solvent was removed under reduced pressure. Four molar HCl in dioxane (5 mL) was added to the crude, and the mixture was stirred at rt for 3 h. The precipitated solid was filtered through a pad of celite and washed with EtOAc. MeOH was added to dissolve the solid, and the suspension was filtered. The solvent was removed under reduced pressure to afford compound <b>8k</b> as a white solid (30 mg, 54%) which did not require further purification. <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.22 (d, <i>J</i> = 8.6 Hz, 2H), 8.13 (d, <i>J</i> = 8.6 Hz, 2H), 7.83 (d, <i>J</i> = 3.9 Hz, 1H), 7.33 (d, <i>J</i> = 3.9 Hz, 1H), 4.39 (s, 2H), 3.72 (t, <i>J</i> = 5.6 Hz, 2H), 3.55 (t, <i>J</i> = 5.6 Hz, 2H), 3.11 (s, 3H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 147.77, 146.76, 146.08, 144.50, 136.04, 131.78, 130.69, 129.24, 66.83, 58.69, 56.78, 38.43. HRMS (ESI) for C<sub>14</sub>H<sub>18</sub>NO<sub>5</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 376.0342; observed 376.0333; error = 2.4 ppm.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> (5-((3-(<i>tert</i>-Butyl)-5-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methanamine (<b>9a</b>)</h3><div class="NLM_p">To a solution of carbaldehyde <b>33</b> (590 mg, 1.66 mmol) in THF (50 mL) at 0 °C was added sodium borohydride (141 mg, 3.72 mmol). The reaction mixture was stirred at rt for 2 h, before it was quenched with ice. The pH of the solution was adjusted to 4–5 with 1 M HCl, and the aqueous phase was extracted with EtOAc. The combined organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the solvent was removed under reduced pressure. The crude was dissolved in DCM (50 mL). mCPBA (77%; 742 mg, 3.31 mmol) was added in small portions at 0 °C. The mixture was stirred at rt for 12 h, and the solvent was subsequently removed under reduced pressure. The crude was purified by chromatography (EtOAc/cyclohexane 0 → 60%) to afford (5-((3-(<i>tert</i>-butyl)-5-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methanol (500 mg, 78% over two steps). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.32 (t, <i>J</i> = 1.4 Hz, 1H), 8.27 (t, <i>J</i> = 1.7 Hz, 1H), 8.13 (t, <i>J</i> = 1.6 Hz, 1H), 7.65 (d, <i>J</i> = 3.8 Hz, 1H), 6.99 (d, <i>J</i> = 3.8 Hz, 1H), 4.87 (s, 2H), 3.10 (s, 3H), 2.24 (br, 1H), 1.40 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 155.4, 155.3, 143.8, 142.0, 140.2, 134.3, 129.1, 128.7, 125.0, 123.7, 60.1, 44.4, 35.8, 31.0. HRMS (ESI) for C<sub>16</sub>H<sub>19</sub>O<sub>4</sub>S<sub>3</sub> ([M – OH]<sup>+</sup>): calculated 371.0445; observed 371.0486.</div><div class="NLM_p last">To a solution of (5-((3-(<i>tert</i>-butyl)-5-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methanol (500 mg, 1.29 mmol) in THF (15 mL) at 0 °C was added PPh<sub>3</sub> (406 mg, 1.54 mmol) and DEAD (0.24 mL, 1.54 mmol). The mixture was stirred at 0 °C for 10 min, followed by the addition of DPPA (0.35 mL, 1.54 mmol). The reaction was warmed to rt over 16 h, and the solvent was removed under reduced pressure. The crude was dissolved in EtOH (50 mL), and Pd/C (10%; 150 mg) was added. The mixture was stirred at rt under H<sub>2</sub> pressure (balloon) for 12 h and then filtered through celite. The solvent was removed under reduced pressure, and the crude was purified by chromatography (EtOH/cyclohexane 0 → 100%) to afford compound <b>9a</b> as an orange gum (262 mg, 52%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.28 (t, <i>J</i> = 1.4 Hz, 1H), 8.23 (t, <i>J</i> = 1.6 Hz, 1H), 8.09 (t, <i>J</i> = 1.6 Hz, 1H), 7.60 (d, <i>J</i> = 3.8 Hz, 1H), 6.90 (d, <i>J</i> = 3.8 Hz, 1H), 4.06 (s, 2H), 3.08 (s, 3H), 1.70 (br, 2H), 1.36 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 159.4, 155.2, 143.9, 141.8, 138.6, 134.5, 128.9, 128.4, 123.9, 123.5, 44.3, 41.4, 35.6, 30.9. HRMS (ESI) for C<sub>16</sub>H<sub>19</sub>O<sub>4</sub>S<sub>3</sub> ([M – NH]<sub>2</sub><sup>+</sup>): calculated 371.0445; observed 371.0428; error = 4.6 ppm.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> (5-((3-(<i>tert</i>-Butoxy)-5-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methanamine (<b>9b</b>)</h3><div class="NLM_p">NaO<i><sup>t</sup></i>Bu (65.8 mg, 0.684 mmol) was added to a degassed mixture of 2-ethylhexyl 3-((3-(<i>tert</i>-butoxy)-5-(methylthio)phenyl)thio)propanoate <b>60</b> (282 mg, 0.684 mmol) and 5-bromothiophene-2-carbonitrile <b>17a</b> (76.1 μL, 0.684 mmol) in DMF (3.4 mL), and the mixture was stirred at 60 °C for 3h. The cooled mixture was diluted with EtOAc (50 mL), washed with H<sub>2</sub>O (3 × 50 mL) and brine (50 mL), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed under reduced pressure, and the crude was purified by chromatography (EtOAc/pet ether 0 → 10%) to afford 5-((3-(<i>tert</i>-Butoxy)-5-(methylthio)phenyl)thio)thiophene-2-carbonitrile as a colorless oil (85 mg, 37%). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.51 (d, <i>J</i> = 3.9 Hz, 1H), 7.12 (d, <i>J</i> = 3.9 Hz, 1H), 6.94 (t, <i>J</i> = 1.7 Hz, 1H), 6.79 (t, <i>J</i> = 1.9 Hz, 1H), 6.72 (t, <i>J</i> = 1.9 Hz, 1H), 2.44 (s, 3H), 1.33 (s, 9H). LCMS (ESI) <i>m</i>/<i>z</i> 280 [M – <i><sup>t</sup></i>Bu + 2H]<sup>+</sup>.</div><div class="NLM_p">5-((3-(<i>tert</i>-Butoxy)-5-(methylsulfonyl)phenyl)sulfonyl)thiophene-2-carbonitrile was synthesized according to general procedure GP5, from 5-((3-(<i>tert</i>-Butoxy)-5-(methylthio)phenyl)thio)thiophene-2-carbonitrile (41 mg, 0.122 mmol), mCPBA (70–75%; 145 mg, 0.612 mmol) and DCM (1.2 mL), rt, 16 h. Chromatography (EtOAc/cyclohexane 0 → 60%) afforded a white solid (43 g, 88%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.17 (t, <i>J</i> = 1.6 Hz, 1H), 7.81 (dd, <i>J</i> = 2.2, 1.7 Hz, 1H), 7.76 (dd, <i>J</i> = 2.2, 1.6 Hz, 1H), 7.71 (d, <i>J</i> = 4.0 Hz, 1H), 7.60 (d, <i>J</i> = 4.1 Hz, 1H), 3.10 (s, 3H), 1.46 (s, 9H). LCMS (ESI, -ve) <i>m</i>/<i>z</i> 398 [M – H]<sup>−</sup>.</div><div class="NLM_p last">Compound <b>9b</b> was synthesized according to general procedure GP3, from BH<sub>3</sub> (1.0 M in THF; 0.53 mL, 0.53 mmol), 5-((3-(<i>tert</i>-Butoxy)-5-(methylsulfonyl)phenyl)sulfonyl)thiophene-2-carbonitrile (70 mg, 0.175 mmol) and THF (0.53 mL), 2 h, rt. Chromatography (EtOH/cyclohexane 30, then 100%) afforded a white foam (60 mg, 85%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.14 (t, <i>J</i> = 1.6 Hz, 1H), 7.81 (m, 1H), 7.79–7.74 (m, 2H), 7.15 (m, 1H), 4.10 (s, 2H), 3.20 (s, 3H), 1.44 (s, 9H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 158.93, 157.22, 146.05, 144.77, 140.99, 136.12, 127.67, 126.97, 126.78, 120.47, 82.68, 43.97, 41.02, 28.83. HRMS (ESI) for C<sub>16</sub>H<sub>22</sub>NO<sub>5</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 404.0655; observed 404.0651; error = 0.99 ppm.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> (5-((3-(Methylsulfonyl)-5-((trimethylsilyl)ethynyl)phenyl)sulfonyl)thiophen-2-yl)methanamine Hydrochloride (<b>9c</b>)</h3><div class="NLM_p last">A mixture of <i>tert</i>-butyl ((5-((3-bromo-5-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>34</b> (170 mg, 0.333 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (38.5 mg, 10%), CuI (12.7 mg, 20%), trimethylsilylacetylene (70.6 μL, 0.500 mmol), Et<sub>3</sub>N (0.5 mL), and 1,4-dioxane (0.5 mL) was degassed with argon and then stirred at rt for 16 h. The solvent was removed under reduced pressure, and the crude was dissolved in DCM (1.0 mL). Four molar HCl in dioxane (1.0 mL) was added, and the mixture was stirred at rt for 16 h. EtOAc (2.0 mL) was added to precipitate the solids, which were filtered, washed with EtOAc, and dried under vacuum to afford compound <b>9c</b> as white powder (80 mg, 88%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.42 (H, 1H), 8.29–8.21 (m, 2H), 7.88 (d, <i>J</i> = 3.7 Hz, 1H), 7.33 (d, <i>J</i> = 3.8 Hz, 1H), 4.39 (s, 2H), 3.21 (s, 3H), 0.28 (s, 9H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>) δ 146.34, 145.18, 144.58, 143.96, 136.34, 136.15, 135.52, 131.87, 127.82, 126.41, 101.83, 54.75, 43.85, 38.40. HRMS (ESI) for C<sub>17</sub>H<sub>22</sub>NO<sub>4</sub>S<sub>3</sub>Si ([M + H]<sup>+</sup>): calculated 428.0475; observed 428.0477; error = 0.47 ppm.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> (5-((3-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-5-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methanamine (<b>9d</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP7 and GP2, from (i) <i>tert</i>-butyl ((5-((3-bromo-5-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>34</b> (100 mg, 0.196 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (22.6 mg, 10%), (1-methyl-1<i>H</i>-pyrazol-4-yl)boronic acid pinacol ester (48.9 mg, 0.235 mmol), Cs<sub>2</sub>CO<sub>3</sub> (76.7 mg, 0.235 mmol), and 1,4-dioxane (1.3 mL), 90 °C, 16 h and (ii) 4 M HCl in dioxane (1.0 mL) and DCM (1.0 mL), rt, 3 h. The crude was basified with 2 N NH<sub>3</sub> in MeOH and purified by chromatography (MeOH/DCM 0 → 25%) to afford a light yellow solid (57 mg, 71%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>/chloroform-<i>d</i>) δ 8.29 (t, <i>J</i> = 1.7 Hz, 1H), 8.27–8.22 (m, 2H), 8.07 (s, 1H), 7.91 (s, 1H), 7.69 (d, <i>J</i> = 3.9 Hz, 1H), 7.04 (d, <i>J</i> = 3.7 Hz, 1H), 4.04 (s, 2H), 3.95 (s, 3H), 3.18 (s, 3H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>/chloroform-<i>d</i>) δ 157.51, 145.17, 143.55, 139.75, 137.56, 137.06, 135.61, 129.87, 128.63, 128.57, 126.43, 123.50, 120.52, 44.25, 41.01, 39.31. HRMS (ESI) for C<sub>16</sub>H<sub>18</sub>N<sub>3</sub>O<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 412.0454; observed 412.0444; error = 2.4 ppm.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> (5-((3-(Methylsulfonyl)-5-(pyridin-4-yl)phenyl)sulfonyl)thiophen-2-yl)methanamine (<b>9e</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP7 and GP2, from (i) <i>tert</i>-butyl ((5-((3-bromo-5-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>34</b> (100 mg, 0.196 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (45.2 mg, 20%), pyridine-4-boronic acid (57.8 mg, 0.470 mmol), Cs<sub>2</sub>CO<sub>3</sub> (76.7 mg, 0.235 mmol), and 1,4-dioxane (1.3 mL), 90 °C, 16 h and (ii) 4 M HCl in dioxane (0.6 mL) and 1,4-dioxane (0.6 mL), rt, 16 h. The crude was basified with 2 N NH<sub>3</sub> in MeOH and purified by chromatography (MeOH/DCM 0 → 20%) to afford a yellow solid (35 mg, 44%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>/chloroform-<i>d</i>) δ 8.72–8.69 (m, 2H), 8.55 (t, <i>J</i> = 1.6 Hz, 1H), 8.50 (t, <i>J</i> = 1.6 Hz, 1H), 8.45 (t, <i>J</i> = 1.6 Hz, 1H), 7.73–7.70 (m, 3H), 7.04 (d, <i>J</i> = 3.9 Hz, 1H), 4.04 (s, 2H), 3.23 (s, 3H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>/chloroform-<i>d</i>) δ 158.47, 150.06, 145.33, 145.14, 143.36, 141.22, 138.23, 135.26, 130.28, 130.21, 126.22, 125.35, 122.13, 43.68, 40.64. HRMS (ESI) for C<sub>17</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 409.0345; observed 409.0340; error = 1.2 ppm.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> (5-((4′-Methyl-5-(methylsulfonyl)-[1,1′-biphenyl]-3-yl)sulfonyl)thiophen-2-yl)methanamine (<b>9g</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP7 and GP2, from (i) <i>tert</i>-butyl ((5-((3-bromo-5-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>34</b> (100 mg, 0.196 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (22.6 mg, 10%), <i>p</i>-tolyl boronic acid (32.0 mg, 0.235 mmol), Cs<sub>2</sub>CO<sub>3</sub> (76.7 mg, 0.235 mmol), and 1,4-dioxane (1.3 mL), 90 °C, 16 h and (ii) 4 M HCl in dioxane (1.0 mL) and DCM (1.0 mL), rt, 3 h. The crude was basified with 2 N NH<sub>3</sub> in MeOH and purified by chromatography (acetone/DCM 0 → 40%) to afford a light yellow foam (20 mg, 24%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.45–8.39 (m, 2H), 8.30 (t, <i>J</i> = 1.6 Hz, 1H), 7.67 (d, <i>J</i> = 3.9 Hz, 1H), 7.54 (d, <i>J</i> = 8.2 Hz, 2H), 7.33 (d, <i>J</i> = 8.0 Hz, 2H), 6.93 (d, <i>J</i> = 3.9 Hz, 1H), 4.09 (s, 2H), 3.14 (s, 3H), 2.44 (s, 3H), 1.61 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 144.95, 144.56, 142.77, 139.79, 138.73, 134.92, 134.43, 130.27, 130.15, 129.73, 127.25, 124.34, 124.16, 44.59, 41.71, 21.36. HRMS (ESI) for C<sub>19</sub>H<sub>20</sub>NO<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 422.0549; observed 422.0561; error = 2.8 ppm.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> (5-((3′,5′-Dimethyl-5-(methylsulfonyl)-[1,1′-biphenyl]-3-yl)sulfonyl)thiophen-2-yl)methanamine Hydrochloride (<b>9h</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP7 and GP2, from (i) <i>tert</i>-butyl ((5-((3-bromo-5-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>34</b> (100 mg, 0.196 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (22.6 mg, 10%), (3,5-dimethylphenyl)boronic acid (35.3 mg, 0.235 mmol), Cs<sub>2</sub>CO<sub>3</sub> (76.7 mg, 0.235 mmol), and 1,4-dioxane (1.3 mL), 90 °C, 16 h and (ii) 4 M HCl in dioxane (0.7 mL) and 1,4-dioxane (0.7 mL), rt, 16 h. The crude was basified with 2 N NH<sub>3</sub> in MeOH and purified by chromatography (EtOH/cyclohexane 0 → 100% then 100%) to afford a white solid (23 mg, 27%). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>/chloroform-<i>d</i>) δ 8.41–8.35 (m, 2H), 8.30 (t, <i>J</i> = 1.6 Hz, 1H), 7.68 (d, <i>J</i> = 3.9 Hz, 1H), 7.22 (br, 2H), 7.09 (br, 1H), 7.03 (d, <i>J</i> = 3.8 Hz, 1H), 4.04 (s, 2H), 3.17 (s, 3H), 2.38 (s, 6H). <sup>13</sup>C NMR (126 MHz, methanol<i>-d</i><sub>4</sub>/chloroform-<i>d</i>) δ 145.50, 144.81, 143.06, 139.62, 139.57, 137.51, 135.39, 131.47, 130.63, 130.52, 126.17, 125.50, 124.57, 44.43, 40.89, 21.44. HRMS (ESI) for C<sub>20</sub>H<sub>22</sub>NO<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 436.0705; observed 436.0700; error = 1.1 ppm.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> (5-((2′-Ethyl-5-(methylsulfonyl)-[1,1′-biphenyl]-3-yl)sulfonyl)thiophen-2-yl)methanamine Hydrochloride (<b>9i</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP7 and GP2, from (i) <i>tert</i>-butyl ((5-((3-bromo-5-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>34</b> (100 mg, 0.196 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (22.6 mg, 10%), (2-ethylphenyl)boronic acid (35.3 mg, 0.235 mmol), Cs<sub>2</sub>CO<sub>3</sub> (76.7 mg, 0.235 mmol), and 1,4-dioxane (1.3 mL), 90 °C, 16 h and (ii) 4 M HCl in dioxane (0.7 mL) and 1,4-dioxane (0.7 mL), rt, 16 h. The crude was basified with 2 N NH<sub>3</sub> in MeOH and purified by chromatography (EtOH/cyclohexane 0 → 100% then 100%) to afford a white foam (42 mg, 49%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.49 (t, <i>J</i> = 1.7 Hz, 1H), 8.21 (t, <i>J</i> = 1.6 Hz, 1H), 8.09 (t, <i>J</i> = 1.6 Hz, 1H), 7.66 (d, <i>J</i> = 3.8 Hz, 1H), 7.42 (td, <i>J</i> = 7.6, 1.3 Hz, 1H), 7.37 (m, 1H), 7.30 (td, <i>J</i> = 7.4, 1.4 Hz, 1H), 7.18 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H), 6.94 (d, <i>J</i> = 3.9 Hz, 1H), 4.10 (s, 2H), 3.14 (s, 3H), 2.53 (q, <i>J</i> = 7.5 Hz, 2H), 1.61 (s, 2H), 1.12 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 159.97, 145.25, 144.31, 142.19, 141.50, 138.66, 137.63, 134.95, 132.72, 132.24, 129.87, 129.41, 129.33, 126.37, 124.59, 124.15, 44.53, 41.73, 26.17, 15.73. HRMS (ESI) for C<sub>20</sub>H<sub>22</sub>NO<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 436.0705; observed 436.0727; error = 5.0 ppm.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> (5-((3-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-4-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methanamine Dihydrochloride (<b>9j</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP7 and GP2, from (i) <i>tert</i>-butyl ((5-((3-bromo-4-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>37</b> (150 mg, 0.294 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (34.0 mg, 10%), (1-methyl-1<i>H</i>-pyrazol-4-yl)boronic acid pinacol ester (73.0 mg, 0.353 mmol), Cs<sub>2</sub>CO<sub>3</sub> (115 mg, 0.353 mmol), and 1,4-dioxane (2.0 mL), 90 °C, 16 h and (ii) 4 M HCl in dioxane (1.5 mL) and DCM (1.5 mL), rt, 3 h. A white solid was obtained (111 mg, 92%). <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O) δ 8.32 (d, <i>J</i> = 8.5 Hz, 1H), 8.16 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 8.05 (d, <i>J</i> = 1.9 Hz, 1H), 7.92 (s, 1H), 7.84 (d, <i>J</i> = 4.0 Hz, 1H), 7.74 (s, 1H), 7.33 (d, <i>J</i> = 4.0 Hz, 1H), 4.44 (s, 2H), 3.96 (s, 3H), 2.96 (s, 3H). <sup>13</sup>C NMR (126 MHz, D<sub>2</sub>O) δ 144.87, 144.70, 142.07, 140.32, 139.70, 135.77, 134.00, 132.82, 131.38, 130.83, 130.08, 126.31, 116.55, 41.49, 38.31, 37.18. HRMS (ESI) for C<sub>16</sub>H<sub>18</sub>N<sub>3</sub>O<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 412.0454; observed 412.0441; error = 3.2 ppm.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> (5-((6-(Methylsulfonyl)-[1,1′-biphenyl]-3-yl)sulfonyl)thiophen-2-yl)methanamine (<b>9k</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP7 and GP2, from (i) <i>tert</i>-butyl ((5-((3-bromo-4-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>37</b> (150 mg, 0.294 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (34.0 mg, 10%), phenylboronic acid (43.1 mg, 0.353 mmol), Cs<sub>2</sub>CO<sub>3</sub> (115 mg, 0.353 mmol), and 1,4-dioxane (2.0 mL), 90 °C, 16 h. Chromatography (EtOAc/DCM 0 → 100%), white foam, 169 mg and (ii) 4 M HCl in dioxane (1.0 mL) and DCM (1.0 mL), rt, 3 h. The crude was basified with 2 N NH<sub>3</sub> in MeOH and purified by chromatography (EtOH/cyclohexane 0 → 100%) to afford a white solid (66 mg, 55%). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 8.37 (d, <i>J</i> = 8.3 Hz, 1H), 8.11 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 7.97 (d, <i>J</i> = 2.0 Hz, 1H), 7.63 (d, <i>J</i> = 3.9 Hz, 1H), 7.55–7.41 (m, 5H), 6.93 (d, <i>J</i> = 3.8 Hz, 1H), 4.10 (s, 2H), 2.61 (s, 3H), 1.63 (s, 2H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>) δ 160.04, 146.65, 143.39, 142.92, 138.54, 136.79, 134.97, 131.05, 130.11, 129.70, 129.38, 128.43, 126.64, 124.12, 43.13, 41.67. HRMS (ESI) for C<sub>18</sub>H<sub>18</sub>NO<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 408.0392; observed 408.0373; error = 4.9 ppm.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> (5-((4′-Methyl-6-(methylsulfonyl)-[1,1′-biphenyl]-3-yl)sulfonyl)thiophen-2-yl)methanamine Hydrochloride (<b>9l</b>)</h3><div class="NLM_p last">The titled compound was synthesized according to general procedures GP7 and GP2, from (i) <i>tert</i>-butyl ((5-((3-bromo-4-(methylsulfonyl)phenyl)sulfonyl)thiophen-2-yl)methyl)carbamate <b>37</b> (150 mg, 0.294 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (34.0 mg, 10%), <i>p</i>-tolyl boronic acid (48.0 mg, 0.353 mmol), Cs<sub>2</sub>CO<sub>3</sub> (115 mg, 0.353 mmol), and 1,4-dioxane (2.0 mL), 90 °C, 16 h and (ii) 4 M HCl in dioxane (1.5 mL) and DCM (1.5 mL), rt, 3 h. A beige solid obtained (83 mg, 62% over). <sup>1</sup>H NMR (500 MHz, methanol<i>-d</i><sub>4</sub>) δ 8.37 (d, <i>J</i> = 8.4 Hz, 1H), 8.22 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.91 (d, <i>J</i> = 2.0 Hz, 1H), 7.83 (d, <i>J</i> = 3.9 Hz, 1H), 7.36–7.30 (m, 5H), 4.40 (s, 2H), 2.70 (s, 3H), 2.43 (s, 3H). <sup>13</sup>C NMR (75 MHz, methanol<i>-d</i><sub>4</sub>) δ 147.21, 146.24, 145.44, 144.69, 144.29, 140.60, 136.19, 135.39, 132.22, 131.88, 131.03, 130.92, 129.94, 127.81, 43.41, 38.43, 21.30. HRMS (ESI) for C<sub>19</sub>H<sub>20</sub>NO<sub>4</sub>S<sub>3</sub> ([M + H]<sup>+</sup>): calculated 422.0549; observed 422.0531; error = 4.3 ppm.</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> Pan Assay Interference Compound (PAINS) Assessment</h3><div class="NLM_p last">To identify compounds that may demonstrate some degree of promiscuity in biochemical screening, the PAINS filters as described by Baell and Holloway<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> were curated as SMARTS and scripted as a flagging protocol deployed in Vortex (version 2018.09.76561.53-s, 2018, <a href="https://www.dotmatics.com/products/vortex" class="extLink">https://www.dotmatics.com/products/vortex</a>) and Pipeline Pilot (Dassault Systèmes BIOVIA, BIOVIA Pipeline Pilot, Release 2018, San Diego: Dassault Systèmes, 2018). The 480 patterns were used to recognize structures that may result in nonspecific binding to multiple biological targets by virtue of being comprised of one or more fragments established to be of concern. No LOX inhibitor in this study showed any potential PAINS liability when screened against this PAINS filter.</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> LOX Protein Preparation and Enzyme Assay</h3><div class="NLM_p last">LOX enzyme was extracted from pig skin by the method of Shackleton and Hulmes.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> LOX catalytic activity was determined using a horseradish peroxidase (HRP)-coupled fluorescent assay previously described,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> with cadaverine hydrochloride as a substrate, BAPN as positive control, and a preincubation time of 20 min with nine dilutions from a top concentration of 100 μM. LOXL2 was purchased from R&D System. LOXL2 catalytic activity was determined using the Promega ROS-Glo assay kit with cadaverine hydrochloride as a substrate, BAPN as positive control, and a preincubation time of 20 min at the same concentrations as above.</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> High-Throughput Screening</h3><div class="NLM_p last">HTS was performed by Evotec AG on 270 000 diverse compounds and 5000 fragments using the enzyme assay described above.</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i126" class="anchor-spacer"></div><h3 class="article-section__title" id="_i126"> Amine Oxidase Assays</h3><div class="NLM_p">Methods for the determination of catalytic activity of DAO, MAO-A, and MAO-B have been previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> All amine oxidase assays were performed with concentrations as above. MAO-A and MAO-B enzymes were purchased from Promega and Sigma, respectively. The catalytic activity of MAO-A and MAO-B was determined using the Promega MAO-Glo assay kit (substrate included), with clorgyline and deprenyl as positive controls, respectively. DAO was purchased from Sigma and the catalytic activity was determined using the Promega ROS-Glo assay kit, with aminoguanidine as the positive control. SSAO was purchased from Sigma. SSAO catalytic activity was determined using the Promega MAO-Glo assay kit, with Mofegiline as positive control.</div><div id="sec5_70_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> Assessment of Compound <b>9f</b> as a Substrate for Amine Oxidases</h4><div class="NLM_p last">The catalytic activities of MAO-A, MAO-B, and SSAO with compound <b>9f</b> as a substrate were determined using the respective enzymes described above, and the hydrogen peroxide produced was quantified using the HRP-coupled fluorescent method as in the LOX activity assay.</div></div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i128" class="anchor-spacer"></div><h3 class="article-section__title" id="_i128"> MLM Stability Assay</h3><div class="NLM_p last">Mouse liver microsomes (BALB/c) were purchased from Tebu-bio, and the assay was performed by methods previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Inhibitors at 10 μM concentration incubated with the microsomes were assessed at 0, 15, and 30 min. Control samples containing no microsomes and no cofactors were also assessed at 0 and 30 min. Samples were extracted by protein precipitation and centrifugation for 20 min in a refrigerated centrifuge (4 °C) at 3700 rpm. The supernatant was analyzed by LCMS/MS for % metabolized over time.</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i129" class="anchor-spacer"></div><h3 class="article-section__title" id="_i129"> In Vivo PK</h3><div class="NLM_p last">All procedures involving animals were performed in accordance with national Home Office regulations under the Animals (Scientific Procedures) Act 1986 and within guidelines set out by the Institute’s Animal Ethics Committee and the United Kingdom Coordinating Committee for Cancer Research’s ad hoc Committee on the Welfare of Animals in Experimental Neoplasia.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Female BALB/c or CD1 mice (Charles River Laboratories) at 6 weeks of age were used for the PK analyses. The mice were dosed orally by gavage (50 mg/kg in dimethyl sulfoxide (DMSO)/water 1:19 v/v; <i>n</i> = 21) or intravenously in the tail vein (10 mg/kg in DMSO/Tween20/saline 10:1:89 v/v/v; <i>n</i> = 24). Samples were taken at seven (po) or eight (iv) time points between 5 min and 24 h. Three mice were used per time point per route. They were placed under halothane or isoflurane anesthesia, and blood for plasma preparation was taken by terminal cardiac puncture into heparinized syringes. Plasma samples were snap-frozen in liquid nitrogen and then stored at −80 °C prior to analysis.</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i130" class="anchor-spacer"></div><h3 class="article-section__title" id="_i130"> In Vivo Anti-metastatic Efficacy</h3><div class="NLM_p last">LOX inhibitor treatment was carried out in mouse GEMM breast cancer model where MMTV-PyMT female mice were randomized as described previously.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Mice were treated daily by oral gavage with 70 mg/kg compound <b>9f</b> (<i>n</i> = 5) in vehicle (5% DMSO/2.5% Tween20 in water) or control with vehicle alone (<i>n</i> = 7). Lungs were collected at the end of the experiment, as previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec5_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i131" class="anchor-spacer"></div><h3 class="article-section__title" id="_i131"> Histology and Immunohistochemistry</h3><div class="NLM_p last">All mouse tissue samples were fixed in 10% formalin (Sigma) and embedded in paraffin. For spontaneous lung metastasis in MMTV-PyMT animals, the number of metastasis in the lung parenchyma was counted and the size was measured.</div></div><div id="sec5_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i132" class="anchor-spacer"></div><h3 class="article-section__title" id="_i132"> Commercial ADME-T Services</h3><div class="NLM_p last">hERG inhibition was determined using the “hERG Human Potassium Ion Channel Cell Based Antagonist Qpatch Assay” by Eurofins Ltd. Cell permeability was determined using the “Caco-2 permeability assay” by Cyprotex Ltd.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i133"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00335" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00335" class="ext-link">10.1021/acs.jmedchem.9b00335</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings of all final inhibitors (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00335/suppl_file/jm9b00335_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Experimental procedures and characterization data for synthetic intermediates, compounds <b>11a</b>, <b>11b</b>, <b>15</b>, <b>16</b>, <b>19</b>, <b>22c</b>, <b>22d</b>, <b>22e</b>, <b>23c</b>, <b>23d</b>, <b>23e</b>, <b>24c</b>, <b>24d</b>, <b>26</b>, <b>27</b>, <b>28</b>, <b>29</b>, <b>30</b>, <b>32</b>, <b>33</b>, <b>36</b>, <b>37</b>, <b>38</b>, <b>39</b>, <b>41</b>, <b>43</b>, <b>45</b>, <b>47</b>, <b>49</b>, <b>52</b>, <b>54</b>, <b>56</b>, <b>58</b>, <b>59</b>, and <b>60</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00335/suppl_file/jm9b00335_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00335/suppl_file/jm9b00335_si_001.csv">jm9b00335_si_001.csv (5.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00335/suppl_file/jm9b00335_si_002.pdf">jm9b00335_si_002.pdf (135.33 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00335" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline Springer</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Cancer Research UK Manchester Institute, 
     and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#86e5e7f4e9eaefe8e3a8f5f6f4efe8e1e3f4c6e5f4f3eda8ebe7e8e5eee3f5f2e3f4a8e7e5a8f3ed"><span class="__cf_email__" data-cfemail="b1d2d0c3deddd8dfd49fc2c1c3d8dfd6d4c3f1d2c3c4da9fdcd0dfd2d9d4c2c5d4c39fd0d29fc4da">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leo Leung</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Cancer Research UK Manchester Institute, 
     and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6537-6178" title="Orcid link">http://orcid.org/0000-0002-6537-6178</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Niculescu-Duvaz</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Cancer Research UK Manchester Institute, 
     and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah Smithen</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Cancer Research UK Manchester Institute, 
     and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Filipa Lopes</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Cancer Research UK Manchester Institute, 
     and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cedric Callens</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert McLeary</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Cancer Research UK Manchester Institute, 
     and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grazia Saturno</span> - <span class="hlFld-Affiliation affiliation">Molecular Oncology
Team, Cancer Research UK Manchester Institute and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence Davies</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohammed Aljarah</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Cancer Research UK Manchester Institute, 
     and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Brown</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Cancer Research UK Manchester Institute, 
     and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louise Johnson</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alfonso Zambon</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tim Chambers</span> - <span class="hlFld-Affiliation affiliation">Molecular Oncology
Team, Cancer Research UK Manchester Institute and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Delphine Ménard</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natasha Bayliss</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruth Knight</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Fish</span> - <span class="hlFld-Affiliation affiliation">Cancer
Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, London SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rae Lawrence</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Cancer Research UK Manchester Institute and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mairi Challinor</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Cancer Research UK Manchester Institute and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">HaoRan Tang</span> - <span class="hlFld-Affiliation affiliation">Molecular Oncology
Team, Cancer Research UK Manchester Institute and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Marais</span> - <span class="hlFld-Affiliation affiliation">Molecular Oncology
Team, Cancer Research UK Manchester Institute and , University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): H.T., L.L., D.N.-D., D.S, C.C, R.Ma. and C.S. have filed a patent application which includes the therapeutic use of aminomethylenethiophene inhibitors such as CCT365623. All authors L.L., D.N.-D, D.S., F.L., C.C., R.Mc., G.S., L.D., M.A., M.B., L.J., A.Z., T.C., D.M., N.B., R.K., L.F., R.L., M.C., H.T., R.Ma. and C.S. could benefit financially if any of the described inhibitors such as CCT365623 is licenced, as part of a reward scheme for employees at ICR and CRUK MI.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e8316-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i134">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the CRUK Manchester Institute (C5759/A27412, C5759/A12328), CRUK Manchester Institute Drug Discovery Unit (C480/A17098), the Division of Cancer Therapeutics at The Institute of Cancer Research (C309/A11566, C309/A8274, C107/A10433), and the Wellcome Trust (1003X, 103021/Z/13/Z). We thank Dr. Maggie Liu, Dr. Amin Mirza, and Meirion Richards for assistance with NMR and MS instrumentation. We would also like to thank Dr. Simon Pearce for his advice on statistics.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AMT</td><td class="NLM_def"><p class="first last">aminomethylenethiophene</p></td></tr><tr><td class="NLM_term">BAPN</td><td class="NLM_def"><p class="first last">3-aminopropionitrile</p></td></tr><tr><td class="NLM_term">DAO</td><td class="NLM_def"><p class="first last">diamine oxidase</p></td></tr><tr><td class="NLM_term">dba</td><td class="NLM_def"><p class="first last">dibenzylideneacetone</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">C<sub>max</sub></td><td class="NLM_def"><p class="first last">maximal concentration</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DPPA</td><td class="NLM_def"><p class="first last">diphenyl phosphoryl azide</p></td></tr><tr><td class="NLM_term">GEMM</td><td class="NLM_def"><p class="first last">genetically engineered mouse model</p></td></tr><tr><td class="NLM_term">HMDS</td><td class="NLM_def"><p class="first last">hexamethyldisilazane</p></td></tr><tr><td class="NLM_term">HRP</td><td class="NLM_def"><p class="first last">horseradish peroxidase</p></td></tr><tr><td class="NLM_term">LOX</td><td class="NLM_def"><p class="first last">lysyl oxidase</p></td></tr><tr><td class="NLM_term">LOXL</td><td class="NLM_def"><p class="first last">lysyl oxidase like</p></td></tr><tr><td class="NLM_term">LTQ</td><td class="NLM_def"><p class="first last">lysine tyrosylquinone</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">mCPBA</td><td class="NLM_def"><p class="first last"><i>meta</i>-chloroperbenzoic acid</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term">MMTV</td><td class="NLM_def"><p class="first last">mouse mammary tumor virus</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan assay interference compounds</p></td></tr><tr><td class="NLM_term">PyMT</td><td class="NLM_def"><p class="first last">polyomavirus middle T-antigen</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SSAO</td><td class="NLM_def"><p class="first last">semicarbazide-sensitive amine oxidase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i136">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronnebaum, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mure, M.</span></span> <span> </span><span class="NLM_article-title">Human Copper-Dependent Amine Oxidases</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>546</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2013.12.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1016%2Fj.abb.2013.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=24407025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksFaisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2014&pages=19-32&author=J.+Finneyauthor=H.-J.+Moonauthor=T.+Ronnebaumauthor=M.+Lantzauthor=M.+Mure&title=Human+Copper-Dependent+Amine+Oxidases&doi=10.1016%2Fj.abb.2013.12.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Human copper-dependent amine oxidases</span></div><div class="casAuthors">Finney, Joel; Moon, Hee-Jung; Ronnebaum, Trey; Lantz, Mason; Mure, Minae</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-32</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Copper amine oxidases (CAOs) are a class of enzymes that contain Cu2+ and a tyrosine-derived quinone cofactor, and catalyze the conversion of a primary amine functional group to an aldehyde, generating H2O2 and NH3 as byproducts.  These enzymes can be classified into 2 non-homologous families: 2,4,5-trihydroxyphenylalanine quinone (TPQ)-dependent CAOs and the lysine tyrosylquinone (LTQ)-dependent lysyl oxidase (LOX) family of proteins.  Here, the authors focus on recent developments in the field of research concerning human CAOs and the LOX family of proteins.  The aberrant expression of these enzymes is linked to inflammation, fibrosis, tumor metastasis/invasion, and other diseases.  Consequently, there is a crit. need to understand the functions of these proteins at the mol. level, so that strategies targeting these enzymes can be developed to combat human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxp8xJQhX_qLVg90H21EOLACvtfcHk0lgs8pvVT2TmAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksFaisbs%253D&md5=f7ecc08c322917ac6c9bf96636b49575</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2013.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2013.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DFinney%26aufirst%3DJ.%26aulast%3DMoon%26aufirst%3DH.-J.%26aulast%3DRonnebaum%26aufirst%3DT.%26aulast%3DLantz%26aufirst%3DM.%26aulast%3DMure%26aufirst%3DM.%26atitle%3DHuman%2520Copper-Dependent%2520Amine%2520Oxidases%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2014%26volume%3D546%26spage%3D19%26epage%3D32%26doi%3D10.1016%2Fj.abb.2013.12.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, H. M.</span>; <span class="NLM_string-name">Ryvkin, F.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase and Lysyl Oxidase-Like Enzymes</span>. In  <i>The Extracellular Matrix: An Overview</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecham, R. P.</span></span>, Ed.; <span class="NLM_publisher-name">Springer</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">335</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1007%2F978-3-642-16555-9_9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=303-335&author=H.+M.+Kagan&author=F.+Ryvkinauthor=R.+P.+Mecham&title=The+Extracellular+Matrix%3A+An+Overview"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-16555-9_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-16555-9_9%26sid%3Dliteratum%253Aachs%26aulast%3DKagan%26aufirst%3DH.%2BM.%26atitle%3DLysyl%2520Oxidase%2520and%2520Lysyl%2520Oxidase-Like%2520Enzymes%26btitle%3DThe%2520Extracellular%2520Matrix%253A%2520An%2520Overview%26aulast%3DMecham%26aufirst%3DR.%2BP.%26pub%3DSpringer%26date%3D2011%26spage%3D303%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucero, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, H. M.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase: an Oxidative Enzyme and Effector of Cell Function</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2304</span>– <span class="NLM_lpage">2316</span>, <span class="refDoi"> DOI: 10.1007/s00018-006-6149-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1007%2Fs00018-006-6149-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=16909208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFyrtrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=2304-2316&author=H.+A.+Luceroauthor=H.+M.+Kagan&title=Lysyl+Oxidase%3A+an+Oxidative+Enzyme+and+Effector+of+Cell+Function&doi=10.1007%2Fs00018-006-6149-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase: an oxidative enzyme and effector of cell function</span></div><div class="casAuthors">Lucero, H. A.; Kagan, H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">19-20</span>),
    <span class="NLM_cas:pages">2304-2316</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Lysyl oxidase (LOX) oxidizes the side-chain of peptidyl-lysine converting specific Lys residues to residues of α-aminoadipic δ-semialdehyde.  This post-translational chem. change permits the covalent crosslinking of the component chains of collagen and those of elastin, thus stabilizing the fibrous deposits of these proteins in the extracellular matrix.  Four LOX-like (LOXL) proteins with varying degrees of similarity to LOX have also been described, constituting a family of related proteins.  LOX is synthesized as a preproprotein which emerges from the cell as proLOX and then is processed to the active enzyme by proteolysis.  In addn. to elastin and collagen, LOX can oxidize lysine within a variety of cationic proteins, suggesting that its functions extend beyond its role in the stabilization of the extracellular matrix.  Indeed, recent findings reveal that LOX and LOXL proteins markedly influence cell behavior including chemotactic responses, proliferation, and shifts between the normal and malignant phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMqzFj7sZh3LVg90H21EOLACvtfcHk0lgs8pvVT2TmAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFyrtrrF&md5=e8efb89825a3f710c09567e6774e80c4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00018-006-6149-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-006-6149-9%26sid%3Dliteratum%253Aachs%26aulast%3DLucero%26aufirst%3DH.%2BA.%26aulast%3DKagan%26aufirst%3DH.%2BM.%26atitle%3DLysyl%2520Oxidase%253A%2520an%2520Oxidative%2520Enzyme%2520and%2520Effector%2520of%2520Cell%2520Function%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2006%26volume%3D63%26spage%3D2304%26epage%3D2316%26doi%3D10.1007%2Fs00018-006-6149-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase: Properties, Specificity, and Biological Roles Inside and Outside of the Cell</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1002/jcb.10413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1002%2Fjcb.10413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=12577300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslWis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=660-672&author=H.+M.+Kaganauthor=W.+Li&title=Lysyl+Oxidase%3A+Properties%2C+Specificity%2C+and+Biological+Roles+Inside+and+Outside+of+the+Cell&doi=10.1002%2Fjcb.10413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell</span></div><div class="casAuthors">Kagan, Herbert M.; Li, Wande</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">660-672</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review and discussion.  Lysyl oxidase (I) plays a crit. role in the formation and repair of the extracellular matrix (ECM) by oxidizing Lys residues in elastin and collagen, thereby initiating the formation of covalent crosslinkages which stabilize these fibrous proteins.  I catalytic activity depends upon both its Cu cofactor and a unique carbonyl cofactor, and has been shown to extend to a variety of basic globular proteins, including histone H1.  Although the 3-dimensional structure of I has yet to be detd., the present treatise offers hypotheses based upon its primary sequence, which may underlie the prominent electrostatic component of its unusual substrate specificity as well as the catalysis-suppressing function of the propeptide domain of pro-I.  Recent studies have demonstrated that I appears to function within the cell in a manner, which strongly modifies cellular activity.  Newly discovered I-like proteins also likely play unique roles in biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9lBpo6dXwWLVg90H21EOLACvtfcHk0lgs8pvVT2TmAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslWis7s%253D&md5=85f72b94a2d9b77615f46572f5536dfa</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fjcb.10413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.10413%26sid%3Dliteratum%253Aachs%26aulast%3DKagan%26aufirst%3DH.%2BM.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DLysyl%2520Oxidase%253A%2520Properties%252C%2520Specificity%252C%2520and%2520Biological%2520Roles%2520Inside%2520and%2520Outside%2520of%2520the%2520Cell%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2003%26volume%3D88%26spage%3D660%26epage%3D672%26doi%3D10.1002%2Fjcb.10413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsia, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, T.-M.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase and the Tumor Microenvironment</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.3390/ijms18010062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.3390%2Fijms18010062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=62-73&author=T.-H.+Wangauthor=S.-M.+Hsiaauthor=T.-M.+Shieh&title=Lysyl+Oxidase+and+the+Tumor+Microenvironment&doi=10.3390%2Fijms18010062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fijms18010062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18010062%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.-H.%26aulast%3DHsia%26aufirst%3DS.-M.%26aulast%3DShieh%26aufirst%3DT.-M.%26atitle%3DLysyl%2520Oxidase%2520and%2520the%2520Tumor%2520Microenvironment%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D18%26spage%3D62%26epage%3D73%26doi%3D10.3390%2Fijms18010062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gartland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erler, J. T.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-2306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1158%2F0008-5472.CAN-15-2306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=26732355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1SrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=188-192&author=T.+R.+Coxauthor=A.+Gartlandauthor=J.+T.+Erler&title=Lysyl+Oxidase%2C+a+Targetable+Secreted+Molecule+Involved+in+Cancer+Metastasis&doi=10.1158%2F0008-5472.CAN-15-2306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis</span></div><div class="casAuthors">Cox, Thomas R.; Gartland, Alison; Erler, Janine T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188-192</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Secondary metastatic cancer remains the single biggest cause of mortality and morbidity across most solid tumors.  In breast cancer, 100% of deaths are attributed to metastasis.  At present, there are no "cures" for secondary metastatic cancer of any form and there is an urgent unmet clin. need to improve the tools available in our arsenal against this disease, both in terms of treatment, but also prevention.  Recently, we showed that hypoxic induction of the extracellular matrix modifying enzyme lysyl oxidase (LOX) correlates with metastatic dissemination to the bone in estrogen receptor neg. breast cancer and is essential for the formation of premetastatic osteolytic lesions.  We showed that in models of breast cancer metastasis, targeting LOX, or its downstream effects, significantly inhibited premetastatic niche formation and the resulting metastatic burden, offering preclin. validation of this enzyme as a therapeutic target for metastatic breast cancer.  Our work is the latest in an emerging body of work supporting the targeting of LOX and calls for greater efforts in developing therapeutics against this extracellular secreted factor in the prevention of cancer progression across multiple solid tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVMTz-jTWh77Vg90H21EOLACvtfcHk0lj3-mtog9xRAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1SrtQ%253D%253D&md5=ed68370a405806847705725db3099701</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-2306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-2306%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DT.%2BR.%26aulast%3DGartland%26aufirst%3DA.%26aulast%3DErler%26aufirst%3DJ.%2BT.%26atitle%3DLysyl%2520Oxidase%252C%2520a%2520Targetable%2520Secreted%2520Molecule%2520Involved%2520in%2520Cancer%2520Metastasis%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D188%26epage%3D192%26doi%3D10.1158%2F0008-5472.CAN-15-2306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trackman, P. C.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.1517/14728222.2016.1151003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1517%2F14728222.2016.1151003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=935-945&author=P.+C.+Trackman&title=Lysyl+Oxidase+Isoforms+and+Potential+Therapeutic+Opportunities+for+Fibrosis+and+Cancer&doi=10.1517%2F14728222.2016.1151003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F14728222.2016.1151003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2016.1151003%26sid%3Dliteratum%253Aachs%26aulast%3DTrackman%26aufirst%3DP.%2BC.%26atitle%3DLysyl%2520Oxidase%2520Isoforms%2520and%2520Potential%2520Therapeutic%2520Opportunities%2520for%2520Fibrosis%2520and%2520Cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2016%26volume%3D3%26spage%3D935%26epage%3D945%26doi%3D10.1517%2F14728222.2016.1151003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perryman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erler, J.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase in Cancer Research</span>. <i>Future Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1709</span>– <span class="NLM_lpage">1717</span>, <span class="refDoi"> DOI: 10.2217/fon.14.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.2217%2Ffon.14.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=25145437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSru7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1709-1717&author=L.+Perrymanauthor=J.+Erler&title=Lysyl+Oxidase+in+Cancer+Research&doi=10.2217%2Ffon.14.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase in cancer research</span></div><div class="casAuthors">Perryman, Lara; Erler, Janine T.</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1709-1717</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1479-6694</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Metastasis is the main reason for cancer-assocd. deaths and therapies are desperately needed to target the progression of cancer.  Lysyl oxidase (LOX) plays a pivotal role in cancer progression, including metastasis, and is therefore is an attractive therapeutic target.  In this review we will breakdown the process of cancer progression and the various roles that LOX plays has in the advancement of cancer.  We will highlight why LOX is an exciting therapeutic target for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJUS3tJbsHtbVg90H21EOLACvtfcHk0lj3-mtog9xRAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSru7rK&md5=39bcdef4656c94521dc97a1fb8fbed30</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2217%2Ffon.14.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon.14.39%26sid%3Dliteratum%253Aachs%26aulast%3DPerryman%26aufirst%3DL.%26aulast%3DErler%26aufirst%3DJ.%26atitle%3DLysyl%2520Oxidase%2520in%2520Cancer%2520Research%26jtitle%3DFuture%2520Oncol.%26date%3D2014%26volume%3D10%26spage%3D1709%26epage%3D1717%26doi%3D10.2217%2Ffon.14.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barker, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erler, J. T.</span></span> <span> </span><span class="NLM_article-title">The Rationale for Targeting the LOX Family in Cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">540</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1038/nrc3319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1038%2Fnrc3319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=22810810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCltLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=540-552&author=H.+E.+Barkerauthor=T.+R.+Coxauthor=J.+T.+Erler&title=The+Rationale+for+Targeting+the+LOX+Family+in+Cancer&doi=10.1038%2Fnrc3319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The rationale for targeting the LOX family in cancer</span></div><div class="casAuthors">Barker, Holly E.; Cox, Thomas R.; Erler, Janine T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">540-552</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The therapeutic targeting of extracellular proteins is becoming hugely attractive in light of evidence implicating the tumor microenvironment as pivotal in all aspects of tumor initiation and progression.  Members of the lysyl oxidase (LOX) family of proteins are secreted by tumors and are the subject of much effort to understand their roles in cancer.  In this Review we discuss the roles of members of this family in the remodelling of the tumor microenvironment and their paradoxical roles in tumorigenesis and metastasis.  We also discuss how targeting this family of proteins might lead to a new avenue of cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZcLr3Y7rPKLVg90H21EOLACvtfcHk0lhEY8HGxXUurg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCltLfE&md5=455064ea8d5332b43fa6490a1aaa0c8f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc3319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3319%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DH.%2BE.%26aulast%3DCox%26aufirst%3DT.%2BR.%26aulast%3DErler%26aufirst%3DJ.%2BT.%26atitle%3DThe%2520Rationale%2520for%2520Targeting%2520the%2520LOX%2520Family%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D540%26epage%3D552%26doi%3D10.1038%2Fnrc3319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishioka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eustace, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase: From Basic Science to Future Cancer Treatment</span>. <i>Cell Struct. Funct.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1247/csf.11015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1247%2Fcsf.11015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=22453058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFShs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=75-80&author=T.+Nishiokaauthor=A.+Eustaceauthor=C.+West&title=Lysyl+Oxidase%3A+From+Basic+Science+to+Future+Cancer+Treatment&doi=10.1247%2Fcsf.11015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase: from basic science to future cancer treatment</span></div><div class="casAuthors">Nishioka, Takeshi; Eustace, Amanda; West, Catharine</div><div class="citationInfo"><span class="NLM_cas:title">Cell Structure and Function</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">75-80</span>CODEN:
                <span class="NLM_cas:coden">CSFUDY</span>;
        ISSN:<span class="NLM_cas:issn">0386-7196</span>.
    
            (<span class="NLM_cas:orgname">Japan Society for Cell Biology</span>)
        </div><div class="casAbstract">A review.  In this mini-review, we discuss the physiol. and pathol. roles of lysyl oxidase (LOX) and its family, LOX-like proteins (LOXL), in relation to prognosis of major cancers.  The no. of reports on LOX family is numerous.  We have decided to review the articles that were recently published (i.e. past 5 years).  Exptl. techniques in mol. biol. have advanced surprisingly in the past decade.  Accordingly, the results of the studies are more reliable.  Most studies reached the same conclusion; a higher LOX- or LOXL-expression is assocd. with a poor prognosis.  Mol. expts. have already started aiming for clin. application, and the results are encouraging.  Suppressing LOX or LOXL activities resulted in lower cell motility in collagen gel and, moreover, succeeded in reducing metastases in mice.  LOX family members were originally recognized as mols. that cross-link collagen fibers in the extracellular matrix.  Recent studies demonstrated that they are also involved in a phenomenon called Epithelial Mesenchymal Transition (EMT).  This may affect cell movement and cancer cell invasiveness.  LOX and LOXL2 are regulated by hypoxia, a major factor in the failure of cancer treatment.  Here we discuss the mol. biol. of the LOX family in relation to its role in tumor biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbGBuCWuIeMrVg90H21EOLACvtfcHk0lhEY8HGxXUurg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFShs7k%253D&md5=0dcfb556b3eed6375b57f09c4589ccad</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1247%2Fcsf.11015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1247%252Fcsf.11015%26sid%3Dliteratum%253Aachs%26aulast%3DNishioka%26aufirst%3DT.%26aulast%3DEustace%26aufirst%3DA.%26aulast%3DWest%26aufirst%3DC.%26atitle%3DLysyl%2520Oxidase%253A%2520From%2520Basic%2520Science%2520to%2520Future%2520Cancer%2520Treatment%26jtitle%3DCell%2520Struct.%2520Funct.%26date%3D2012%26volume%3D37%26spage%3D75%26epage%3D80%26doi%3D10.1247%2Fcsf.11015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddikuzzaman</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, V. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guruvayoorappan, C.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase: a Potential Target for Cancer Therapy</span>. <i>Inflammopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1007/s10787-010-0073-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1007%2Fs10787-010-0073-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=21107914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFWhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=117-129&author=+Siddikuzzamanauthor=V.+M.+B.+Graceauthor=C.+Guruvayoorappan&title=Lysyl+Oxidase%3A+a+Potential+Target+for+Cancer+Therapy&doi=10.1007%2Fs10787-010-0073-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase: a potential target for cancer therapy</span></div><div class="casAuthors">Siddikuzzaman; Berlin Grace, V. M.; Guruvayoorappan, C.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">117-129</span>CODEN:
                <span class="NLM_cas:coden">IAOAES</span>;
        ISSN:<span class="NLM_cas:issn">0925-4692</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Lysyl oxidases (LysOX; EC 1.4.3.13, protein-lysine 6-oxidases) are extracellular copper enzymes that catalyze the crosslinking of collagens or elastin in the extracellular matrix (ECM), thereby regulating the tensile strength of tissues.  Recent implication of LysOX in cancer, wound healing, cell motility, chemotaxis, and differentiation reflects its remarkable functional diversity and also in the central nervous system pathologies.  However, recent reports also demonstrated novel roles for LysOX, including the ability to regulate gene transcription, motility/migration, and cell adhesion.  These diverse functions have led researchers to hypothesize that LysOX may have multiple roles affecting both extra- and intracellular cell function(s).  Both down and up-regulation of LysOX in tumor tissues and cancer cell lines have been described, suggesting a dual role for LysOX as a tumor suppressor, as well as a metastasis promoter gene.  In this review we explain in detail the role of lysyl oxidase in tumor progression and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq12xRTcVwuEbVg90H21EOLACvtfcHk0lhEY8HGxXUurg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFWhurg%253D&md5=e147ad97f23acc050b87db1f73ab8876</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10787-010-0073-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10787-010-0073-1%26sid%3Dliteratum%253Aachs%26aulast%3DSiddikuzzaman%26aulast%3DGrace%26aufirst%3DV.%2BM.%2BB.%26aulast%3DGuruvayoorappan%26aufirst%3DC.%26atitle%3DLysyl%2520Oxidase%253A%2520a%2520Potential%2520Target%2520for%2520Cancer%2520Therapy%26jtitle%3DInflammopharmacology%26date%3D2011%26volume%3D19%26spage%3D117%26epage%3D129%26doi%3D10.1007%2Fs10787-010-0073-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, K. M.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase in Cancer Inhibition and Metastasis</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2018.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1016%2Fj.canlet.2018.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=29309816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVehurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2018&pages=174-181&author=K.+A.+Johnstonauthor=K.+M.+Lopez&title=Lysyl+Oxidase+in+Cancer+Inhibition+and+Metastasis&doi=10.1016%2Fj.canlet.2018.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase in cancer inhibition and metastasis</span></div><div class="casAuthors">Johnston, Kathryn A.; Lopez, Karlo M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">174-181</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Lysyl oxidase is an extracellular matrix, copper dependent amine oxidase that catalyzes a key enzymic step in the crosslinking of collagen and elastin.  The enzyme is synthesized as a propeptide that is cleaved by procollagen C proteinase into two distinct parts: the mature form and the LOX propeptide.  The mature enzyme plays a key role in modifying the extracellular matrix and as a result has been implicated in playing a role in the formation of cancer 'niches' where tumors will develop and eventually metastasize.  On the other hand, the LOX propeptide has been shown to have an inhibitory effect in the development of cancer tumors.  New approaches are being developed to test the use of small mol. inhibitors on LOX; however, the lack of a crystal structure has hampered these efforts as it is extremely difficult to design selective inhibitors without knowing what the target receptor looks like.  In this mini review we discuss the lysyl oxidase enzyme and its role several types of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_mMh21TZDR7Vg90H21EOLACvtfcHk0ljd1-TtzjORoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVehurs%253D&md5=27c8b558ba9f6b1a978e4f587755fcc4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2018.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2018.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DK.%2BA.%26aulast%3DLopez%26aufirst%3DK.%2BM.%26atitle%3DLysyl%2520Oxidase%2520in%2520Cancer%2520Inhibition%2520and%2520Metastasis%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D417%26spage%3D174%26epage%3D181%26doi%3D10.1016%2Fj.canlet.2018.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erler, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennewith, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dornhofer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J. T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase is Essential for Hypoxia-Induced Metastasis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>440</i></span>,  <span class="NLM_fpage">1222</span>– <span class="NLM_lpage">1226</span>, <span class="refDoi"> DOI: 10.1038/nature04695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1038%2Fnature04695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=16642001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvVGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=1222-1226&author=J.+T.+Erlerauthor=K.+L.+Bennewithauthor=M.+Nicolauauthor=N.+Dornhoferauthor=C.+Kongauthor=Q.+T.+Leauthor=J.+T.+A.+Chiauthor=S.+S.+Jeffreyauthor=A.+J.+Giaccia&title=Lysyl+Oxidase+is+Essential+for+Hypoxia-Induced+Metastasis&doi=10.1038%2Fnature04695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase is essential for hypoxia-induced metastasis</span></div><div class="casAuthors">Erler, Janine T.; Bennewith, Kevin L.; Nicolau, Monica; Dornhoefer, Nadja; Kong, Christina; Le, Quynh-Thu; Chi, Jen-Tsan Ashley; Jeffrey, Stefanie S.; Giaccia, Amato J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7088</span>),
    <span class="NLM_cas:pages">1222-1226</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metastasis is a multistep process responsible for most cancer deaths, and it can be influenced by both the immediate microenvironment (cell-cell or cell-matrix interactions) and the extended tumor microenvironment (for example vascularization).  Hypoxia (low oxygen) is clin. assocd. with metastasis and poor patient outcome, although the underlying processes remain unclear.  Microarray studies have shown the expression of lysyl oxidase (LOX) to be elevated in hypoxic human tumor cells.  Paradoxically, LOX expression is assocd. with both tumor suppression and tumor progression, and its role in tumorigenesis seems dependent on cellular location, cell type and transformation status.  Here we show that LOX expression is regulated by hypoxia-inducible factor (HIF) and is assocd. with hypoxia in human breast and head and neck tumors.  Patients with high LOX-expressing tumors have poor distant metastasis-free and overall survivals.  Inhibition of LOX eliminates metastasis in mice with orthotopically grown breast cancer tumors.  Mechanistically, secreted LOX is responsible for the invasive properties of hypoxic human cancer cells through focal adhesion kinase activity and cell to matrix adhesion.  Furthermore, LOX may be required to create a niche permissive for metastatic growth.  Our findings indicate that LOX is essential for hypoxia-induced metastasis and is a good therapeutic target for preventing and treating metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6kzyBjAAe1LVg90H21EOLACvtfcHk0ljd1-TtzjORoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvVGltb8%253D&md5=e38966cb7190643ab4dbdf4ebd721044</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature04695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04695%26sid%3Dliteratum%253Aachs%26aulast%3DErler%26aufirst%3DJ.%2BT.%26aulast%3DBennewith%26aufirst%3DK.%2BL.%26aulast%3DNicolau%26aufirst%3DM.%26aulast%3DDornhofer%26aufirst%3DN.%26aulast%3DKong%26aufirst%3DC.%26aulast%3DLe%26aufirst%3DQ.%2BT.%26aulast%3DChi%26aufirst%3DJ.%2BT.%2BA.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26atitle%3DLysyl%2520Oxidase%2520is%2520Essential%2520for%2520Hypoxia-Induced%2520Metastasis%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D1222%26epage%3D1226%26doi%3D10.1038%2Fnature04695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trackman, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, H. M.</span></span> <span> </span><span class="NLM_article-title">Reaction of Aortic Lysyl Oxidase with beta-Aminopropionitrile</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">4331</span>– <span class="NLM_lpage">4338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=6131892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADyaL3sXhslGmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1983&pages=4331-4338&author=S.+S.+Tangauthor=P.+C.+Trackmanauthor=H.+M.+Kagan&title=Reaction+of+Aortic+Lysyl+Oxidase+with+beta-Aminopropionitrile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of aortic lysyl oxidase with β-aminopropionitrile</span></div><div class="casAuthors">Tang, Shiow Shih; Trackman, Philip C.; Kagan, Herbert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4331-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">β-Aminopropionitrile (I) is a potent irreversible inhibitor of lysyl oxidase (II), which initiates crosslinkage formation in elastin and collagen.  The initial interaction of I with aortic II is competitive with elastin or alkyl amine substrates.  Irreversible inhibition develops in a time- and temp.-dependent fashion upon incubation of II with I in the absence of substrate with a limiting inactivation rate const. of 0.16 min-1 and a Ki of 6 μM at 37°.  The labeled C atoms of [1,2-14C]I and [3-14C]I covalently bind to II to equiv. extents and in parallel with the development of inactivation, negating the possibility that the nitrile moiety is eliminated from I by enzymic action.  The Cu content of II is not significantly altered upon interaction with I.  The extent of labeling by [14C]I is reduced by prior treatment of II with carbonyl-modifying reagents, suggesting the possibility of I-II Schiff base formation.  However, I is not processed to a free aldehyde product upon incubation with II.  A mechanism of inhibition is postulated which involves the formation of a covalent bond between an enzyme nucleophile and a ketenimine formed from I by II-assisted β-proton abstraction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6R41H2SgQY7Vg90H21EOLACvtfcHk0ljd1-TtzjORoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhslGmsr4%253D&md5=b64e1c85d58fb8c2c47d8beb939fa59a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DS.%2BS.%26aulast%3DTrackman%26aufirst%3DP.%2BC.%26aulast%3DKagan%26aufirst%3DH.%2BM.%26atitle%3DReaction%2520of%2520Aortic%2520Lysyl%2520Oxidase%2520with%2520beta-Aminopropionitrile%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1983%26volume%3D258%26spage%3D4331%26epage%3D4338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinnell, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, G. R.</span></span> <span> </span><span class="NLM_article-title">The Cross-Linking of Collagen and Elastin: Enzymatic Conversion of Lysine in Peptide Linage to α-Aminoadipic-δ-Semialdehyde (Allysine) by an Extract from Bone</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1073/pnas.61.2.708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1073%2Fpnas.61.2.708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=5246001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADyaF1MXisFOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1968&pages=708-714&author=S.+R.+Pinnellauthor=G.+R.+Martin&title=The+Cross-Linking+of+Collagen+and+Elastin%3A+Enzymatic+Conversion+of+Lysine+in+Peptide+Linage+to+%CE%B1-Aminoadipic-%CE%B4-Semialdehyde+%28Allysine%29+by+an+Extract+from+Bone&doi=10.1073%2Fpnas.61.2.708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The cross-linking of collagen and elastin:  enzymic conversion of lysine in peptide linkage to 5-formylnorvaline (allylsine) by an extract from bone</span></div><div class="casAuthors">Pinnell, Sheldon R.; Martin, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">708-16</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Assays for and some of the properties of an enzyme from bone, which converts peptide-bound lysine to allylsine, are described.  It is inhibited by physiol. active levels of the lathyrogen, β-aminopropionitrile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyTr_mMVHX57Vg90H21EOLACvtfcHk0ljDT9zqBgUoIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXisFOruw%253D%253D&md5=fd2ea54b8bf1990c5d0d634835813bdd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.61.2.708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.61.2.708%26sid%3Dliteratum%253Aachs%26aulast%3DPinnell%26aufirst%3DS.%2BR.%26aulast%3DMartin%26aufirst%3DG.%2BR.%26atitle%3DThe%2520Cross-Linking%2520of%2520Collagen%2520and%2520Elastin%253A%2520Enzymatic%2520Conversion%2520of%2520Lysine%2520in%2520Peptide%2520Linage%2520to%2520%25CE%25B1-Aminoadipic-%25CE%25B4-Semialdehyde%2520%2528Allysine%2529%2520by%2520an%2520Extract%2520from%2520Bone%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1968%26volume%3D61%26spage%3D708%26epage%3D714%26doi%3D10.1073%2Fpnas.61.2.708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonte, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Montolio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Findlay, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deodhar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarolimek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timpson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erler, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, T. R.</span></span> <span> </span><span class="NLM_article-title">Pre-clinical Evaluation of Small Molecule LOXL2 Inhibitors in Breast Cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">26066</span>– <span class="NLM_lpage">26078</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.15257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.18632%2Foncotarget.15257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=28199967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A280%3ADC%252BC1c3mvFOnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=26066-26078&author=J.+Changauthor=M.+C.+Lucasauthor=L.+E.+Leonteauthor=M.+Garcia-Montolioauthor=L.+B.+Singhauthor=A.+D.+Findlayauthor=M.+Deodharauthor=J.+Footauthor=W.+Jarolimekauthor=P.+Timpsonauthor=J.+T.+Erlerauthor=T.+R.+Cox&title=Pre-clinical+Evaluation+of+Small+Molecule+LOXL2+Inhibitors+in+Breast+Cancer&doi=10.18632%2Foncotarget.15257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer</span></div><div class="casAuthors">Chang Joan; Leonte Lidia E; Garcia-Montolio Marc; Singh Lukram Babloo; Erler Janine T; Cox Thomas R; Lucas Morghan C; Timpson Paul; Cox Thomas R; Findlay Alison D; Deodhar Mandar; Foot Jonathan S; Jarolimek Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">26066-26078</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lysyl Oxidase-like 2 (LOXL2), a member of the lysyl oxidase family of amine oxidases is known to be important in normal tissue development and homeostasis, as well as the onset and progression of solid tumors.  Here we tested the anti-tumor properties of two generations of novel small molecule LOXL2 inhibitor in the MDA-MB-231 human model of breast cancer.  We confirmed a functional role for LOXL2 activity in the progression of primary breast cancer.  Inhibition of LOXL2 activity inhibited the growth of primary tumors and reduced primary tumor angiogenesis.  Dual inhibition of LOXL2 and LOX showed a greater effect and also led to a lower overall metastatic burden in the lung and liver.  Our data provides the first evidence to support a role for LOXL2 specific small molecule inhibitors as a potential therapy in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOpqvFkfAy6suCWE5mhx1RfW6udTcc2ebSUipJXsSSDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3mvFOnsQ%253D%253D&md5=eda7044a327ae1746d7ae3ab2c2386fc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15257%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLeonte%26aufirst%3DL.%2BE.%26aulast%3DGarcia-Montolio%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DL.%2BB.%26aulast%3DFindlay%26aufirst%3DA.%2BD.%26aulast%3DDeodhar%26aufirst%3DM.%26aulast%3DFoot%26aufirst%3DJ.%26aulast%3DJarolimek%26aufirst%3DW.%26aulast%3DTimpson%26aufirst%3DP.%26aulast%3DErler%26aufirst%3DJ.%2BT.%26aulast%3DCox%26aufirst%3DT.%2BR.%26atitle%3DPre-clinical%2520Evaluation%2520of%2520Small%2520Molecule%2520LOXL2%2520Inhibitors%2520in%2520Breast%2520Cancer%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D26066%26epage%3D26078%26doi%3D10.18632%2Foncotarget.15257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowbottom, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasof, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonergan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darlington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodanovich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santini, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenna, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J. H.</span></span> <span> </span><span class="NLM_article-title">Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4403</span>– <span class="NLM_lpage">4423</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFSksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4403-4423&author=M.+W.+Rowbottomauthor=G.+Bainauthor=I.+Calderonauthor=T.+Lasofauthor=D.+Lonerganauthor=A.+Laiauthor=F.+Huangauthor=J.+Darlingtonauthor=P.+Prodanovichauthor=A.+M.+Santiniauthor=C.+D.+Kingauthor=L.+Gouletauthor=K.+E.+Shannonauthor=G.+L.+Maauthor=K.+Nguyenauthor=D.+A.+MacKennaauthor=J.+F.+Evansauthor=J.+H.+Hutchinson&title=Identification+of+4-%28Aminomethyl%29-6-%28trifluoromethyl%29-2-%28phenoxy%29pyridine+Derivatives+as+Potent%2C+Selective%2C+and+Orally+Efficacious+Inhibitors+of+the+Copper-Dependent+Amine+Oxidase%2C+Lysyl+Oxidase-Like+2+%28LOXL2%29&doi=10.1021%2Facs.jmedchem.7b00345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2)</span></div><div class="casAuthors">Rowbottom, Martin W.; Bain, Gretchen; Calderon, Imelda; Lasof, Taylor; Lonergan, David; Lai, Andiliy; Huang, Fei; Darlington, Janice; Prodanovich, Patricia; Santini, Angelina M.; King, Christopher D.; Goulet, Lance; Shannon, Kristen E.; Ma, Gina L.; Nguyen, Katherine; MacKenna, Deidre A.; Evans, Jilly F.; Hutchinson, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4403-4423</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">LOXL2 catalyzes the oxidative deamination of ε-amines of lysine and hydroxylysine residues within collagen and elastin, generating reactive aldehydes (allysine).  Condensation with other allysines or lysines drives the formation of inter- and intramol. cross-linkages, a process crit. for the remodeling of the ECM.  Dysregulation of this process can lead to fibrosis, and LOXL2 is known to be upregulated in fibrotic tissue.  Small-mols. that directly inhibit LOXL2 catalytic activity represent a useful option for the treatment of fibrosis.  Herein, the authors describe optimization of an initial hit, resulting in identification of racemic I, a potent irreversible inhibitor of LOXL2 that is highly selective over LOX and other amine oxidases.  Oral administration of I significantly reduced fibrosis in a 14-day mouse lung bleomycin model.  The (R,R)-enantiomer of I (PAT-1251) was selected as the clin. compd. which has progressed into healthy volunteer Phase 1 trials, making it the "first-in-class" small-mol. LOXL2 inhibitor to enter clin. development. KEY LOXL2 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX-yiHL-BRUrVg90H21EOLACvtfcHk0ljDT9zqBgUoIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFSksrs%253D&md5=c71db3046b5ed711043b39181fdf87c9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00345%26sid%3Dliteratum%253Aachs%26aulast%3DRowbottom%26aufirst%3DM.%2BW.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DLasof%26aufirst%3DT.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DShannon%26aufirst%3DK.%2BE.%26aulast%3DMa%26aufirst%3DG.%2BL.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DMacKenna%26aufirst%3DD.%2BA.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DIdentification%2520of%25204-%2528Aminomethyl%2529-6-%2528trifluoromethyl%2529-2-%2528phenoxy%2529pyridine%2520Derivatives%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Efficacious%2520Inhibitors%2520of%2520the%2520Copper-Dependent%2520Amine%2520Oxidase%252C%2520Lysyl%2520Oxidase-Like%25202%2520%2528LOXL2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4403%26epage%3D4423%26doi%3D10.1021%2Facs.jmedchem.7b00345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbottom, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonergan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darlington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodanovich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, G.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">423</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFaltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=423-427&author=J.+H.+Hutchinsonauthor=M.+W.+Rowbottomauthor=D.+Lonerganauthor=J.+Darlingtonauthor=P.+Prodanovichauthor=C.+D.+Kingauthor=J.+F.+Evansauthor=G.+Bain&title=Small+Molecule+Lysyl+Oxidase-like+2+%28LOXL2%29+Inhibitors%3A+The+Identification+of+an+Inhibitor+Selective+for+LOXL2+over+LOX&doi=10.1021%2Facsmedchemlett.7b00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX</span></div><div class="casAuthors">Hutchinson, John H.; Rowbottom, Martin W.; Lonergan, David; Darlington, Janice; Prodanovich, Pat; King, Christopher D.; Evans, Jilly F.; Bain, Gretchen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">423-427</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abstr.: Two series of novel LOXL2 enzyme inhibitors are described.  Benzylamines substituted with electron withdrawing groups in the para position and 2-substituted pyridine-4-ylmethanamines.  The most potent compd., (2-chloropyridin-4-yl)methanamine 20 (hLOXL2 IC50 = 126 nM) was shown to be selective for LOXL2 over LOX and three other amine oxidases (MAO-A, MAO-B and SSAO).  Compd. 20 is the first published small mol. inhibitor selective for LOXL2 over LOX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI9k75wz2jKrVg90H21EOLACvtfcHk0ljLqbBA2JRk-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFaltLs%253D&md5=64938315fde4a34c52020e4126636acc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00014%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DRowbottom%26aufirst%3DM.%2BW.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DBain%26aufirst%3DG.%26atitle%3DSmall%2520Molecule%2520Lysyl%2520Oxidase-like%25202%2520%2528LOXL2%2529%2520Inhibitors%253A%2520The%2520Identification%2520of%2520an%2520Inhibitor%2520Selective%2520for%2520LOXL2%2520over%2520LOX%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D423%26epage%3D427%26doi%3D10.1021%2Facsmedchemlett.7b00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saturno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Leva, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niculescu-Duvaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhomen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marais, R.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase Drives Tumour Progression by Trapping EGF Receptors at the Cell Surface</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">14909</span> <span class="refDoi"> DOI: 10.1038/ncomms14909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1038%2Fncomms14909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=28416796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=H.+R.+Tangauthor=L.+Leungauthor=G.+Saturnoauthor=A.+Virosauthor=D.+Smithauthor=G.+Di+Levaauthor=E.+Morrisonauthor=D.+Niculescu-Duvazauthor=F.+Lopesauthor=L.+Johnsonauthor=N.+Dhomenauthor=C.+Springerauthor=R.+Marais&title=Lysyl+Oxidase+Drives+Tumour+Progression+by+Trapping+EGF+Receptors+at+the+Cell+Surface&doi=10.1038%2Fncomms14909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface</span></div><div class="casAuthors">Tang, Hao Ran; Leung, Leo; Saturno, Grazia; Viros, Amaya; Smith, Duncan; Di Leva, Gianpiero; Morrison, Eamonn; Niculescu-Duvaz, Dan; Lopes, Filipa; Johnson, Louise; Dhomen, Nathalie; Springer, Caroline; Marais, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14909</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysyl oxidase (LOX) remodels the tumor microenvironment by crosslinking the extracellular matrix.  LOX overexpression is assocd. with poor cancer outcomes.  Here, we find that LOX regulates the epidermal growth factor receptor (EGFR) to drive tumor progression.  We show that LOX regulates EGFR by suppressing TGFβ1 signalling through the secreted protease HTRA1.  This increases the expression of Matrilin2 (MATN2), an EGF-like domain-contg. protein that traps EGFR at the cell surface to facilitate its activation by EGF.  We describe a pharmacol. inhibitor of LOX, CCT365623, which disrupts EGFR cell surface retention and delays the growth of primary and metastatic tumor cells in vivo.  Thus, we show that LOX regulates EGFR cell surface retention to drive tumor progression, and we validate the therapeutic potential of inhibiting this pathway with the small mol. inhibitor CCT365623.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjI8odBCa4OLVg90H21EOLACvtfcHk0ljLqbBA2JRk-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFKgtbw%253D&md5=d0db599dc8344c8685196f6d289fd3cf</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fncomms14909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14909%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DH.%2BR.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DSaturno%26aufirst%3DG.%26aulast%3DViros%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DDi%2BLeva%26aufirst%3DG.%26aulast%3DMorrison%26aufirst%3DE.%26aulast%3DNiculescu-Duvaz%26aufirst%3DD.%26aulast%3DLopes%26aufirst%3DF.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DDhomen%26aufirst%3DN.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DLysyl%2520Oxidase%2520Drives%2520Tumour%2520Progression%2520by%2520Trapping%2520EGF%2520Receptors%2520at%2520the%2520Cell%2520Surface%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26doi%3D10.1038%2Fncomms14909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grippi-Vallotton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkinstall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Church, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halazy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotteland, J.-P.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">6921</span>– <span class="NLM_lpage">6934</span>, <span class="refDoi"> DOI: 10.1021/jm031112e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031112e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCmsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6921-6934&author=T.+R%C3%BCckleauthor=M.+Biamonteauthor=T.+Grippi-Vallottonauthor=S.+Arkinstallauthor=Y.+Cambetauthor=M.+Campsauthor=C.+Chabertauthor=D.+J.+Churchauthor=S.+Halazyauthor=X.+Jiangauthor=I.+Martinouauthor=A.+Nicholsauthor=W.+Sauerauthor=J.-P.+Gotteland&title=Design%2C+Synthesis%2C+and+Biological+Activity+of+Novel%2C+Potent%2C+and+Selective+%28Benzoylaminomethyl%29thiophene+Sulfonamide+Inhibitors+of+c-Jun-N-Terminal+Kinase&doi=10.1021%2Fjm031112e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase</span></div><div class="casAuthors">Rueckle, Thomas; Biamonte, Marco; Grippi-Vallotton, Tania; Arkinstall, Steve; Cambet, Yves; Camps, Montserrat; Chabert, Christian; Church, Dennis J.; Halazy, Serge; Jiang, Xuliang; Martinou, Isabelle; Nichols, Anthony; Sauer, Wolfgang; Gotteland, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">6921-6934</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several lines of evidence support the hypothesis that c-Jun N-terminal kinases (JNKs) play a crit. role in a wide range of disease states including cell death (apoptosis)-related and inflammatory disorders (epilepsy, brain, heart and renal ischemia, neurodegenerative diseases, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel syndrome).  The screening of a compd. collection led to the identification of a 2-(benzoylaminomethyl)thiophene sulfonamide (AS004509, I) as a potent and selective JNK inhibitor.  Chem. and structure-activity relationship (SAR) studies performed around this novel kinase-inhibiting motif indicated that the left and central parts of the mol. were instrumental to maintaining potency at the enzyme.  Accordingly, we investigated the JNK-inhibiting properties of a no. of variants of the right-hand moiety of the mol., which led to the identification of 2-(benzoylaminomethyl)thiophene sulfonamide benzotriazole (AS600292, II), the first potent and selective JNK inhibitor of this class which demonstrates a protective action against neuronal cell death induced by growth factor and serum deprivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMEEwsmNwmprVg90H21EOLACvtfcHk0ljm1sTHN_YaAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCmsLzL&md5=0a0eab4608e2051c4881a453a9f1e5e4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm031112e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031112e%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DBiamonte%26aufirst%3DM.%26aulast%3DGrippi-Vallotton%26aufirst%3DT.%26aulast%3DArkinstall%26aufirst%3DS.%26aulast%3DCambet%26aufirst%3DY.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DChurch%26aufirst%3DD.%2BJ.%26aulast%3DHalazy%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMartinou%26aufirst%3DI.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DSauer%26aufirst%3DW.%26aulast%3DGotteland%26aufirst%3DJ.-P.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Activity%2520of%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520%2528Benzoylaminomethyl%2529thiophene%2520Sulfonamide%2520Inhibitors%2520of%2520c-Jun-N-Terminal%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6921%26epage%3D6934%26doi%3D10.1021%2Fjm031112e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapadar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiran Kumar, S.</span></span> <span> </span><span class="NLM_article-title">Cyclic Trimer of 5-(Aminomethyl)-2-furancarboxylic Acid as a Novel Synthetic Receptor for Carboxylate Recognition</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1317</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)02367-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1016%2FS0040-4039%2801%2902367-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslGrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1317-1320&author=T.+K.+Chakrabortyauthor=S.+Tapadarauthor=S.+Kiran+Kumar&title=Cyclic+Trimer+of+5-%28Aminomethyl%29-2-furancarboxylic+Acid+as+a+Novel+Synthetic+Receptor+for+Carboxylate+Recognition&doi=10.1016%2FS0040-4039%2801%2902367-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic trimer of 5-(aminomethyl)-2-furancarboxylic acid as a novel synthetic receptor for carboxylate recognition</span></div><div class="casAuthors">Chakraborty, Tushar K.; Tapadar, Subhasish; Kiran Kumar, S.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1317-1320</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A novel 18-membered cyclic oligopeptide based on 5-(aminomethyl)-2-furancarboxylic acid (Faa) is developed as an excellent receptor for carboxylate binding having an assocn. const. of 8.64×103 M-1 for tetrabutylammonium acetate in CD3CN.  The synthesis of cyclo(Faa)3 was achieved by a high-yielding cyclotrimerization reaction of the unfunctionalized furan amino acid Faa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1gkOv4AkqE7Vg90H21EOLACvtfcHk0ljm1sTHN_YaAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslGrtA%253D%253D&md5=40b048ee9f47adb611374ee7158d0ed4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2902367-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252902367-X%26sid%3Dliteratum%253Aachs%26aulast%3DChakraborty%26aufirst%3DT.%2BK.%26aulast%3DTapadar%26aufirst%3DS.%26aulast%3DKiran%2BKumar%26aufirst%3DS.%26atitle%3DCyclic%2520Trimer%2520of%25205-%2528Aminomethyl%2529-2-furancarboxylic%2520Acid%2520as%2520a%2520Novel%2520Synthetic%2520Receptor%2520for%2520Carboxylate%2520Recognition%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D1317%26epage%3D1320%26doi%3D10.1016%2FS0040-4039%2801%2902367-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span>; <span class="NLM_string-name">Ando, T.</span>; <span class="NLM_string-name">Yamamoto, Y.</span>; <span class="NLM_string-name">Imai, T.</span>; <span class="NLM_string-name">Kubota, D.</span>; <span class="NLM_string-name">Noguchi, K.</span>; <span class="NLM_string-name">Hori, N.</span>; <span class="NLM_string-name">Shitara, E.</span>; <span class="NLM_string-name">Atsumi, K.</span>; <span class="NLM_string-name">Yasuda, S.</span></span> <span> </span><span class="NLM_article-title">Intermediate for 2-Substituted Carbapenem Derivative and Production Process</span>. <span class="NLM_patent">WO2004/055027</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=T.+Sasaki&author=T.+Ando&author=Y.+Yamamoto&author=T.+Imai&author=D.+Kubota&author=K.+Noguchi&author=N.+Hori&author=E.+Shitara&author=K.+Atsumi&author=S.+Yasuda&title=Intermediate+for+2-Substituted+Carbapenem+Derivative+and+Production+Process"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DT.%26atitle%3DIntermediate%2520for%25202-Substituted%2520Carbapenem%2520Derivative%2520and%2520Production%2520Process%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+Substructure+Filters+for+Removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+Screening+Libraries+and+for+Their+Exclusion+in+Bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0ljm1sTHN_YaAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520Substructure%2520Filters%2520for%2520Removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520Screening%2520Libraries%2520and%2520for%2520Their%2520Exclusion%2520in%2520Bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shackleton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulmes, D. J.</span></span> <span> </span><span class="NLM_article-title">Purification of Lysyl Oxidase from Piglet Skin by Selective Interaction with Sephacryl S-200</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1970238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADyaK3cXhslCmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1990&pages=917-919&author=D.+R.+Shackletonauthor=D.+J.+Hulmes&title=Purification+of+Lysyl+Oxidase+from+Piglet+Skin+by+Selective+Interaction+with+Sephacryl+S-200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of lysyl oxidase from piglet skin by selective interaction with Sephacryl S-200</span></div><div class="casAuthors">Shackleton, David R.; Hulmes, David J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">917-19</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">A method is described for the purifn. of piglet skin lysyl oxidase from a crude urea ext. by 2 simple chromatog. procedures.  The method relies on the selective interaction between Sephacryl S-200 and lysyl oxidase that occurs in the absence of urea and in conditions of low ionic strength.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0gfvaIRXl-7Vg90H21EOLACvtfcHk0lhj9-rAK9G0RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhslCmtbg%253D&md5=368284c6cadb0ec2fe7f11d6c5e8f8f0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShackleton%26aufirst%3DD.%2BR.%26aulast%3DHulmes%26aufirst%3DD.%2BJ.%26atitle%3DPurification%2520of%2520Lysyl%2520Oxidase%2520from%2520Piglet%2520Skin%2520by%2520Selective%2520Interaction%2520with%2520Sephacryl%2520S-200%26jtitle%3DBiochem.%2520J.%26date%3D1990%26volume%3D266%26spage%3D917%26epage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohas, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierrepoint, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowlatt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, T. C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia</span>. <i>Lab. Anim.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1258/002367788780746467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1258%2F002367788780746467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=3172698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A280%3ADyaL1M%252Fht1ymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1988&pages=195-201&author=P.+Workmanauthor=A.+Balmainauthor=J.+A.+Hickmanauthor=N.+J.+McNallyauthor=A.+M.+Rohasauthor=N.+A.+Mitchisonauthor=C.+G.+Pierrepointauthor=R.+Raymondauthor=C.+Rowlattauthor=T.+C.+Stephens&title=UKCCCR+Guidelines+for+the+Welfare+of+Animals+in+Experimental+Neoplasia&doi=10.1258%2F002367788780746467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">UKCCCR guidelines for the welfare of animals in experimental neoplasia</span></div><div class="casAuthors">Workman P; Balmain A; Hickman J A; McNally N J; Rohas A M; Mitchison N A; Pierrepoint C G; Raymond R; Rowlatt C; Stephens T C</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory animals</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">195-201</span>
        ISSN:<span class="NLM_cas:issn">0023-6772</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpbCFa3IXp3kcLvDNbOD4DfW6udTcc2eZJTTfbouq8Rrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M%252Fht1ymtA%253D%253D&md5=632d4a2f5869b721721884546190da34</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1258%2F002367788780746467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252F002367788780746467%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DHickman%26aufirst%3DJ.%2BA.%26aulast%3DMcNally%26aufirst%3DN.%2BJ.%26aulast%3DRohas%26aufirst%3DA.%2BM.%26aulast%3DMitchison%26aufirst%3DN.%2BA.%26aulast%3DPierrepoint%26aufirst%3DC.%2BG.%26aulast%3DRaymond%26aufirst%3DR.%26aulast%3DRowlatt%26aufirst%3DC.%26aulast%3DStephens%26aufirst%3DT.%2BC.%26atitle%3DUKCCCR%2520Guidelines%2520for%2520the%2520Welfare%2520of%2520Animals%2520in%2520Experimental%2520Neoplasia%26jtitle%3DLab.%2520Anim.%26date%3D1988%26volume%3D22%26spage%3D195%26epage%3D201%26doi%3D10.1258%2F002367788780746467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yan He, Jintao Yang, Qimeng Liu, Xinying Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xuesen Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of β-Methylsulfonylated N-Heterocycles from Saturated Cyclic Amines with the Insertion of Sulfur Dioxide. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (23)
                                     , 15600-15609. <a href="https://doi.org/10.1021/acs.joc.0c02368" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02368%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B2-Methylsulfonylated%252BN-Heterocycles%252Bfrom%252BSaturated%252BCyclic%252BAmines%252Bwith%252Bthe%252BInsertion%252Bof%252BSulfur%252BDioxide%26aulast%3DHe%26aufirst%3DYan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06102020%26date%3D12112020%26volume%3D85%26issue%3D23%26spage%3D15600%26epage%3D15609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Deborah A. Smithen, Leo M. H. Leung, Mairi Challinor, Rae Lawrence, HaoRan Tang, Dan Niculescu-Duvaz, Simon P. Pearce, Robert Mcleary, Filipa Lopes, Mohammed Aljarah, Michael Brown, Louise Johnson, Graeme Thomson, Richard Marais, <span class="NLM_string-name hlFld-ContribAuthor">Caroline Springer</span>. </span><span class="cited-content_cbyCitation_article-title">2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2308-2324. <a href="https://doi.org/10.1021/acs.jmedchem.9b01112" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01112%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Aminomethylene-5-sulfonylthiazole%252BInhibitors%252Bof%252BLysyl%252BOxidase%252B%252528LOX%252529%252Band%252BLOXL2%252BShow%252BSignificant%252BEfficacy%252Bin%252BDelaying%252BTumor%252BGrowth%26aulast%3DSmithen%26aufirst%3DDeborah%2BA.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D11072019%26date%3D04092019%26date%3D20082019%26volume%3D63%26issue%3D5%26spage%3D2308%26epage%3D2324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alison D. Findlay, Jonathan S. Foot, Alberto Buson, Mandar Deodhar, Andrew G. Jarnicki, Philip M. Hansbro, Gang Liu, Heidi Schilter, Craig I. Turner, Wenbin Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Wolfgang Jarolimek</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9874-9889. <a href="https://doi.org/10.1021/acs.jmedchem.9b01283" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01283%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BOptimization%252Bof%252BMechanism-Based%252BFluoroallylamine%252BInhibitors%252Bof%252BLysyl%252BOxidase-like%252B2%25252F3%26aulast%3DFindlay%26aufirst%3DAlison%2BD.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07082019%26date%3D16102019%26date%3D03102019%26volume%3D62%26issue%3D21%26spage%3D9874%26epage%3D9889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryuhei  Takemoto</span>, <span class="hlFld-ContribAuthor ">Tetsuro  Kamiya</span>, <span class="hlFld-ContribAuthor ">Taku  Atobe</span>, <span class="hlFld-ContribAuthor ">Hirokazu  Hara</span>, <span class="hlFld-ContribAuthor ">Tetsuo  Adachi</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of lysyl oxidase expression in THP‐1 cell‐derived M2‐like macrophages. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2021,</strong> <em>122 </em>
                                    (8)
                                     , 777-786. <a href="https://doi.org/10.1002/jcb.29911" title="DOI URL">https://doi.org/10.1002/jcb.29911</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.29911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.29911%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DRegulation%252Bof%252Blysyl%252Boxidase%252Bexpression%252Bin%252BTHP%2525E2%252580%2525901%252Bcell%2525E2%252580%252590derived%252BM2%2525E2%252580%252590like%252Bmacrophages%26aulast%3DTakemoto%26aufirst%3DRyuhei%26date%3D2021%26date%3D2021%26volume%3D122%26issue%3D8%26spage%3D777%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fan  Tang</span>, <span class="hlFld-ContribAuthor ">Yan  Tie</span>, <span class="hlFld-ContribAuthor ">Weiqi  Hong</span>, <span class="hlFld-ContribAuthor ">Yuquan  Wei</span>, <span class="hlFld-ContribAuthor ">Chongqi  Tu</span>, <span class="hlFld-ContribAuthor ">Xiawei  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection. </span><span class="cited-content_cbyCitation_journal-name">Annals of Surgical Oncology</span><span> <strong>2021,</strong> <em>28 </em>
                                    (7)
                                     , 4030-4048. <a href="https://doi.org/10.1245/s10434-020-09371-z" title="DOI URL">https://doi.org/10.1245/s10434-020-09371-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1245/s10434-020-09371-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1245%2Fs10434-020-09371-z%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Surgical%2520Oncology%26atitle%3DTargeting%252BMyeloid-Derived%252BSuppressor%252BCells%252Bfor%252BPremetastatic%252BNiche%252BDisruption%252BAfter%252BTumor%252BResection%26aulast%3DTang%26aufirst%3DFan%26date%3D2021%26date%3D2020%26volume%3D28%26issue%3D7%26spage%3D4030%26epage%3D4048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhanusha  Yesudhas</span>, <span class="hlFld-ContribAuthor ">Ambuj  Srivastava</span>, <span class="hlFld-ContribAuthor ">M. Michael  Gromiha</span>. </span><span class="cited-content_cbyCitation_article-title">COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Infection</span><span> <strong>2021,</strong> <em>49 </em>
                                    (2)
                                     , 199-213. <a href="https://doi.org/10.1007/s15010-020-01516-2" title="DOI URL">https://doi.org/10.1007/s15010-020-01516-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s15010-020-01516-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs15010-020-01516-2%26sid%3Dliteratum%253Aachs%26jtitle%3DInfection%26atitle%3DCOVID-19%252Boutbreak%25253A%252Bhistory%25252C%252Bmechanism%25252C%252Btransmission%25252C%252Bstructural%252Bstudies%252Band%252Btherapeutics%26aulast%3DYesudhas%26aufirst%3DDhanusha%26date%3D2021%26date%3D2020%26volume%3D49%26issue%3D2%26spage%3D199%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Ferreira</span>, <span class="hlFld-ContribAuthor ">Nuno  Saraiva</span>, <span class="hlFld-ContribAuthor ">Patrícia  Rijo</span>, <span class="hlFld-ContribAuthor ">Ana S.  Fernandes</span>. </span><span class="cited-content_cbyCitation_article-title">LOXL2 Inhibitors and Breast Cancer Progression. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2021,</strong> <em>10 </em>
                                    (2)
                                     , 312. <a href="https://doi.org/10.3390/antiox10020312" title="DOI URL">https://doi.org/10.3390/antiox10020312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox10020312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox10020312%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DLOXL2%252BInhibitors%252Band%252BBreast%252BCancer%252BProgression%26aulast%3DFerreira%26aufirst%3DSandra%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D2%26spage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yordanos F.I.  Setargew</span>, <span class="hlFld-ContribAuthor ">Kaitlin  Wyllie</span>, <span class="hlFld-ContribAuthor ">Rhiannon D.  Grant</span>, <span class="hlFld-ContribAuthor ">Jessica L.  Chitty</span>, <span class="hlFld-ContribAuthor ">Thomas R.  Cox</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (3)
                                     , 491. <a href="https://doi.org/10.3390/cancers13030491" title="DOI URL">https://doi.org/10.3390/cancers13030491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13030491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13030491%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeting%252BLysyl%252BOxidase%252BFamily%252BMeditated%252BMatrix%252BCross-Linking%252Bas%252Ban%252BAnti-Stromal%252BTherapy%252Bin%252BSolid%252BTumours%26aulast%3DSetargew%26aufirst%3DYordanos%2BF.I.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D3%26spage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hung-Yu  Lin</span>, <span class="hlFld-ContribAuthor ">Chia-Jung  Li</span>, <span class="hlFld-ContribAuthor ">Ya-Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Ying-Hsien  Huang</span>, <span class="hlFld-ContribAuthor ">Ya-Tze  Hsiau</span>, <span class="hlFld-ContribAuthor ">Pei-Yi  Chu</span>. </span><span class="cited-content_cbyCitation_article-title">Roles of Lysyl Oxidase Family Members in the Tumor Microenvironment and Progression of Liver Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (24)
                                     , 9751. <a href="https://doi.org/10.3390/ijms21249751" title="DOI URL">https://doi.org/10.3390/ijms21249751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21249751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21249751%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DRoles%252Bof%252BLysyl%252BOxidase%252BFamily%252BMembers%252Bin%252Bthe%252BTumor%252BMicroenvironment%252Band%252BProgression%252Bof%252BLiver%252BCancer%26aulast%3DLin%26aufirst%3DHung-Yu%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D24%26spage%3D9751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ozge  Saatci</span>, <span class="hlFld-ContribAuthor ">Aysegul  Kaymak</span>, <span class="hlFld-ContribAuthor ">Umar  Raza</span>, <span class="hlFld-ContribAuthor ">Pelin G.  Ersan</span>, <span class="hlFld-ContribAuthor ">Ozge  Akbulut</span>, <span class="hlFld-ContribAuthor ">Carolyn E.  Banister</span>, <span class="hlFld-ContribAuthor ">Vitali  Sikirzhytski</span>, <span class="hlFld-ContribAuthor ">Unal Metin  Tokat</span>, <span class="hlFld-ContribAuthor ">Gamze  Aykut</span>, <span class="hlFld-ContribAuthor ">Suhail A.  Ansari</span>, <span class="hlFld-ContribAuthor ">Hayriye Tatli  Dogan</span>, <span class="hlFld-ContribAuthor ">Mehmet  Dogan</span>, <span class="hlFld-ContribAuthor ">Pouria  Jandaghi</span>, <span class="hlFld-ContribAuthor ">Aynur  Isik</span>, <span class="hlFld-ContribAuthor ">Fatma  Gundogdu</span>, <span class="hlFld-ContribAuthor ">Kemal  Kosemehmetoglu</span>, <span class="hlFld-ContribAuthor ">Omer  Dizdar</span>, <span class="hlFld-ContribAuthor ">Sercan  Aksoy</span>, <span class="hlFld-ContribAuthor ">Aytekin  Akyol</span>, <span class="hlFld-ContribAuthor ">Aysegul  Uner</span>, <span class="hlFld-ContribAuthor ">Phillip J.  Buckhaults</span>, <span class="hlFld-ContribAuthor ">Yasser  Riazalhosseini</span>, <span class="hlFld-ContribAuthor ">Ozgur  Sahin</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-16199-4" title="DOI URL">https://doi.org/10.1038/s41467-020-16199-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-16199-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-16199-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DTargeting%252Blysyl%252Boxidase%252B%252528LOX%252529%252Bovercomes%252Bchemotherapy%252Bresistance%252Bin%252Btriple%252Bnegative%252Bbreast%252Bcancer%26aulast%3DSaatci%26aufirst%3DOzge%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miaomiao  Ye</span>, <span class="hlFld-ContribAuthor ">Yizuo  Song</span>, <span class="hlFld-ContribAuthor ">Shuya  Pan</span>, <span class="hlFld-ContribAuthor ">Man  Chu</span>, <span class="hlFld-ContribAuthor ">Zhi-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Xueqiong  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>215 </em>, 107633. <a href="https://doi.org/10.1016/j.pharmthera.2020.107633" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107633%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DEvolving%252Broles%252Bof%252Blysyl%252Boxidase%252Bfamily%252Bin%252Btumorigenesis%252Band%252Bcancer%252Btherapy%26aulast%3DYe%26aufirst%3DMiaomiao%26date%3D2020%26volume%3D215%26spage%3D107633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rozalia  Laczko</span>, <span class="hlFld-ContribAuthor ">Katalin  Csiszar</span>. </span><span class="cited-content_cbyCitation_article-title">Lysyl Oxidase (LOX): Functional Contributions to Signaling Pathways. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (8)
                                     , 1093. <a href="https://doi.org/10.3390/biom10081093" title="DOI URL">https://doi.org/10.3390/biom10081093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10081093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10081093%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DLysyl%252BOxidase%252B%252528LOX%252529%25253A%252BFunctional%252BContributions%252Bto%252BSignaling%252BPathways%26aulast%3DLaczko%26aufirst%3DRozalia%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D8%26spage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amanda  Garrido</span>, <span class="hlFld-ContribAuthor ">Alban  Lepailleur</span>, <span class="hlFld-ContribAuthor ">Serge M.  Mignani</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">hERG toxicity assessment: Useful guidelines for drug design. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112290. <a href="https://doi.org/10.1016/j.ejmech.2020.112290" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112290</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112290%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DhERG%252Btoxicity%252Bassessment%25253A%252BUseful%252Bguidelines%252Bfor%252Bdrug%252Bdesign%26aulast%3DGarrido%26aufirst%3DAmanda%26date%3D2020%26volume%3D195%26spage%3D112290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Han</span>, <span class="hlFld-ContribAuthor ">Guochao  Yan</span>, <span class="hlFld-ContribAuthor ">Jianping  Feng</span>, <span class="hlFld-ContribAuthor ">Xianglin  Yang</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Using Topomer Comparative Molecular Field Analysis to Elucidate Activity Differences of Aminomethylenethiophene Derivatives as Lysyl Oxidase Inhibitors: Implications for Rational Design of Antimetastatic Agents for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>, 1-10. <a href="https://doi.org/10.1155/2020/2036585" title="DOI URL">https://doi.org/10.1155/2020/2036585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/2036585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F2036585%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemistry%26atitle%3DUsing%252BTopomer%252BComparative%252BMolecular%252BField%252BAnalysis%252Bto%252BElucidate%252BActivity%252BDifferences%252Bof%252BAminomethylenethiophene%252BDerivatives%252Bas%252BLysyl%252BOxidase%252BInhibitors%25253A%252BImplications%252Bfor%252BRational%252BDesign%252Bof%252BAntimetastatic%252BAgents%252Bfor%252BCancer%252BTherapy%26aulast%3DHan%26aufirst%3DJing%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vriddhi  Chopra</span>, <span class="hlFld-ContribAuthor ">Ruth M.  Sangarappillai</span>, <span class="hlFld-ContribAuthor ">Isolda  Romero‐Canelón</span>, <span class="hlFld-ContribAuthor ">Alan M.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Lysyl Oxidase Like‐2 (LOXL2): An Emerging Oncology Target. </span><span class="cited-content_cbyCitation_journal-name">Advanced Therapeutics</span><span> <strong>2020,</strong> <em>3 </em>
                                    (2)
                                     , 1900119. <a href="https://doi.org/10.1002/adtp.201900119" title="DOI URL">https://doi.org/10.1002/adtp.201900119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adtp.201900119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadtp.201900119%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Therapeutics%26atitle%3DLysyl%252BOxidase%252BLike%2525E2%252580%2525902%252B%252528LOXL2%252529%25253A%252BAn%252BEmerging%252BOncology%252BTarget%26aulast%3DChopra%26aufirst%3DVriddhi%26date%3D2020%26date%3D2020%26volume%3D3%26issue%3D2%26spage%3D1900119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Papanicolaou</span>, <span class="hlFld-ContribAuthor ">Thomas R.  Cox</span>. </span><span class="cited-content_cbyCitation_article-title">Extracellular Matrix (ECM). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-8. <a href="https://doi.org/10.1007/978-3-030-21573-6_5691-1" title="DOI URL">https://doi.org/10.1007/978-3-030-21573-6_5691-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-21573-6_5691-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-21573-6_5691-1%26sid%3Dliteratum%253Aachs%26atitle%3DExtracellular%252BMatrix%252B%252528ECM%252529%26aulast%3DPapanicolaou%26aufirst%3DMichael%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D8%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEncyclopedia%252Bof%252BMolecular%252BPharmacology%26aulast%3DOffermanns%26aufirst%3DStefan%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica L.  Chitty</span>, <span class="hlFld-ContribAuthor ">Yordanos F.I.  Setargew</span>, <span class="hlFld-ContribAuthor ">Thomas R.  Cox</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the lysyl oxidases in tumour desmoplasia. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Society Transactions</span><span> <strong>2019,</strong> <em>47 </em>
                                    (6)
                                     , 1661-1678. <a href="https://doi.org/10.1042/BST20190098" title="DOI URL">https://doi.org/10.1042/BST20190098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BST20190098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBST20190098%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Society%2520Transactions%26atitle%3DTargeting%252Bthe%252Blysyl%252Boxidases%252Bin%252Btumour%252Bdesmoplasia%26aulast%3DChitty%26aufirst%3DJessica%2BL.%26date%3D2019%26date%3D2019%26volume%3D47%26issue%3D6%26spage%3D1661%26epage%3D1678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Fernandes</span>, <span class="hlFld-ContribAuthor ">Daniel  Rosel</span>, <span class="hlFld-ContribAuthor ">Jan  Brábek</span>. </span><span class="cited-content_cbyCitation_article-title">Solid cancer: the new tumour spread endpoint opens novel opportunities. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2019,</strong> <em>121 </em>
                                    (7)
                                     , 513-514. <a href="https://doi.org/10.1038/s41416-019-0536-0" title="DOI URL">https://doi.org/10.1038/s41416-019-0536-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-019-0536-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-019-0536-0%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DSolid%252Bcancer%25253A%252Bthe%252Bnew%252Btumour%252Bspread%252Bendpoint%252Bopens%252Bnovel%252Bopportunities%26aulast%3DFernandes%26aufirst%3DMichael%26date%3D2019%26date%3D2019%26volume%3D121%26issue%3D7%26spage%3D513%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Sylvain D.  Vallet</span>, <span class="hlFld-ContribAuthor ">Sylvie  Ricard-Blum</span>. </span><span class="cited-content_cbyCitation_article-title">Lysyl oxidases: from enzyme activity to extracellular matrix cross-links. </span><span class="cited-content_cbyCitation_journal-name">Essays in Biochemistry</span><span> <strong>2019,</strong> <em>63 </em>
                                    (3)
                                     , 349-364. <a href="https://doi.org/10.1042/EBC20180050" title="DOI URL">https://doi.org/10.1042/EBC20180050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/EBC20180050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FEBC20180050%26sid%3Dliteratum%253Aachs%26jtitle%3DEssays%2520in%2520Biochemistry%26atitle%3DLysyl%252Boxidases%25253A%252Bfrom%252Benzyme%252Bactivity%252Bto%252Bextracellular%252Bmatrix%252Bcross-links%26aulast%3DAdams%26aufirst%3DJosephine%26date%3D2019%26date%3D2019%26volume%3D63%26issue%3D3%26spage%3D349%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0033.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0001.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Small molecule inhibitors of LOX-family enzymes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0002.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed binding mode of AMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0003.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Anti-metastatic efficacy of compound <b>9f</b> in LOX-driven GEMM model. Animals treated with vehicle (black) or compound <b>9f</b> at 70 mg/kg qd (blue). All values are reported as the arithmetic mean with the error expressed as the standard error of the means. (<b>A</b>) Number of lung metastasis, vehicle, <i>n</i> = 7; <b>9f</b> treated, <i>n</i> = 5; (B) Lung metastasis area in μm<sup>2</sup>, vehicle, <i>n</i> = 7; <b>9f</b> treated, <i>n</i> = 5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Routes to AMT-Sulfonamide Analogues <b>2a</b>–<b>n</b> and <b>5f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFAA, Et<sub>3</sub>N, DCM, room temperature (rt); (b) ClSO<sub>3</sub>H, DCM, −78 °C to rt, then H<sub>2</sub>O; (c) oxalyl chloride, dimethylformamide (DMF), DCM, rt; (d) R<sub>2</sub>NH, Et<sub>3</sub>N, DCM, rt; (e) aq. NaOH, MeOH, rt or 7 N NH<sub>3</sub> in MeOH, rt; (f) <i>N</i>-Boc-homopiperazine, Et<sub>3</sub>N, DCM, rt; (g) 2 M HCl in Et<sub>2</sub>O, rt; (h) R′-Cl (EtNCO for <b>2l</b>), Et<sub>3</sub>N, DCM, rt.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes to AMT-Sulfone Analogues <b>3c</b> and <b>3j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i><sup>n</sup></i>BuLi, tetrahydrofuran (THF), −40 °C, then aldrithiol-2, −40 °C to rt; (b) mCPBA, DCM, rt; (c) NBS, Bz<sub>2</sub>O<sub>2</sub>, 1,2-dichloroethane (DCE), 70 °C; (d) NaN<sub>3</sub>, DMF, rt; (e) H<sub>2</sub>, Pd/C, THF, rt; (f) <i><sup>n</sup></i>BuLi, THF, −40 °C, then 1,2-dithiane, −40 °C to rt, then MeI, rt.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes to AMT-sulfone Analogues <b>3a</b>, <b>3b</b>, <b>3d</b>–<b>3i</b>, <b>5b</b>, <b>5c</b>, <b>8a</b>, <b>8b</b>, and <b>9b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) RSH, K<sub>2</sub>CO<sub>3</sub>, DMF, heat; (b) mCPBA, DCM, rt; (c) BH<sub>3</sub>·THF, THF, rt; (d) MsCl, Et<sub>3</sub>N, DCM, rt; (e) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt; (f) 4 M HCl in dioxane, rt.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to Sulfonamide-Substituted Phenylsulfonyl-AMTs <b>8c</b>–<b>8e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HNR<sub>2</sub>, DCM; (b) NaSMe, DMF, 165 °C; (c) 5-chloro-2-thiophene-carbonitrile, K<sub>2</sub>CO<sub>3</sub>, DMF, 120–130 °C; (d) BH<sub>3</sub>·THF, THF, rt; (e) TFAA, Et<sub>3</sub>N, DCM; (f) mCPBA, DCM, rt; (g) 7 N NH<sub>3</sub> in MeOH, rt.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Routes to Phenylsulfonyl-AMTs with Sulfonyl Side-Chain Modifications (<b>8g</b>–<b>8k</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-mercaptoethanol or 3-mercaptopropanol, K<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C; (b) mCPBA, DCM, rt (45–61% over two steps); (c) 4 M HCl in dioxane, rt; (d) MsCl, Et<sub>3</sub>N, DCM, rt (quant.); (e) pyrrolidine, DCM, rt (85% for steps e + c); (f) 7 N NH<sub>3</sub> in MeOH, rt; (g) Ac<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt; (h) K<sub>2</sub>CO<sub>3</sub>, MeOH, rt.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route to Bis-sulfonylphenyl-AMT <b>8f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PhSO<sub>2</sub>Cl, FeCl<sub>3</sub>, neat, 100 °C; (b) mCPBA, DCM, rt (c) BH<sub>3</sub>·THF, THF, rt.</p></p></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthetic Route to <i>tert</i>-Butyl-bis-sulfonylphenyl-AMT <b>9a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i><sup>t</sup></i>BuLi, THF, −78 °C then MeSSMe, −78 °C to rt; (b) mCPBA, DCM, rt; (c) thiophene-2-thiol, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, K<sub>2</sub>CO<sub>3</sub>, <i>p</i>-xylene; 140 °C; (d) POCl<sub>3</sub>, DMF, 50 °C; (e) NaBH<sub>4</sub>, THF, rt; (f) DPPA, PPh<sub>3</sub>, diisopropyl azodicarboxylate, THF, rt; (g) H<sub>2</sub>, Pd/C, EtOH, rt.</p></p></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthetic Routes to Substituted Bis-sulfonylphenyl-AMTs <b>9c</b>–<b>9i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, Et<sub>3</sub>N, trimethylsilylacetylene, dioxane, rt; (b) 4 M HCl in dioxane, DCM, rt; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, RB(OR′)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C.</p></p></figure><figure data-id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthetic Routes to Substituted Bis-sulfonylphenyl-AMTs <b>9j</b>–<b>9l</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaSMe, DMF, rt; (b) mCPBA, DCM, rt; (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, RB(OR′)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C; (d) 4 M HCl in dioxane, DCM, rt.</p></p></figure><figure data-id="sch10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthetic Routes to Compounds <b>4a</b>, <b>4b</b>, <b>6a</b>, <b>6c</b>–<b>6e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) mCPBA (2 equiv), DCM, rt; (b) mCPBA (1 equiv), DCM, rt; (c) BH<sub>3</sub>·THF, THF, rt; (d) InCl<sub>3</sub>, acetaldoxime, toluene, reflux; (e) LiHMDS, Et<sub>2</sub>O, rt, then 2 M HCl, rt; (f) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt; (g) NaH, MeI, THF, rt; (h) 4 M HCl in dioxane, DCM, rt; (i) sodium benzenesulfinate, DMF, 135 °C.</p></p></figure><figure data-id="sch11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0014.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthetic Routes to Compounds <b>6b</b> and <b>6f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) thiophenol, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; (b) mCPBA, DCM, rt; (c) H<sub>2</sub>NOH·HCl, <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), EtOH, rt; (d) Zn, TFA, rt; (e) DIBAL-H, DCM, 45 °C; (f) H<sub>2</sub>NOH·HCl, K<sub>2</sub>CO<sub>3</sub>, EtOH, 70 °C.</p></p></figure><figure data-id="sch12" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0015.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Synthetic Routes to Amide Analogues <b>4d</b> and <b>5e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1 M NaOH, MeOH, rt; (b) (COCl)<sub>2</sub>, DMF, DCM, rt; (c) benzylamine, DCM, rt; (d) H<sub>2</sub>, Pd/C, THF, rt.</p></p></figure><figure data-id="sch13" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0016.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Synthetic Routes to Aminomethylene-Pyridine, Aminomethylene-Thiazole, and Aminomethylene-Imidazole <b>5a</b> and <b>5d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, benzylmercaptan, DMF, 70 °C; (b) mCPBA, DCM, rt; (c) 2 M HCl in Et<sub>2</sub>O or 4 M HCl in dioxane, rt; (d) Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, naphthalene-2-thiol, NaO<i><sup>t</sup></i>Bu, <i><sup>t</sup></i>BuOH/toluene, 100 °C.</p></p></figure><figure data-id="sch14" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0017.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Synthetic Routes to AMT Regioisomers <b>7a</b>–<b>7c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) naphthalene-2-thiol, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; (b) mCPBA, DCM, rt; (c) BH<sub>3</sub>·THF, THF, rt; (d) Pd<sub>2</sub>dba<sub>3</sub>, xantphos, naphthalene-2-thiol, NaO<i><sup>t</sup></i>Bu, toluene, 110 °C.</p></p></figure><figure data-id="sch15" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/medium/jm-2019-00335z_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0018.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 15. Synthetic Route to Phenyl-Linked AMT <b>4e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00335/20191226/images/large/jm-2019-00335z_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00335&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 °C; (b) BH<sub>3</sub>·THF, THF, rt; (c) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt; (d) mCPBA, DCM, rt; (e) 4 M HCl in dioxane, DCM, rt.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i136">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81644" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81644" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronnebaum, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mure, M.</span></span> <span> </span><span class="NLM_article-title">Human Copper-Dependent Amine Oxidases</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>546</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2013.12.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1016%2Fj.abb.2013.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=24407025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksFaisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2014&pages=19-32&author=J.+Finneyauthor=H.-J.+Moonauthor=T.+Ronnebaumauthor=M.+Lantzauthor=M.+Mure&title=Human+Copper-Dependent+Amine+Oxidases&doi=10.1016%2Fj.abb.2013.12.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Human copper-dependent amine oxidases</span></div><div class="casAuthors">Finney, Joel; Moon, Hee-Jung; Ronnebaum, Trey; Lantz, Mason; Mure, Minae</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-32</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Copper amine oxidases (CAOs) are a class of enzymes that contain Cu2+ and a tyrosine-derived quinone cofactor, and catalyze the conversion of a primary amine functional group to an aldehyde, generating H2O2 and NH3 as byproducts.  These enzymes can be classified into 2 non-homologous families: 2,4,5-trihydroxyphenylalanine quinone (TPQ)-dependent CAOs and the lysine tyrosylquinone (LTQ)-dependent lysyl oxidase (LOX) family of proteins.  Here, the authors focus on recent developments in the field of research concerning human CAOs and the LOX family of proteins.  The aberrant expression of these enzymes is linked to inflammation, fibrosis, tumor metastasis/invasion, and other diseases.  Consequently, there is a crit. need to understand the functions of these proteins at the mol. level, so that strategies targeting these enzymes can be developed to combat human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxp8xJQhX_qLVg90H21EOLACvtfcHk0lhVZl-rQ7Uc0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksFaisbs%253D&md5=f7ecc08c322917ac6c9bf96636b49575</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2013.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2013.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DFinney%26aufirst%3DJ.%26aulast%3DMoon%26aufirst%3DH.-J.%26aulast%3DRonnebaum%26aufirst%3DT.%26aulast%3DLantz%26aufirst%3DM.%26aulast%3DMure%26aufirst%3DM.%26atitle%3DHuman%2520Copper-Dependent%2520Amine%2520Oxidases%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2014%26volume%3D546%26spage%3D19%26epage%3D32%26doi%3D10.1016%2Fj.abb.2013.12.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, H. M.</span>; <span class="NLM_string-name">Ryvkin, F.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase and Lysyl Oxidase-Like Enzymes</span>. In  <i>The Extracellular Matrix: An Overview</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecham, R. P.</span></span>, Ed.; <span class="NLM_publisher-name">Springer</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">335</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1007%2F978-3-642-16555-9_9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=303-335&author=H.+M.+Kagan&author=F.+Ryvkinauthor=R.+P.+Mecham&title=The+Extracellular+Matrix%3A+An+Overview"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-16555-9_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-16555-9_9%26sid%3Dliteratum%253Aachs%26aulast%3DKagan%26aufirst%3DH.%2BM.%26atitle%3DLysyl%2520Oxidase%2520and%2520Lysyl%2520Oxidase-Like%2520Enzymes%26btitle%3DThe%2520Extracellular%2520Matrix%253A%2520An%2520Overview%26aulast%3DMecham%26aufirst%3DR.%2BP.%26pub%3DSpringer%26date%3D2011%26spage%3D303%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucero, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, H. M.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase: an Oxidative Enzyme and Effector of Cell Function</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2304</span>– <span class="NLM_lpage">2316</span>, <span class="refDoi"> DOI: 10.1007/s00018-006-6149-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1007%2Fs00018-006-6149-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=16909208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFyrtrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2006&pages=2304-2316&author=H.+A.+Luceroauthor=H.+M.+Kagan&title=Lysyl+Oxidase%3A+an+Oxidative+Enzyme+and+Effector+of+Cell+Function&doi=10.1007%2Fs00018-006-6149-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase: an oxidative enzyme and effector of cell function</span></div><div class="casAuthors">Lucero, H. A.; Kagan, H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">19-20</span>),
    <span class="NLM_cas:pages">2304-2316</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Lysyl oxidase (LOX) oxidizes the side-chain of peptidyl-lysine converting specific Lys residues to residues of α-aminoadipic δ-semialdehyde.  This post-translational chem. change permits the covalent crosslinking of the component chains of collagen and those of elastin, thus stabilizing the fibrous deposits of these proteins in the extracellular matrix.  Four LOX-like (LOXL) proteins with varying degrees of similarity to LOX have also been described, constituting a family of related proteins.  LOX is synthesized as a preproprotein which emerges from the cell as proLOX and then is processed to the active enzyme by proteolysis.  In addn. to elastin and collagen, LOX can oxidize lysine within a variety of cationic proteins, suggesting that its functions extend beyond its role in the stabilization of the extracellular matrix.  Indeed, recent findings reveal that LOX and LOXL proteins markedly influence cell behavior including chemotactic responses, proliferation, and shifts between the normal and malignant phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMqzFj7sZh3LVg90H21EOLACvtfcHk0lhVZl-rQ7Uc0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFyrtrrF&md5=e8efb89825a3f710c09567e6774e80c4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00018-006-6149-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-006-6149-9%26sid%3Dliteratum%253Aachs%26aulast%3DLucero%26aufirst%3DH.%2BA.%26aulast%3DKagan%26aufirst%3DH.%2BM.%26atitle%3DLysyl%2520Oxidase%253A%2520an%2520Oxidative%2520Enzyme%2520and%2520Effector%2520of%2520Cell%2520Function%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2006%26volume%3D63%26spage%3D2304%26epage%3D2316%26doi%3D10.1007%2Fs00018-006-6149-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase: Properties, Specificity, and Biological Roles Inside and Outside of the Cell</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1002/jcb.10413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1002%2Fjcb.10413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=12577300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhslWis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=660-672&author=H.+M.+Kaganauthor=W.+Li&title=Lysyl+Oxidase%3A+Properties%2C+Specificity%2C+and+Biological+Roles+Inside+and+Outside+of+the+Cell&doi=10.1002%2Fjcb.10413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell</span></div><div class="casAuthors">Kagan, Herbert M.; Li, Wande</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">660-672</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review and discussion.  Lysyl oxidase (I) plays a crit. role in the formation and repair of the extracellular matrix (ECM) by oxidizing Lys residues in elastin and collagen, thereby initiating the formation of covalent crosslinkages which stabilize these fibrous proteins.  I catalytic activity depends upon both its Cu cofactor and a unique carbonyl cofactor, and has been shown to extend to a variety of basic globular proteins, including histone H1.  Although the 3-dimensional structure of I has yet to be detd., the present treatise offers hypotheses based upon its primary sequence, which may underlie the prominent electrostatic component of its unusual substrate specificity as well as the catalysis-suppressing function of the propeptide domain of pro-I.  Recent studies have demonstrated that I appears to function within the cell in a manner, which strongly modifies cellular activity.  Newly discovered I-like proteins also likely play unique roles in biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9lBpo6dXwWLVg90H21EOLACvtfcHk0lifxhlN31LsnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhslWis7s%253D&md5=85f72b94a2d9b77615f46572f5536dfa</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fjcb.10413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.10413%26sid%3Dliteratum%253Aachs%26aulast%3DKagan%26aufirst%3DH.%2BM.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DLysyl%2520Oxidase%253A%2520Properties%252C%2520Specificity%252C%2520and%2520Biological%2520Roles%2520Inside%2520and%2520Outside%2520of%2520the%2520Cell%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2003%26volume%3D88%26spage%3D660%26epage%3D672%26doi%3D10.1002%2Fjcb.10413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsia, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, T.-M.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase and the Tumor Microenvironment</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.3390/ijms18010062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.3390%2Fijms18010062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=62-73&author=T.-H.+Wangauthor=S.-M.+Hsiaauthor=T.-M.+Shieh&title=Lysyl+Oxidase+and+the+Tumor+Microenvironment&doi=10.3390%2Fijms18010062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fijms18010062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18010062%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.-H.%26aulast%3DHsia%26aufirst%3DS.-M.%26aulast%3DShieh%26aufirst%3DT.-M.%26atitle%3DLysyl%2520Oxidase%2520and%2520the%2520Tumor%2520Microenvironment%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D18%26spage%3D62%26epage%3D73%26doi%3D10.3390%2Fijms18010062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gartland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erler, J. T.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-2306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1158%2F0008-5472.CAN-15-2306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=26732355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1SrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=188-192&author=T.+R.+Coxauthor=A.+Gartlandauthor=J.+T.+Erler&title=Lysyl+Oxidase%2C+a+Targetable+Secreted+Molecule+Involved+in+Cancer+Metastasis&doi=10.1158%2F0008-5472.CAN-15-2306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis</span></div><div class="casAuthors">Cox, Thomas R.; Gartland, Alison; Erler, Janine T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">188-192</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Secondary metastatic cancer remains the single biggest cause of mortality and morbidity across most solid tumors.  In breast cancer, 100% of deaths are attributed to metastasis.  At present, there are no "cures" for secondary metastatic cancer of any form and there is an urgent unmet clin. need to improve the tools available in our arsenal against this disease, both in terms of treatment, but also prevention.  Recently, we showed that hypoxic induction of the extracellular matrix modifying enzyme lysyl oxidase (LOX) correlates with metastatic dissemination to the bone in estrogen receptor neg. breast cancer and is essential for the formation of premetastatic osteolytic lesions.  We showed that in models of breast cancer metastasis, targeting LOX, or its downstream effects, significantly inhibited premetastatic niche formation and the resulting metastatic burden, offering preclin. validation of this enzyme as a therapeutic target for metastatic breast cancer.  Our work is the latest in an emerging body of work supporting the targeting of LOX and calls for greater efforts in developing therapeutics against this extracellular secreted factor in the prevention of cancer progression across multiple solid tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVMTz-jTWh77Vg90H21EOLACvtfcHk0lifxhlN31LsnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1SrtQ%253D%253D&md5=ed68370a405806847705725db3099701</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-2306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-2306%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DT.%2BR.%26aulast%3DGartland%26aufirst%3DA.%26aulast%3DErler%26aufirst%3DJ.%2BT.%26atitle%3DLysyl%2520Oxidase%252C%2520a%2520Targetable%2520Secreted%2520Molecule%2520Involved%2520in%2520Cancer%2520Metastasis%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D188%26epage%3D192%26doi%3D10.1158%2F0008-5472.CAN-15-2306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trackman, P. C.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.1517/14728222.2016.1151003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1517%2F14728222.2016.1151003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=935-945&author=P.+C.+Trackman&title=Lysyl+Oxidase+Isoforms+and+Potential+Therapeutic+Opportunities+for+Fibrosis+and+Cancer&doi=10.1517%2F14728222.2016.1151003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F14728222.2016.1151003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2016.1151003%26sid%3Dliteratum%253Aachs%26aulast%3DTrackman%26aufirst%3DP.%2BC.%26atitle%3DLysyl%2520Oxidase%2520Isoforms%2520and%2520Potential%2520Therapeutic%2520Opportunities%2520for%2520Fibrosis%2520and%2520Cancer%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2016%26volume%3D3%26spage%3D935%26epage%3D945%26doi%3D10.1517%2F14728222.2016.1151003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perryman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erler, J.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase in Cancer Research</span>. <i>Future Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1709</span>– <span class="NLM_lpage">1717</span>, <span class="refDoi"> DOI: 10.2217/fon.14.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.2217%2Ffon.14.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=25145437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSru7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1709-1717&author=L.+Perrymanauthor=J.+Erler&title=Lysyl+Oxidase+in+Cancer+Research&doi=10.2217%2Ffon.14.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase in cancer research</span></div><div class="casAuthors">Perryman, Lara; Erler, Janine T.</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1709-1717</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1479-6694</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Metastasis is the main reason for cancer-assocd. deaths and therapies are desperately needed to target the progression of cancer.  Lysyl oxidase (LOX) plays a pivotal role in cancer progression, including metastasis, and is therefore is an attractive therapeutic target.  In this review we will breakdown the process of cancer progression and the various roles that LOX plays has in the advancement of cancer.  We will highlight why LOX is an exciting therapeutic target for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJUS3tJbsHtbVg90H21EOLACvtfcHk0lg52_IHvkhfSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSru7rK&md5=39bcdef4656c94521dc97a1fb8fbed30</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2217%2Ffon.14.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon.14.39%26sid%3Dliteratum%253Aachs%26aulast%3DPerryman%26aufirst%3DL.%26aulast%3DErler%26aufirst%3DJ.%26atitle%3DLysyl%2520Oxidase%2520in%2520Cancer%2520Research%26jtitle%3DFuture%2520Oncol.%26date%3D2014%26volume%3D10%26spage%3D1709%26epage%3D1717%26doi%3D10.2217%2Ffon.14.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barker, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erler, J. T.</span></span> <span> </span><span class="NLM_article-title">The Rationale for Targeting the LOX Family in Cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">540</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1038/nrc3319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1038%2Fnrc3319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=22810810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCltLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=540-552&author=H.+E.+Barkerauthor=T.+R.+Coxauthor=J.+T.+Erler&title=The+Rationale+for+Targeting+the+LOX+Family+in+Cancer&doi=10.1038%2Fnrc3319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The rationale for targeting the LOX family in cancer</span></div><div class="casAuthors">Barker, Holly E.; Cox, Thomas R.; Erler, Janine T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">540-552</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The therapeutic targeting of extracellular proteins is becoming hugely attractive in light of evidence implicating the tumor microenvironment as pivotal in all aspects of tumor initiation and progression.  Members of the lysyl oxidase (LOX) family of proteins are secreted by tumors and are the subject of much effort to understand their roles in cancer.  In this Review we discuss the roles of members of this family in the remodelling of the tumor microenvironment and their paradoxical roles in tumorigenesis and metastasis.  We also discuss how targeting this family of proteins might lead to a new avenue of cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZcLr3Y7rPKLVg90H21EOLACvtfcHk0lg52_IHvkhfSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCltLfE&md5=455064ea8d5332b43fa6490a1aaa0c8f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc3319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3319%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DH.%2BE.%26aulast%3DCox%26aufirst%3DT.%2BR.%26aulast%3DErler%26aufirst%3DJ.%2BT.%26atitle%3DThe%2520Rationale%2520for%2520Targeting%2520the%2520LOX%2520Family%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D540%26epage%3D552%26doi%3D10.1038%2Fnrc3319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishioka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eustace, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase: From Basic Science to Future Cancer Treatment</span>. <i>Cell Struct. Funct.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1247/csf.11015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1247%2Fcsf.11015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=22453058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFShs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=75-80&author=T.+Nishiokaauthor=A.+Eustaceauthor=C.+West&title=Lysyl+Oxidase%3A+From+Basic+Science+to+Future+Cancer+Treatment&doi=10.1247%2Fcsf.11015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase: from basic science to future cancer treatment</span></div><div class="casAuthors">Nishioka, Takeshi; Eustace, Amanda; West, Catharine</div><div class="citationInfo"><span class="NLM_cas:title">Cell Structure and Function</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">75-80</span>CODEN:
                <span class="NLM_cas:coden">CSFUDY</span>;
        ISSN:<span class="NLM_cas:issn">0386-7196</span>.
    
            (<span class="NLM_cas:orgname">Japan Society for Cell Biology</span>)
        </div><div class="casAbstract">A review.  In this mini-review, we discuss the physiol. and pathol. roles of lysyl oxidase (LOX) and its family, LOX-like proteins (LOXL), in relation to prognosis of major cancers.  The no. of reports on LOX family is numerous.  We have decided to review the articles that were recently published (i.e. past 5 years).  Exptl. techniques in mol. biol. have advanced surprisingly in the past decade.  Accordingly, the results of the studies are more reliable.  Most studies reached the same conclusion; a higher LOX- or LOXL-expression is assocd. with a poor prognosis.  Mol. expts. have already started aiming for clin. application, and the results are encouraging.  Suppressing LOX or LOXL activities resulted in lower cell motility in collagen gel and, moreover, succeeded in reducing metastases in mice.  LOX family members were originally recognized as mols. that cross-link collagen fibers in the extracellular matrix.  Recent studies demonstrated that they are also involved in a phenomenon called Epithelial Mesenchymal Transition (EMT).  This may affect cell movement and cancer cell invasiveness.  LOX and LOXL2 are regulated by hypoxia, a major factor in the failure of cancer treatment.  Here we discuss the mol. biol. of the LOX family in relation to its role in tumor biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbGBuCWuIeMrVg90H21EOLACvtfcHk0lg52_IHvkhfSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFShs7k%253D&md5=0dcfb556b3eed6375b57f09c4589ccad</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1247%2Fcsf.11015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1247%252Fcsf.11015%26sid%3Dliteratum%253Aachs%26aulast%3DNishioka%26aufirst%3DT.%26aulast%3DEustace%26aufirst%3DA.%26aulast%3DWest%26aufirst%3DC.%26atitle%3DLysyl%2520Oxidase%253A%2520From%2520Basic%2520Science%2520to%2520Future%2520Cancer%2520Treatment%26jtitle%3DCell%2520Struct.%2520Funct.%26date%3D2012%26volume%3D37%26spage%3D75%26epage%3D80%26doi%3D10.1247%2Fcsf.11015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddikuzzaman</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, V. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guruvayoorappan, C.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase: a Potential Target for Cancer Therapy</span>. <i>Inflammopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1007/s10787-010-0073-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1007%2Fs10787-010-0073-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=21107914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFWhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=117-129&author=+Siddikuzzamanauthor=V.+M.+B.+Graceauthor=C.+Guruvayoorappan&title=Lysyl+Oxidase%3A+a+Potential+Target+for+Cancer+Therapy&doi=10.1007%2Fs10787-010-0073-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase: a potential target for cancer therapy</span></div><div class="casAuthors">Siddikuzzaman; Berlin Grace, V. M.; Guruvayoorappan, C.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">117-129</span>CODEN:
                <span class="NLM_cas:coden">IAOAES</span>;
        ISSN:<span class="NLM_cas:issn">0925-4692</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Lysyl oxidases (LysOX; EC 1.4.3.13, protein-lysine 6-oxidases) are extracellular copper enzymes that catalyze the crosslinking of collagens or elastin in the extracellular matrix (ECM), thereby regulating the tensile strength of tissues.  Recent implication of LysOX in cancer, wound healing, cell motility, chemotaxis, and differentiation reflects its remarkable functional diversity and also in the central nervous system pathologies.  However, recent reports also demonstrated novel roles for LysOX, including the ability to regulate gene transcription, motility/migration, and cell adhesion.  These diverse functions have led researchers to hypothesize that LysOX may have multiple roles affecting both extra- and intracellular cell function(s).  Both down and up-regulation of LysOX in tumor tissues and cancer cell lines have been described, suggesting a dual role for LysOX as a tumor suppressor, as well as a metastasis promoter gene.  In this review we explain in detail the role of lysyl oxidase in tumor progression and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq12xRTcVwuEbVg90H21EOLACvtfcHk0ljiAOU0ELQbng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFWhurg%253D&md5=e147ad97f23acc050b87db1f73ab8876</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10787-010-0073-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10787-010-0073-1%26sid%3Dliteratum%253Aachs%26aulast%3DSiddikuzzaman%26aulast%3DGrace%26aufirst%3DV.%2BM.%2BB.%26aulast%3DGuruvayoorappan%26aufirst%3DC.%26atitle%3DLysyl%2520Oxidase%253A%2520a%2520Potential%2520Target%2520for%2520Cancer%2520Therapy%26jtitle%3DInflammopharmacology%26date%3D2011%26volume%3D19%26spage%3D117%26epage%3D129%26doi%3D10.1007%2Fs10787-010-0073-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, K. M.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase in Cancer Inhibition and Metastasis</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2018.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1016%2Fj.canlet.2018.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=29309816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVehurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2018&pages=174-181&author=K.+A.+Johnstonauthor=K.+M.+Lopez&title=Lysyl+Oxidase+in+Cancer+Inhibition+and+Metastasis&doi=10.1016%2Fj.canlet.2018.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase in cancer inhibition and metastasis</span></div><div class="casAuthors">Johnston, Kathryn A.; Lopez, Karlo M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">174-181</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Lysyl oxidase is an extracellular matrix, copper dependent amine oxidase that catalyzes a key enzymic step in the crosslinking of collagen and elastin.  The enzyme is synthesized as a propeptide that is cleaved by procollagen C proteinase into two distinct parts: the mature form and the LOX propeptide.  The mature enzyme plays a key role in modifying the extracellular matrix and as a result has been implicated in playing a role in the formation of cancer 'niches' where tumors will develop and eventually metastasize.  On the other hand, the LOX propeptide has been shown to have an inhibitory effect in the development of cancer tumors.  New approaches are being developed to test the use of small mol. inhibitors on LOX; however, the lack of a crystal structure has hampered these efforts as it is extremely difficult to design selective inhibitors without knowing what the target receptor looks like.  In this mini review we discuss the lysyl oxidase enzyme and its role several types of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_mMh21TZDR7Vg90H21EOLACvtfcHk0ljiAOU0ELQbng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVehurs%253D&md5=27c8b558ba9f6b1a978e4f587755fcc4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2018.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2018.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DK.%2BA.%26aulast%3DLopez%26aufirst%3DK.%2BM.%26atitle%3DLysyl%2520Oxidase%2520in%2520Cancer%2520Inhibition%2520and%2520Metastasis%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D417%26spage%3D174%26epage%3D181%26doi%3D10.1016%2Fj.canlet.2018.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erler, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennewith, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dornhofer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J. T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase is Essential for Hypoxia-Induced Metastasis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>440</i></span>,  <span class="NLM_fpage">1222</span>– <span class="NLM_lpage">1226</span>, <span class="refDoi"> DOI: 10.1038/nature04695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1038%2Fnature04695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=16642001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvVGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=1222-1226&author=J.+T.+Erlerauthor=K.+L.+Bennewithauthor=M.+Nicolauauthor=N.+Dornhoferauthor=C.+Kongauthor=Q.+T.+Leauthor=J.+T.+A.+Chiauthor=S.+S.+Jeffreyauthor=A.+J.+Giaccia&title=Lysyl+Oxidase+is+Essential+for+Hypoxia-Induced+Metastasis&doi=10.1038%2Fnature04695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase is essential for hypoxia-induced metastasis</span></div><div class="casAuthors">Erler, Janine T.; Bennewith, Kevin L.; Nicolau, Monica; Dornhoefer, Nadja; Kong, Christina; Le, Quynh-Thu; Chi, Jen-Tsan Ashley; Jeffrey, Stefanie S.; Giaccia, Amato J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7088</span>),
    <span class="NLM_cas:pages">1222-1226</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metastasis is a multistep process responsible for most cancer deaths, and it can be influenced by both the immediate microenvironment (cell-cell or cell-matrix interactions) and the extended tumor microenvironment (for example vascularization).  Hypoxia (low oxygen) is clin. assocd. with metastasis and poor patient outcome, although the underlying processes remain unclear.  Microarray studies have shown the expression of lysyl oxidase (LOX) to be elevated in hypoxic human tumor cells.  Paradoxically, LOX expression is assocd. with both tumor suppression and tumor progression, and its role in tumorigenesis seems dependent on cellular location, cell type and transformation status.  Here we show that LOX expression is regulated by hypoxia-inducible factor (HIF) and is assocd. with hypoxia in human breast and head and neck tumors.  Patients with high LOX-expressing tumors have poor distant metastasis-free and overall survivals.  Inhibition of LOX eliminates metastasis in mice with orthotopically grown breast cancer tumors.  Mechanistically, secreted LOX is responsible for the invasive properties of hypoxic human cancer cells through focal adhesion kinase activity and cell to matrix adhesion.  Furthermore, LOX may be required to create a niche permissive for metastatic growth.  Our findings indicate that LOX is essential for hypoxia-induced metastasis and is a good therapeutic target for preventing and treating metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6kzyBjAAe1LVg90H21EOLACvtfcHk0ljiAOU0ELQbng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvVGltb8%253D&md5=e38966cb7190643ab4dbdf4ebd721044</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature04695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04695%26sid%3Dliteratum%253Aachs%26aulast%3DErler%26aufirst%3DJ.%2BT.%26aulast%3DBennewith%26aufirst%3DK.%2BL.%26aulast%3DNicolau%26aufirst%3DM.%26aulast%3DDornhofer%26aufirst%3DN.%26aulast%3DKong%26aufirst%3DC.%26aulast%3DLe%26aufirst%3DQ.%2BT.%26aulast%3DChi%26aufirst%3DJ.%2BT.%2BA.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26atitle%3DLysyl%2520Oxidase%2520is%2520Essential%2520for%2520Hypoxia-Induced%2520Metastasis%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D1222%26epage%3D1226%26doi%3D10.1038%2Fnature04695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trackman, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, H. M.</span></span> <span> </span><span class="NLM_article-title">Reaction of Aortic Lysyl Oxidase with beta-Aminopropionitrile</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">4331</span>– <span class="NLM_lpage">4338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=6131892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADyaL3sXhslGmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1983&pages=4331-4338&author=S.+S.+Tangauthor=P.+C.+Trackmanauthor=H.+M.+Kagan&title=Reaction+of+Aortic+Lysyl+Oxidase+with+beta-Aminopropionitrile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of aortic lysyl oxidase with β-aminopropionitrile</span></div><div class="casAuthors">Tang, Shiow Shih; Trackman, Philip C.; Kagan, Herbert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4331-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">β-Aminopropionitrile (I) is a potent irreversible inhibitor of lysyl oxidase (II), which initiates crosslinkage formation in elastin and collagen.  The initial interaction of I with aortic II is competitive with elastin or alkyl amine substrates.  Irreversible inhibition develops in a time- and temp.-dependent fashion upon incubation of II with I in the absence of substrate with a limiting inactivation rate const. of 0.16 min-1 and a Ki of 6 μM at 37°.  The labeled C atoms of [1,2-14C]I and [3-14C]I covalently bind to II to equiv. extents and in parallel with the development of inactivation, negating the possibility that the nitrile moiety is eliminated from I by enzymic action.  The Cu content of II is not significantly altered upon interaction with I.  The extent of labeling by [14C]I is reduced by prior treatment of II with carbonyl-modifying reagents, suggesting the possibility of I-II Schiff base formation.  However, I is not processed to a free aldehyde product upon incubation with II.  A mechanism of inhibition is postulated which involves the formation of a covalent bond between an enzyme nucleophile and a ketenimine formed from I by II-assisted β-proton abstraction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6R41H2SgQY7Vg90H21EOLACvtfcHk0ljEHS-We93Lpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhslGmsr4%253D&md5=b64e1c85d58fb8c2c47d8beb939fa59a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DS.%2BS.%26aulast%3DTrackman%26aufirst%3DP.%2BC.%26aulast%3DKagan%26aufirst%3DH.%2BM.%26atitle%3DReaction%2520of%2520Aortic%2520Lysyl%2520Oxidase%2520with%2520beta-Aminopropionitrile%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1983%26volume%3D258%26spage%3D4331%26epage%3D4338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinnell, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, G. R.</span></span> <span> </span><span class="NLM_article-title">The Cross-Linking of Collagen and Elastin: Enzymatic Conversion of Lysine in Peptide Linage to α-Aminoadipic-δ-Semialdehyde (Allysine) by an Extract from Bone</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1073/pnas.61.2.708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1073%2Fpnas.61.2.708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=5246001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADyaF1MXisFOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1968&pages=708-714&author=S.+R.+Pinnellauthor=G.+R.+Martin&title=The+Cross-Linking+of+Collagen+and+Elastin%3A+Enzymatic+Conversion+of+Lysine+in+Peptide+Linage+to+%CE%B1-Aminoadipic-%CE%B4-Semialdehyde+%28Allysine%29+by+an+Extract+from+Bone&doi=10.1073%2Fpnas.61.2.708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The cross-linking of collagen and elastin:  enzymic conversion of lysine in peptide linkage to 5-formylnorvaline (allylsine) by an extract from bone</span></div><div class="casAuthors">Pinnell, Sheldon R.; Martin, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">708-16</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Assays for and some of the properties of an enzyme from bone, which converts peptide-bound lysine to allylsine, are described.  It is inhibited by physiol. active levels of the lathyrogen, β-aminopropionitrile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyTr_mMVHX57Vg90H21EOLACvtfcHk0ljEHS-We93Lpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXisFOruw%253D%253D&md5=fd2ea54b8bf1990c5d0d634835813bdd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.61.2.708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.61.2.708%26sid%3Dliteratum%253Aachs%26aulast%3DPinnell%26aufirst%3DS.%2BR.%26aulast%3DMartin%26aufirst%3DG.%2BR.%26atitle%3DThe%2520Cross-Linking%2520of%2520Collagen%2520and%2520Elastin%253A%2520Enzymatic%2520Conversion%2520of%2520Lysine%2520in%2520Peptide%2520Linage%2520to%2520%25CE%25B1-Aminoadipic-%25CE%25B4-Semialdehyde%2520%2528Allysine%2529%2520by%2520an%2520Extract%2520from%2520Bone%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1968%26volume%3D61%26spage%3D708%26epage%3D714%26doi%3D10.1073%2Fpnas.61.2.708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonte, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Montolio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Findlay, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deodhar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarolimek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timpson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erler, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, T. R.</span></span> <span> </span><span class="NLM_article-title">Pre-clinical Evaluation of Small Molecule LOXL2 Inhibitors in Breast Cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">26066</span>– <span class="NLM_lpage">26078</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.15257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.18632%2Foncotarget.15257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=28199967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A280%3ADC%252BC1c3mvFOnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=26066-26078&author=J.+Changauthor=M.+C.+Lucasauthor=L.+E.+Leonteauthor=M.+Garcia-Montolioauthor=L.+B.+Singhauthor=A.+D.+Findlayauthor=M.+Deodharauthor=J.+Footauthor=W.+Jarolimekauthor=P.+Timpsonauthor=J.+T.+Erlerauthor=T.+R.+Cox&title=Pre-clinical+Evaluation+of+Small+Molecule+LOXL2+Inhibitors+in+Breast+Cancer&doi=10.18632%2Foncotarget.15257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer</span></div><div class="casAuthors">Chang Joan; Leonte Lidia E; Garcia-Montolio Marc; Singh Lukram Babloo; Erler Janine T; Cox Thomas R; Lucas Morghan C; Timpson Paul; Cox Thomas R; Findlay Alison D; Deodhar Mandar; Foot Jonathan S; Jarolimek Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">26066-26078</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lysyl Oxidase-like 2 (LOXL2), a member of the lysyl oxidase family of amine oxidases is known to be important in normal tissue development and homeostasis, as well as the onset and progression of solid tumors.  Here we tested the anti-tumor properties of two generations of novel small molecule LOXL2 inhibitor in the MDA-MB-231 human model of breast cancer.  We confirmed a functional role for LOXL2 activity in the progression of primary breast cancer.  Inhibition of LOXL2 activity inhibited the growth of primary tumors and reduced primary tumor angiogenesis.  Dual inhibition of LOXL2 and LOX showed a greater effect and also led to a lower overall metastatic burden in the lung and liver.  Our data provides the first evidence to support a role for LOXL2 specific small molecule inhibitors as a potential therapy in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOpqvFkfAy6suCWE5mhx1RfW6udTcc2ebNUrtSxjoFtrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3mvFOnsQ%253D%253D&md5=eda7044a327ae1746d7ae3ab2c2386fc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15257%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLeonte%26aufirst%3DL.%2BE.%26aulast%3DGarcia-Montolio%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DL.%2BB.%26aulast%3DFindlay%26aufirst%3DA.%2BD.%26aulast%3DDeodhar%26aufirst%3DM.%26aulast%3DFoot%26aufirst%3DJ.%26aulast%3DJarolimek%26aufirst%3DW.%26aulast%3DTimpson%26aufirst%3DP.%26aulast%3DErler%26aufirst%3DJ.%2BT.%26aulast%3DCox%26aufirst%3DT.%2BR.%26atitle%3DPre-clinical%2520Evaluation%2520of%2520Small%2520Molecule%2520LOXL2%2520Inhibitors%2520in%2520Breast%2520Cancer%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D26066%26epage%3D26078%26doi%3D10.18632%2Foncotarget.15257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowbottom, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasof, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonergan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darlington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodanovich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santini, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenna, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J. H.</span></span> <span> </span><span class="NLM_article-title">Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4403</span>– <span class="NLM_lpage">4423</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFSksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4403-4423&author=M.+W.+Rowbottomauthor=G.+Bainauthor=I.+Calderonauthor=T.+Lasofauthor=D.+Lonerganauthor=A.+Laiauthor=F.+Huangauthor=J.+Darlingtonauthor=P.+Prodanovichauthor=A.+M.+Santiniauthor=C.+D.+Kingauthor=L.+Gouletauthor=K.+E.+Shannonauthor=G.+L.+Maauthor=K.+Nguyenauthor=D.+A.+MacKennaauthor=J.+F.+Evansauthor=J.+H.+Hutchinson&title=Identification+of+4-%28Aminomethyl%29-6-%28trifluoromethyl%29-2-%28phenoxy%29pyridine+Derivatives+as+Potent%2C+Selective%2C+and+Orally+Efficacious+Inhibitors+of+the+Copper-Dependent+Amine+Oxidase%2C+Lysyl+Oxidase-Like+2+%28LOXL2%29&doi=10.1021%2Facs.jmedchem.7b00345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2)</span></div><div class="casAuthors">Rowbottom, Martin W.; Bain, Gretchen; Calderon, Imelda; Lasof, Taylor; Lonergan, David; Lai, Andiliy; Huang, Fei; Darlington, Janice; Prodanovich, Patricia; Santini, Angelina M.; King, Christopher D.; Goulet, Lance; Shannon, Kristen E.; Ma, Gina L.; Nguyen, Katherine; MacKenna, Deidre A.; Evans, Jilly F.; Hutchinson, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4403-4423</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">LOXL2 catalyzes the oxidative deamination of ε-amines of lysine and hydroxylysine residues within collagen and elastin, generating reactive aldehydes (allysine).  Condensation with other allysines or lysines drives the formation of inter- and intramol. cross-linkages, a process crit. for the remodeling of the ECM.  Dysregulation of this process can lead to fibrosis, and LOXL2 is known to be upregulated in fibrotic tissue.  Small-mols. that directly inhibit LOXL2 catalytic activity represent a useful option for the treatment of fibrosis.  Herein, the authors describe optimization of an initial hit, resulting in identification of racemic I, a potent irreversible inhibitor of LOXL2 that is highly selective over LOX and other amine oxidases.  Oral administration of I significantly reduced fibrosis in a 14-day mouse lung bleomycin model.  The (R,R)-enantiomer of I (PAT-1251) was selected as the clin. compd. which has progressed into healthy volunteer Phase 1 trials, making it the "first-in-class" small-mol. LOXL2 inhibitor to enter clin. development. KEY LOXL2 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX-yiHL-BRUrVg90H21EOLACvtfcHk0lgTLvv_LkxK2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFSksrs%253D&md5=c71db3046b5ed711043b39181fdf87c9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00345%26sid%3Dliteratum%253Aachs%26aulast%3DRowbottom%26aufirst%3DM.%2BW.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DLasof%26aufirst%3DT.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DGoulet%26aufirst%3DL.%26aulast%3DShannon%26aufirst%3DK.%2BE.%26aulast%3DMa%26aufirst%3DG.%2BL.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DMacKenna%26aufirst%3DD.%2BA.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DIdentification%2520of%25204-%2528Aminomethyl%2529-6-%2528trifluoromethyl%2529-2-%2528phenoxy%2529pyridine%2520Derivatives%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Efficacious%2520Inhibitors%2520of%2520the%2520Copper-Dependent%2520Amine%2520Oxidase%252C%2520Lysyl%2520Oxidase-Like%25202%2520%2528LOXL2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4403%26epage%3D4423%26doi%3D10.1021%2Facs.jmedchem.7b00345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbottom, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonergan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darlington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodanovich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, G.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">423</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFaltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=423-427&author=J.+H.+Hutchinsonauthor=M.+W.+Rowbottomauthor=D.+Lonerganauthor=J.+Darlingtonauthor=P.+Prodanovichauthor=C.+D.+Kingauthor=J.+F.+Evansauthor=G.+Bain&title=Small+Molecule+Lysyl+Oxidase-like+2+%28LOXL2%29+Inhibitors%3A+The+Identification+of+an+Inhibitor+Selective+for+LOXL2+over+LOX&doi=10.1021%2Facsmedchemlett.7b00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX</span></div><div class="casAuthors">Hutchinson, John H.; Rowbottom, Martin W.; Lonergan, David; Darlington, Janice; Prodanovich, Pat; King, Christopher D.; Evans, Jilly F.; Bain, Gretchen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">423-427</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abstr.: Two series of novel LOXL2 enzyme inhibitors are described.  Benzylamines substituted with electron withdrawing groups in the para position and 2-substituted pyridine-4-ylmethanamines.  The most potent compd., (2-chloropyridin-4-yl)methanamine 20 (hLOXL2 IC50 = 126 nM) was shown to be selective for LOXL2 over LOX and three other amine oxidases (MAO-A, MAO-B and SSAO).  Compd. 20 is the first published small mol. inhibitor selective for LOXL2 over LOX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI9k75wz2jKrVg90H21EOLACvtfcHk0lhhctYVpofroA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFaltLs%253D&md5=64938315fde4a34c52020e4126636acc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00014%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DRowbottom%26aufirst%3DM.%2BW.%26aulast%3DLonergan%26aufirst%3DD.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DBain%26aufirst%3DG.%26atitle%3DSmall%2520Molecule%2520Lysyl%2520Oxidase-like%25202%2520%2528LOXL2%2529%2520Inhibitors%253A%2520The%2520Identification%2520of%2520an%2520Inhibitor%2520Selective%2520for%2520LOXL2%2520over%2520LOX%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D423%26epage%3D427%26doi%3D10.1021%2Facsmedchemlett.7b00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saturno, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Leva, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niculescu-Duvaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhomen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marais, R.</span></span> <span> </span><span class="NLM_article-title">Lysyl Oxidase Drives Tumour Progression by Trapping EGF Receptors at the Cell Surface</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">14909</span> <span class="refDoi"> DOI: 10.1038/ncomms14909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1038%2Fncomms14909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=28416796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=H.+R.+Tangauthor=L.+Leungauthor=G.+Saturnoauthor=A.+Virosauthor=D.+Smithauthor=G.+Di+Levaauthor=E.+Morrisonauthor=D.+Niculescu-Duvazauthor=F.+Lopesauthor=L.+Johnsonauthor=N.+Dhomenauthor=C.+Springerauthor=R.+Marais&title=Lysyl+Oxidase+Drives+Tumour+Progression+by+Trapping+EGF+Receptors+at+the+Cell+Surface&doi=10.1038%2Fncomms14909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface</span></div><div class="casAuthors">Tang, Hao Ran; Leung, Leo; Saturno, Grazia; Viros, Amaya; Smith, Duncan; Di Leva, Gianpiero; Morrison, Eamonn; Niculescu-Duvaz, Dan; Lopes, Filipa; Johnson, Louise; Dhomen, Nathalie; Springer, Caroline; Marais, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14909</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lysyl oxidase (LOX) remodels the tumor microenvironment by crosslinking the extracellular matrix.  LOX overexpression is assocd. with poor cancer outcomes.  Here, we find that LOX regulates the epidermal growth factor receptor (EGFR) to drive tumor progression.  We show that LOX regulates EGFR by suppressing TGFβ1 signalling through the secreted protease HTRA1.  This increases the expression of Matrilin2 (MATN2), an EGF-like domain-contg. protein that traps EGFR at the cell surface to facilitate its activation by EGF.  We describe a pharmacol. inhibitor of LOX, CCT365623, which disrupts EGFR cell surface retention and delays the growth of primary and metastatic tumor cells in vivo.  Thus, we show that LOX regulates EGFR cell surface retention to drive tumor progression, and we validate the therapeutic potential of inhibiting this pathway with the small mol. inhibitor CCT365623.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjI8odBCa4OLVg90H21EOLACvtfcHk0lhhctYVpofroA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFKgtbw%253D&md5=d0db599dc8344c8685196f6d289fd3cf</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fncomms14909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14909%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DH.%2BR.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DSaturno%26aufirst%3DG.%26aulast%3DViros%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DDi%2BLeva%26aufirst%3DG.%26aulast%3DMorrison%26aufirst%3DE.%26aulast%3DNiculescu-Duvaz%26aufirst%3DD.%26aulast%3DLopes%26aufirst%3DF.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DDhomen%26aufirst%3DN.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DLysyl%2520Oxidase%2520Drives%2520Tumour%2520Progression%2520by%2520Trapping%2520EGF%2520Receptors%2520at%2520the%2520Cell%2520Surface%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26doi%3D10.1038%2Fncomms14909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grippi-Vallotton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkinstall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Church, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halazy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotteland, J.-P.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">6921</span>– <span class="NLM_lpage">6934</span>, <span class="refDoi"> DOI: 10.1021/jm031112e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031112e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCmsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6921-6934&author=T.+R%C3%BCckleauthor=M.+Biamonteauthor=T.+Grippi-Vallottonauthor=S.+Arkinstallauthor=Y.+Cambetauthor=M.+Campsauthor=C.+Chabertauthor=D.+J.+Churchauthor=S.+Halazyauthor=X.+Jiangauthor=I.+Martinouauthor=A.+Nicholsauthor=W.+Sauerauthor=J.-P.+Gotteland&title=Design%2C+Synthesis%2C+and+Biological+Activity+of+Novel%2C+Potent%2C+and+Selective+%28Benzoylaminomethyl%29thiophene+Sulfonamide+Inhibitors+of+c-Jun-N-Terminal+Kinase&doi=10.1021%2Fjm031112e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase</span></div><div class="casAuthors">Rueckle, Thomas; Biamonte, Marco; Grippi-Vallotton, Tania; Arkinstall, Steve; Cambet, Yves; Camps, Montserrat; Chabert, Christian; Church, Dennis J.; Halazy, Serge; Jiang, Xuliang; Martinou, Isabelle; Nichols, Anthony; Sauer, Wolfgang; Gotteland, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">6921-6934</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several lines of evidence support the hypothesis that c-Jun N-terminal kinases (JNKs) play a crit. role in a wide range of disease states including cell death (apoptosis)-related and inflammatory disorders (epilepsy, brain, heart and renal ischemia, neurodegenerative diseases, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel syndrome).  The screening of a compd. collection led to the identification of a 2-(benzoylaminomethyl)thiophene sulfonamide (AS004509, I) as a potent and selective JNK inhibitor.  Chem. and structure-activity relationship (SAR) studies performed around this novel kinase-inhibiting motif indicated that the left and central parts of the mol. were instrumental to maintaining potency at the enzyme.  Accordingly, we investigated the JNK-inhibiting properties of a no. of variants of the right-hand moiety of the mol., which led to the identification of 2-(benzoylaminomethyl)thiophene sulfonamide benzotriazole (AS600292, II), the first potent and selective JNK inhibitor of this class which demonstrates a protective action against neuronal cell death induced by growth factor and serum deprivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMEEwsmNwmprVg90H21EOLACvtfcHk0lg3gDU4afWuhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCmsLzL&md5=0a0eab4608e2051c4881a453a9f1e5e4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm031112e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031112e%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DBiamonte%26aufirst%3DM.%26aulast%3DGrippi-Vallotton%26aufirst%3DT.%26aulast%3DArkinstall%26aufirst%3DS.%26aulast%3DCambet%26aufirst%3DY.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DChurch%26aufirst%3DD.%2BJ.%26aulast%3DHalazy%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMartinou%26aufirst%3DI.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DSauer%26aufirst%3DW.%26aulast%3DGotteland%26aufirst%3DJ.-P.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Activity%2520of%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520%2528Benzoylaminomethyl%2529thiophene%2520Sulfonamide%2520Inhibitors%2520of%2520c-Jun-N-Terminal%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6921%26epage%3D6934%26doi%3D10.1021%2Fjm031112e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapadar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiran Kumar, S.</span></span> <span> </span><span class="NLM_article-title">Cyclic Trimer of 5-(Aminomethyl)-2-furancarboxylic Acid as a Novel Synthetic Receptor for Carboxylate Recognition</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1317</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)02367-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1016%2FS0040-4039%2801%2902367-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslGrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1317-1320&author=T.+K.+Chakrabortyauthor=S.+Tapadarauthor=S.+Kiran+Kumar&title=Cyclic+Trimer+of+5-%28Aminomethyl%29-2-furancarboxylic+Acid+as+a+Novel+Synthetic+Receptor+for+Carboxylate+Recognition&doi=10.1016%2FS0040-4039%2801%2902367-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic trimer of 5-(aminomethyl)-2-furancarboxylic acid as a novel synthetic receptor for carboxylate recognition</span></div><div class="casAuthors">Chakraborty, Tushar K.; Tapadar, Subhasish; Kiran Kumar, S.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1317-1320</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A novel 18-membered cyclic oligopeptide based on 5-(aminomethyl)-2-furancarboxylic acid (Faa) is developed as an excellent receptor for carboxylate binding having an assocn. const. of 8.64×103 M-1 for tetrabutylammonium acetate in CD3CN.  The synthesis of cyclo(Faa)3 was achieved by a high-yielding cyclotrimerization reaction of the unfunctionalized furan amino acid Faa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1gkOv4AkqE7Vg90H21EOLACvtfcHk0lg3gDU4afWuhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslGrtA%253D%253D&md5=40b048ee9f47adb611374ee7158d0ed4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2902367-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252902367-X%26sid%3Dliteratum%253Aachs%26aulast%3DChakraborty%26aufirst%3DT.%2BK.%26aulast%3DTapadar%26aufirst%3DS.%26aulast%3DKiran%2BKumar%26aufirst%3DS.%26atitle%3DCyclic%2520Trimer%2520of%25205-%2528Aminomethyl%2529-2-furancarboxylic%2520Acid%2520as%2520a%2520Novel%2520Synthetic%2520Receptor%2520for%2520Carboxylate%2520Recognition%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D1317%26epage%3D1320%26doi%3D10.1016%2FS0040-4039%2801%2902367-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span>; <span class="NLM_string-name">Ando, T.</span>; <span class="NLM_string-name">Yamamoto, Y.</span>; <span class="NLM_string-name">Imai, T.</span>; <span class="NLM_string-name">Kubota, D.</span>; <span class="NLM_string-name">Noguchi, K.</span>; <span class="NLM_string-name">Hori, N.</span>; <span class="NLM_string-name">Shitara, E.</span>; <span class="NLM_string-name">Atsumi, K.</span>; <span class="NLM_string-name">Yasuda, S.</span></span> <span> </span><span class="NLM_article-title">Intermediate for 2-Substituted Carbapenem Derivative and Production Process</span>. <span class="NLM_patent">WO2004/055027</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=T.+Sasaki&author=T.+Ando&author=Y.+Yamamoto&author=T.+Imai&author=D.+Kubota&author=K.+Noguchi&author=N.+Hori&author=E.+Shitara&author=K.+Atsumi&author=S.+Yasuda&title=Intermediate+for+2-Substituted+Carbapenem+Derivative+and+Production+Process"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DT.%26atitle%3DIntermediate%2520for%25202-Substituted%2520Carbapenem%2520Derivative%2520and%2520Production%2520Process%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+Substructure+Filters+for+Removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+Screening+Libraries+and+for+Their+Exclusion+in+Bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lh8OHLSr7KF8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520Substructure%2520Filters%2520for%2520Removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520Screening%2520Libraries%2520and%2520for%2520Their%2520Exclusion%2520in%2520Bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shackleton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulmes, D. J.</span></span> <span> </span><span class="NLM_article-title">Purification of Lysyl Oxidase from Piglet Skin by Selective Interaction with Sephacryl S-200</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1970238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A528%3ADyaK3cXhslCmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1990&pages=917-919&author=D.+R.+Shackletonauthor=D.+J.+Hulmes&title=Purification+of+Lysyl+Oxidase+from+Piglet+Skin+by+Selective+Interaction+with+Sephacryl+S-200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of lysyl oxidase from piglet skin by selective interaction with Sephacryl S-200</span></div><div class="casAuthors">Shackleton, David R.; Hulmes, David J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">917-19</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">A method is described for the purifn. of piglet skin lysyl oxidase from a crude urea ext. by 2 simple chromatog. procedures.  The method relies on the selective interaction between Sephacryl S-200 and lysyl oxidase that occurs in the absence of urea and in conditions of low ionic strength.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0gfvaIRXl-7Vg90H21EOLACvtfcHk0lh8OHLSr7KF8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhslCmtbg%253D&md5=368284c6cadb0ec2fe7f11d6c5e8f8f0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShackleton%26aufirst%3DD.%2BR.%26aulast%3DHulmes%26aufirst%3DD.%2BJ.%26atitle%3DPurification%2520of%2520Lysyl%2520Oxidase%2520from%2520Piglet%2520Skin%2520by%2520Selective%2520Interaction%2520with%2520Sephacryl%2520S-200%26jtitle%3DBiochem.%2520J.%26date%3D1990%26volume%3D266%26spage%3D917%26epage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balmain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNally, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohas, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierrepoint, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowlatt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, T. C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia</span>. <i>Lab. Anim.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1258/002367788780746467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=10.1258%2F002367788780746467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=3172698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;key=1%3ACAS%3A280%3ADyaL1M%252Fht1ymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1988&pages=195-201&author=P.+Workmanauthor=A.+Balmainauthor=J.+A.+Hickmanauthor=N.+J.+McNallyauthor=A.+M.+Rohasauthor=N.+A.+Mitchisonauthor=C.+G.+Pierrepointauthor=R.+Raymondauthor=C.+Rowlattauthor=T.+C.+Stephens&title=UKCCCR+Guidelines+for+the+Welfare+of+Animals+in+Experimental+Neoplasia&doi=10.1258%2F002367788780746467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">UKCCCR guidelines for the welfare of animals in experimental neoplasia</span></div><div class="casAuthors">Workman P; Balmain A; Hickman J A; McNally N J; Rohas A M; Mitchison N A; Pierrepoint C G; Raymond R; Rowlatt C; Stephens T C</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory animals</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">195-201</span>
        ISSN:<span class="NLM_cas:issn">0023-6772</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpbCFa3IXp3kcLvDNbOD4DfW6udTcc2eZCV3pVDUJNbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M%252Fht1ymtA%253D%253D&md5=632d4a2f5869b721721884546190da34</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1258%2F002367788780746467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252F002367788780746467%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DHickman%26aufirst%3DJ.%2BA.%26aulast%3DMcNally%26aufirst%3DN.%2BJ.%26aulast%3DRohas%26aufirst%3DA.%2BM.%26aulast%3DMitchison%26aufirst%3DN.%2BA.%26aulast%3DPierrepoint%26aufirst%3DC.%2BG.%26aulast%3DRaymond%26aufirst%3DR.%26aulast%3DRowlatt%26aufirst%3DC.%26aulast%3DStephens%26aufirst%3DT.%2BC.%26atitle%3DUKCCCR%2520Guidelines%2520for%2520the%2520Welfare%2520of%2520Animals%2520in%2520Experimental%2520Neoplasia%26jtitle%3DLab.%2520Anim.%26date%3D1988%26volume%3D22%26spage%3D195%26epage%3D201%26doi%3D10.1258%2F002367788780746467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i133"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00335">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_13202"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00335">10.1021/acs.jmedchem.9b00335</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings of all final inhibitors (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00335/suppl_file/jm9b00335_si_001.csv">CSV</a>)</p></li><li><p class="inline">Experimental procedures and characterization data for synthetic intermediates, compounds <b>11a</b>, <b>11b</b>, <b>15</b>, <b>16</b>, <b>19</b>, <b>22c</b>, <b>22d</b>, <b>22e</b>, <b>23c</b>, <b>23d</b>, <b>23e</b>, <b>24c</b>, <b>24d</b>, <b>26</b>, <b>27</b>, <b>28</b>, <b>29</b>, <b>30</b>, <b>32</b>, <b>33</b>, <b>36</b>, <b>37</b>, <b>38</b>, <b>39</b>, <b>41</b>, <b>43</b>, <b>45</b>, <b>47</b>, <b>49</b>, <b>52</b>, <b>54</b>, <b>56</b>, <b>58</b>, <b>59</b>, and <b>60</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00335/suppl_file/jm9b00335_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00335/suppl_file/jm9b00335_si_001.csv">jm9b00335_si_001.csv (5.83 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00335/suppl_file/jm9b00335_si_002.pdf">jm9b00335_si_002.pdf (135.33 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00335&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00335%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-12" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00335" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994fa968683ce8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
